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Abstract
Maternal Engineered Nanomaterial Inhalation Exposure: Cardiac Molecular
Reprogramming in Progeny through Epigenetic and Epitranscriptomic Mechanisms

Amina Kunovac

Introduction: Nano-titanium dioxide (TiO2), a prominently utilized engineered nanomaterial
(ENM), is being employed for its physiochemical properties in several fields including the food
industry, manufacturing, and biomedicine. As the prevalence of this ENM, and other particulate
matter grows, so does the concern for antagonistic consequences on long-term heart function in
vulnerable populations, which until now have not been investigated. Due to the reliance of the
heart on the ATP generating capacity of mitochondria for contraction, understanding the role of
mitochondrial bioenergetics and structure is pivotal in understanding the repercussions of
particulate matter exposure during gestation. As the mass population in cities, where particulate
matter exposure is highest, do not have many options for mitigating their exposure, it is of utmost
importance that strategies are developed that limit the detriments associated with xenobiotic
exposure. Understanding the mechanisms, both epigenetic and epitranscriptomic, that regulate
mitochondrial and cardiac function under these circumstances will allow for a better understanding
of potential therapeutic or preventative strategies and mitigate the disease burden related to
particulate matter exposure each year. The purpose of this compilation of work is to identify the
mechanisms contributing to the acute and chronic pathological effects of ENM inhalation exposure
during gestation as a prerequisite to developing strategies to reduce risks to public health.
Methods and Results: Using an inhalation exposure paradigm that mimics the lung burden seen in
an occupational setting, we first examined the effects of maternal nano-TiO2 inhalation exposure
during gestation on the cardiac function of wild type offspring at the fetal (acute) and adult
(chronic) stage using both conventional and speckle tracking stress-strain echocardiographic
assessments. Cardiac contractile function was decreased in both the fetal (gestational day 15 (GD
15)) and the adult (11 weeks) offspring. Assessment of mitochondrial bioenergetic and electron
transport chain (ETC) complex activities revealed a decreased oxygen consumption rate in
offspring and decreased ETC Complex IV at both the fetal and adult stage following maternal
ENM inhalation exposure during gestation. Furthermore ELISA-based assessment of 5methylcytosine (5mC methylation) and Dnmt expression pointed to the involvement of epigenetic
mechanisms in altered mitochondrial and cardiac function. Implementation of a novel breeding
strategy, using a transgenic mouse model that overexpresses mitochondrial phospholipid
hydroperoxide glutathione peroxidase (mPHGPx), an antioxidant enzyme, determined that
enhanced antioxidant expression in the maternal environment can mitigate the effects of
gestational nano-TiO2 inhalation exposure on fetal and adult offspring cardiac and mitochondrial
function. N6-methyladenosine (m6A) was implicated as a modulator of altered mPHGPx activity
following maternal ENM exposure in adult offspring, suggesting that epitranscriptomics also has
a regulatory role in the adverse effects of particulate matter exposure.

Conclusions: The work presented in this presentation demonstrates the ability for ENM inhalation
exposure during gestation to alter cardiac function through a mechanism that involves altering
mitochondrial function and elevating ROS levels. These studies also provide evidence that there
is likely overlap and interplay between epitranscriptomic and epigenetic mechanisms that
contribute to changes in the mitochondrial proteome that reduces the ability of the mitochondrion
to regulate stress in the form of ROS and leads to dysfunction. Limiting ROS levels through
mitochondrially-targeted antioxidant defense enhancement provides a potential preventative route
that may allow for the evasion of the adverse cardiac outcomes in offspring that are gestationally
exposed to xenobiotics.
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Specific Aims:
Xenobiotic exposure is a causative agent of cardiovascular dysfunction, ensuing as a result
of mitochondrial bioenergetic dysregulation. The implementation of engineered nanomaterials
(ENMs) in consumer products, manufacturing processes, and clinical applications is expanding
rapidly despite our limited understanding of their impacts on human health. Exposure to ENMs
are of particular concern for vulnerable populations such as the developing fetus, which is prone
to deleterious effects that can alter the epigenomic profile and result in sustained dysfunction or
susceptibility to other metabolic disturbances into adulthood. Our laboratory was the first to
evaluate the consequences of maternal ENM inhalation exposure during gestation. The findings of
this study indicated that gestational nano-TiO2 exposure has a detrimental impact on cardiac
contractile function, mitochondrial respiration and bioenergetics that are sustained into adulthood.
The functional deficits seen following ENM inhalation exposure have been attributed to increased
production of reactive oxygen species (ROS), that was ameliorated by overexpression of
mitochondria phospholipid hydroperoxide glutathione peroxidase (mPHGPx), an antioxidant
enzyme that protects cells from oxidative stress. ROS insult has the capacity to induce mRNA
epigenetic modifications, such as 5-methylcytosine or epitranscriptomic changes, such as N6methyladenosine (m6A), which is predicted to occur in a critical region of the 3’ UTR of mPHGPx
and can thus alter mRNA stability. However, there is a paucity of information regarding the effects
of the altered epigenetic/epitranscriptomic mechanisms and whether they are connected to changes
in the mitochondrial proteome in progeny. The studies outlined in this dissertation address these
critical gaps in knowledge and are designed to determine if enhanced antioxidant protection can
provide a protective role to offspring following maternal ENM inhalation exposure and elucidate
the epigenomic remodeling mechanisms that impact development. The long-term goal of these
studies is to identify mechanisms contributing to the pathological effects of xenobiotic exposure
as a prerequisite to developing strategies for reducing risks to public health.

The objectives of this dissertation are to: (1) determine whether maternal engineered nanomaterial
(ENM) inhalation exposure influences progeny cardiac function and epigenomic remodeling (2)
elucidate the impact of mPHGPx overexpression in various contexts on contractile function and
mitochondrial bioenergetics in offspring following maternal ENM inhalation exposure; and (3)

xv

determine whether disruption of mitochondrial bioenergetics and cardiovascular dysfunction
elicited by maternal exposure can be attributed to epitranscriptomic remodeling that is associated
with an altered mitochondrial proteome that is incapable of managing high levels of ROS. My
central hypothesis is that changes in the m6A methylome, concomitant with an altered
mitochondrial proteome at the fetal stage, precipitate cardiac contractile dysfunction that is
sustained into adulthood following maternal ENM inhalation exposure. Sustained dysfunction may
be averted through limiting ROS via overexpression of mPHGPx. Preliminary data from our lab
indicate that ENM exposure results in altered mitochondrial and cardiac contractile function as a
result of elevated ROS levels and diminished antioxidant capacity. Additionally, our laboratory
has shown that following exposure, fetal offspring presented with an altered transcriptome and
changes in DNA histone modifications. We have chosen nano-TiO2 as a representative ENM
because it is widely tested in academic, industrial, and biomedical research. To test our central
hypothesis, we propose three Specific Aims:

Specific Aim 1: Elucidate the effects of maternal nano-TiO2 inhalation exposure on cardiac
contractile function and mitochondrial function in fetal offspring and whether these detriments
persist into adulthood. We will test our working hypothesis that maternal nano-TiO2 inhalation
exposure during gestation may evoke an ROS response resulting in mitochondrial bioenergetic
disruption and cardiac contractile dysfunction in offspring that persists into adulthood.
1.1

Evaluate cardiac contractile function using conventional and speckle tracking stressstrain parameters in fetal (gestational day (GD) 15) and adult (11 weeks) offspring
following maternal nano-TiO2 inhalation exposure during gestation.

1.2

Examine the effects of inhalation nano-TiO2 during gestation on fetal and adult
offspring cardiac mitochondrial bioenergetics and ultrastructure.

1.3

Determine the role of epigenetic modifications and their mediators in modulating
mitochondrial function in offspring maternal nano-TiO2 inhalation exposure during
gestation.

The expected outcomes of Specific Aim 1 are that cardiac function is negatively altered following
gestational ENM inhalation exposure along with mitochondrial dysregulation in fetal and adult
offspring, likely as a result of reprogramming that causes changes in ROS levels.
xvi

Specific Aim 2: Determine whether enhanced mPHGPx expression preserves cardiac contractile
function and bioenergetics in adult offspring following maternal ENM inhalation exposure, and
whether m6A methylation contributes to altered antioxidant capacity. We will test our working
hypothesis that enhanced antioxidant defense at the level of the dam and fetus will provide the
most impactful protection by lessening cardiac contractile dysfunction and bioenergetic disruption
in adult offspring following gestational ENM exposure. The enhanced antioxidant defense will
mitigate the contractile and mitochondrial dysfunction by evading changes to the m6A methylome.
2.1

Determine whether increasing ROS scavenging through mPHGPx expression in
maternal, fetal, or both provides the most protective profile.

2.2

Elucidate whether enhanced antioxidant protection has the ability to mitigate ROS
levels such that cardiac function and mitochondrial activity are restored.

2.3

Ascertain whether m6A plays a role in diminished mitochondrial bioenergetics and
ROS scavenging ability at the adult stage following maternal ENM inhalation exposure
during

gestation

and

whether

mPHGPx

overexpression

ameliorates

these

consequences.
The expected outcomes of Specific Aim 2 are that overexpression of mPHGPx in the fetus
combined with the overexpression of mPHGPx in the pregnant dam will provide the most
protective profile, thereby lowering mitochondrial ROS levels, ameliorating mitochondrial
dysregulation, and preserving proper cardiac function following maternal ENM inhalation
exposure.

Specific Aim 3: Evaluate the epitranscriptomic changes and the mechanism associated with
increased ROS following maternal ENM inhalation exposure that contribute to mitochondrial and
cardiac dysfunction at the fetal stage. We will test our working hypothesis that nuclear and changes
to the epitranscriptome of mitochondrial genes following maternal ENM inhalation exposure
contribute to cardiac dysfunction at the fetal stage that persists into adulthood as a result of altered
regulator expression.

xvii

3.1

Explicate the repercussions of maternal nano-TiO2 inhalation exposure during
gestation on the overall m6A methylome in wild type fetal offspring to determine the
role of epitranscriptomics in diminished cardiac function.

3.2

Elucidate how maternal nano-TiO2 inhalation exposure during gestation alters the
mitochondrial proteome in wild type fetal offspring and whether these changes are
associated with epitranscriptomic reprogramming.

The expected outcomes of Specific Aim 3 are that changes in m6A of crucial nuclear-encoded
mitochondrial mRNA will correlate with a deficient mitochondrial proteome that can account for
diminished mitochondrial bioenergetics that occurs in fetal offspring following gestational ENM
exposure and contributes to the long-term cardiac effects that also persist into adulthood.

With respect to the overall expected outcomes, successful completion of these studies will provide
fundamental information concerning the relationship between epigenetic/epitranscriptomic
regulation during the critical window of fetal development and the subsequent long-term
cardiovascular effects. The information will aid in the design of protective antioxidant strategies
and assessment of consumer risks to ensure safer development of nanotechnologies.

xviii

RESEARCH STRATEGY
SIGNIFICANCE. While nanotechnology has provided important advancements in biomedical
engineering, the increased interactions of nanomaterials and biological tissue warrants assessments
of associated toxicological effects (2, 4, 16). Engineered nanomaterials (ENMs) pose occupational
and public risks due their abundance in consumer products (17, 20) and the primary route of
exposure, inhalation, allows particles to enter the bloodstream and systemically impact the body
(20). Nano titanium dioxide (TiO2), one of the most utilized ENMs, is incorporated into versatile
industrial, environmental, and consumer products (17), with application in consumer products
escalating by 300% from 2011 to 2013 (22). Maternal ENM exposure during gestation interferes
with fetal development and has long-term consequences for offspring that persist into adulthood
(2, 4, 11, 21). Over the last decade, the developmental origins of health and diseases (DOHaD)
hypothesis has increased emphasis on understanding how parental exposure to environmental
stressors can alter the susceptibility of offspring to various diseases including obesity (24).
Currently, 40% of all adults (over the age of 20) in the United States are obese (8), which is one
of the top risk factors for heart disease. Cardiovascular disease is the leading cause of death,
accounting for every 1 in 4 deaths in the US (1). Understanding the risk factors that increase the
propensity for developing cardiovascular disease and how they can be prevented is critical in
lowering the associated death toll.

Previous studies, in conjunction with preliminary data presented in this application, provide
the scientific premise for the proposed experimentation. Our laboratory was the first to report
sustained (into adulthood) cardiac contractile dysfunction following maternal nano-TiO2
inhalation exposure during gestation (10, 19). These effects were associated with disruption to the
fetal cardiac epigenome, dysregulated mitochondrial bioenergetics, and decreased mPHGPx
expression levels in offspring. Increased reactive oxygen species (ROS) generation indicated
oxidative stress following acute ENM inhalation exposure (15), which could be linked to cardiac
contractile dysfunction through epigenomic changes such as DNA methylation and posttranslation histone modifications (12). These data support the proposition that targeted
interventions lessening ROS during gestation may provide relief from the damaging effects of
ENMs. Elevated ROS has also been associated with altered levels of N6-methyladenosine (m6A),
the most prevalent mRNA modification in higher eukaryotes, which regulates transcription and
xix

translation (13, 23, 26). Investigation of m6A sites in crucial coding regions of nuclear genomeencoded mitochondrial mRNA that are pivotal in antioxidant defense is therefore pertinent as it
will provide insight into the mechanism by which ROS may be controlling mPHGPx protein
expression. Further, understanding the repercussions of early-life exposure in terms of
susceptibility to obesity and other metabolic diseases, such as diabetes, mellitus is critical, as
epigenomic adaptations may alter the ability of an organism to cope with a secondary insult (7).
Maternal exposure to particulate matter, as it relates to the susceptibility of offspring to develop
obesity, have previously been investigated in several epidemiological studies (3, 5, 6, 14, 24). All
in all, the previous studies suggest a critical need for understanding the epigenetic mechanisms
involved in developmental reprogramming that causes such detriments. Our laboratory has shown
that in mice, following a single ENM inhalation exposure, fatty acid metabolism has been impacted
(9, 10). Additionally, diminished m6A methylation has been demonstrated in diabetic patients,
concomitant with elevated fat mass and obesity-associated (FTO) protein expression, a well
characterized m6A demethylase (18, 25).

The contribution of this work is significant because it will identify epitranscriptomic mechanisms
contributing to the cardiovascular deficits elicited by ENM exposure as a prerequisite for assessing
consumer and occupational risks. Additionally, this work will determine the benefit of enhanced
antioxidant defense in attenuating cardiac dysfunction associated with ENM exposure. This
information will be critical as we consider public health risks of nanotechnology, while aiding in
the development of biomarkers and prophylactic strategies to lessen cardiovascular complications
associated with ENM inhalation exposure. The proposed research is conceptually and
mechanistically innovative because it is the first study to propose m6A modifications as a
contributing cause of cardiac dysfunction elicited by ENM inhalation exposure. The proposed
research is technically innovative in its application of echocardiographic imaging of offspring in
utero and application of a transgenic mouse model that overexpresses mPHGPx as an antioxidant
protective strategy to prevent mitochondrial and cardiac deficits in progeny following maternal
ENM inhalation exposure. Understanding the epitranscriptomic changes that occur and
establishing a therapeutic approach that may attenuate elevated ROS and its associated detriments,
enhances the impact of the studies.
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Abstract:
Ambient air, occupational settings, and the use and distribution of consumer products all serve as
conduits for toxicant exposure through inhalation. While the pulmonary system remains a primary
target following inhalation exposure, cardiovascular implications are exceptionally culpable for
increased morbidity and mortality. The epidemiological evidence for cardiovascular dysfunction
resulting from acute or chronic inhalation exposure to particulate matter has been well
documented, but the mechanisms driving the resulting disturbances remain elusive. In the current
review, we aim to summarize the cellular and molecular mechanisms that are directly linked to
cardiovascular health following exposure to a variety of inhaled toxicants. The purpose of this
review is to provide a comprehensive overview of the biochemical changes in the cardiovascular
system following particle inhalation exposure and to highlight potential biomarkers that exist
across multiple exposure paradigms. We attempt to integrate these molecular signatures in an
effort to provide direction for future investigations. This review also characterizes how molecular
responses are modified in at-risk populations, specifically the impact of environmental exposure
during critical windows of development. Maternal exposure to particulate matter during gestation
can lead to fetal epigenetic reprogramming, resulting in long-term deficits to the cardiovascular
system. In both direct and indirect (gestational) exposures, connecting the biochemical
mechanisms with functional deficits outlines pathways that can be targeted for future therapeutic
intervention. Ultimately, future investigations integrating “omics” based approaches will better
elucidate the mechanisms that are altered by xenobiotic inhalation exposure, identify biomarkers,
and guide in clinical decision making.
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Introduction
Irrespective of diet, physical fitness, or other controllable risk factors, the quality and
contents of the air we breathe are often unavoidable. In industrial cities and large metropolitan
areas, the most pervasive mode of exposure to aerosolized toxicants is through the ambient air.
Long term exposure to ambient air pollution contributes to 7.6% of global mortality, with 91% of
the world’s population residing in places where air quality exceeds the guideline limits put forth
by the World Health Organization (WHO) (31, 171, 172). The number of annual premature deaths
as a result of outdoor air pollution are staggering, with projections indicating 6-9 million deaths in
2060 (18, 121). Subsequently, the predicted economic costs are increasing substantially as a
repercussion of the illnesses resulting from exposure (121). The importance of lowering ambient
fine particulate matter exposure is highlighted specifically by the notion that if all countries met
the WHO Air Quality Guidelines, life expectancy could increase by over 7 months (2). This
becomes a daunting task with increasing urbanization (171) and implementation of nanoparticles
for their advantageous physical, chemical, and biological properties in industrial, commercial and
medical sectors (136).
There are numerous factors that contribute to the diminishing air quality including
industrial sources, energy power plants, traffic, agriculture, and fires (37, 80, 142). Particulate
matter (PM) is the sum of all organic and inorganic compounds dispersed in the solid and liquid
phases that can be carried by air (22, 81). PM components are typically categorized by particle
size including coarse (PM10; ≤10 µm in diameter), fine (PM2.5; ≤2.5 µm in diameter), and ultrafine
(UFP, PM0.1; ≤0.1 µm in diameter) particles. However, the surface area, chemical composition,
number, solubility and reactivity are some of the other characteristics that must be considered (16,
22, 106, 148). Decreasing the size of particulates from PM10 to PM2.5 increases the capacity for
the material to travel further into the bronchoalveolar airways and allows for a broader interaction
area (53, 175). Similar to PM2.5, UFP, also have the capacity to penetrate deeply into the alveoli
of the tracheobronchial airways (117, 150), but UFP exhibit an increased capacity for
interstitialization and can transport systemically throughout the body due to their high surface-tovolume ratios (22, 40, 106, 117, 148). Because the bulk of cardiovascular effects originate from
fine PM and nanoparticles (53, 144), this review will focus on PM2.5, UFP, and engineered
nanomaterials (ENM).
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ENM (at least one dimension ≤100 nm in diameter), which are similar in size to UFP, are
anthropogenic materials that pose additional risk to public cardiovascular health (82, 125, 136,
146). Nanomaterials represent an ever-increasing vehicle for inhalation toxicology (85). Whether
during the manufacturing of nanomaterials (85) or in consumer use (113), production and rate of
application continue to rise (7, 68). While inhalation studies examining ENMs and UFP typically
differ in the number and standardization of compounds found within the mixtures, both share
commonality in the nanometer scale that permits similar dispersion within the lungs during
inhalation (148). Nanomaterials, similar to UFP, exist exclusively at a biological scale that alters
the dynamics of interactions with organic matter (112, 157), potentially altering toxicities
compared to their micrometer-sized equivalents (22, 53, 144, 148). One example of ENM, is nanotitanium dioxide (TiO2), which is predominantly used for its photocatalytic properties, like its
ability to refract light and enhance colors. Nano-TiO2 is therefore implemented in products such
as paint pigments, sunscreen, paper, pharmaceuticals, tattoo ink, and water purification systems.
There are specific physicochemical properties of inhaled particles that determine its applications.
The size, composition, pore size, and surface charge and chemistry are some of the main properties
that govern the applicability of inhaled particles (60). In the attempt to understand the biological
effects of inhaled particles, particularly on the cardiovascular system, these varying properties
have posed a challenge such that any attempt to understand an individual particle or co-exposure
would require each particle within the exposure to be purified and characterized based on the many
relevant particle properties. Our laboratory has specifically focused on understanding the
mechanisms associated with nano-TiO2 inhalation exposure. Although the properties of nano-TiO2
may differ from other inhaled particles by size, solubility, porosity, crystallinity, shape, etc., we
utilize this particle as a surrogate to focus on the mechanism that is elicited by almost all inhaled
particle exposures, increased reactive oxygen species (ROS) (61). It is outside the scope of most
studies to identify the unique spectrum of molecular changes that each ENM may produce (14).
Using a surrogate particle is beneficial in that it eliminates the variability introduced when a
mixture of particles is present that contain particulate matter of varying physicochemical
properties.
There are three prevailing theories on the mechanism by which inhaled pollutants result in
deleterious effects on the cardiovascular system (106, 107, 115, 117). The first of these theories
involves inflammation, whereby particles that reach the lungs initiate an inflammatory response
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that leads to the release of cytokines and other mediators that can then be introduced into the
circulation, causing downstream effects (107). The other possibility is that, based on the size of
the particles, they may not only enter the systemic circulation but also translocate across the
alveolar wall and impact the cardiovascular system directly (typically only applies to ultrafine
particles), such as by influencing the vascular endothelium. Lastly, the particles may affect
autonomic regulation and alter the parasympathetic: sympathetic balance through sensory
receptors on the alveolar surface. This can result in changes in heart rate variability and other
parameters of cardiac function. It would be naive to state that one of these specific pathways is
solely responsible for the cardiovascular effects induced by inhaled particle exposure. A more
likely scenario is that all three pathways work in concert, and likely contribute and exacerbate the
effects of each one. For example, an initial inflammatory response may result in tissue damage
that increases permeability and makes it easier for particles to translocate and incite further
damage. Regardless of the initial response within the lungs, understanding the cardiovascular
molecular pathways that exposure mediates is essential for identifying appropriate prophylactic
and/or therapeutic strategies. A potential starting point in developing prophylactic and/or
therapeutic strategies for limiting particle-induced cardiovascular effects would be limiting
reactive oxygen species (ROS) production and dissipation (107). This is instrumental as oxidative
stress has the potential to contribute to all three prevailing theories that explain how inhaled
particles could cause cardiovascular effects and furthermore likely promotes interactions between
the three pathways. Depending on the physicochemical properties of the inhaled particle, the
surface chemicals of the particulate matter (such as special coatings that are utilized for its specific
effects) or other pollutants in the air may interact and result in redox reactions that produce free
radicals. As mentioned previously, inhaled particles can also activate inflammatory cells, which
causes a release of cytokines and oxidative mediators. Lastly, oxidative stress can be a response
from the particle interaction with tissue enzymes like the stimulation of xanthine oxidase or
depletion of antioxidant defenses (107). Due to the high likelihood that ROS is involved in the
cardiovascular effects of inhaled particles, increasing antioxidant protection is a promising
therapeutic strategy that requires further explication.
According to the WHO, over four million people die every year from outdoor air pollution,
with cardiovascular disease accounting for about 40% of those deaths (2, 91, 172). While the
pulmonary system is considered the primary site of interaction with these particles, secondary
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target organs, such as the heart and circulatory system, may be subject to the most detrimental
long-term effects. The overt epidemiological risk of cardiovascular injury following chronic and
acute inhalation exposure to PM2.5, UFP, and ENM has been well documented and includes
increased propensity for ischemic heart disease, heart failure, out-of-hospital cardiac arrests,
arrhythmias, atherosclerosis, and other cardiovascular complications (16, 28, 58, 128-130, 134,
152, 156, 187). The effects of PM inhalation exposure on the heart function of individuals who are
susceptible to cardiovascular disease (CVD) have also gained recent interest. One of the main
points of concern emanates from the increasing rate of patients with diet-induced obesity and type
2 diabetes (24). These populations with metabolic disorders can have further modifications to
insulin-signaling pathways that arise from inhalation exposure, ultimately increasing susceptibility
and aggravating underlying pathophysiology (5, 15, 26, 74, 122, 124, 130).
Among those whom are most vulnerable to the repercussions of inhaled particulates, are
those exposed at a critical point in development, such as during gestation. While the main focus
has been on the effects of toxicant inhalation exposure directly to an individual, recent studies have
highlighted the importance of understanding how exposure during gestation impacts future
progeny (12, 13, 52, 87, 100, 104, 108). Maternal inhalation exposure to particles can affect
offspring through both direct and indirect mechanisms or a combination of the two (41). Direct
effects can ensue if the particle size enables the particulate matter to enter the maternal blood, cross
the placental barrier, and directly damage fetal tissue via inflammatory and oxidative stress
pathways. Indirect mechanisms can occur if the particle inhalation results in deep instillation of
the particle in the lower airways that result in oxidative stress and inflammatory responses.
Subsequently, this response may trigger the release of inflammatory mediators that can reach the
placenta and fetus resulting in short and long-term repercussions. Lastly, it is possible that a similar
response occurs if the particles inhaled reach the placental tissue (even if they are unable to cross
the barrier) and incite an oxidative stress and inflammatory response that compromises the
placental function and thereby causes oxidative stress, inflammation, growth restriction, preterm
birth, as well as cardiovascular and behavioral impairments. It is important to recognize that
maternal inflammation may not directly indicate that fetal inflammation is occurring, but the
placenta may act as a sensor of maternal inflammation and thereby initiate an adaptive response
that causes changes to the fetal environment and potentially reprogramming (41). As per the
developmental origins of health and diseases (DOHaD) hypothesis, a baleful gestational
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environment results in epigenetic alterations and has a notable influence on the health of the
offspring (11, 49). Currently, there are limited studies defining the longitudinal cardiovascular
effects of offspring exposed to inhaled particles during gestation and whether exposure increases
susceptibility to metabolic diseases at a later point in life due to alterations in overlapping pathways
(17, 72). Delineating the long-term effects of inhaled particle exposure on cardiovascular function,
particularly in progeny, along with the molecular mechanisms governing predisposition to CVD
is critical for limiting premature mortality rates. One potential way that is being investigated is
increasing antioxidant protection to evade the cardiovascular defects that are associated with
inhaled particulate matter exposure as the balance of oxidants and antioxidants are critical for
physiological homeostasis. Under normal pregnancy conditions, the maternal environment can
maintain this balance (41). However, because inhaled particles result in excessive amounts of ROS
production through direct and indirect pathways, the intrinsic antioxidant system may not be able
to manage these levels and can thereby result in diminished antioxidant capacity and elevated
oxidative stress. One of the studies that will be discussed in this dissertation, therefore implements
antioxidant protection in different contexts to determine which context will provide the most
protective profile for long-term offspring cardiovascular health.
The compilation of the works presented herein serves to examine the molecular pathways
that are implicated in cardiovascular adaptions to various inhaled particles and attempts to provide
a cohesive framework of how each of these molecular pathways has been evaluated across multiple
models. Summarized findings of these molecular mechanisms for various exposures and exposure
models are presented in Table 1.1. Furthermore, there are limited studies examining the
cardiovascular consequences of gestational PM exposure on progeny. Therefore, this review will
also focus on the effects of PM exposure during gestation on the cardiovascular system in progeny
and highlight the molecular pathways that PM exposure alters during this critical window of fetal
development. The studies discussed also highlight the necessity for unbiased omics approaches in
understanding the indirect mechanisms that play a role in long-term cardiovascular health defects
following inhaled particle exposure (41). The following sections are divided into categories, with
each section interweaving similar molecular pathways/responses to PM inhalation exposure.
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Study

Findings

Model

(6)

Fine PM2.5 and coarse PM decreased Alu and
TLR4 methylation, respectively
No changes seen in inflammatory markers related
to PM2.5 exposure (monocytes, TNF-α, IL-10, IL6, IL-8, IL-1β)
PM2.5 exposure was associated with mtDNA DLoop methylation in peripheral blood leukocytes
Elemental carbon (48 genes), PM2.5 (49 genes), and
organic carbon (260 genes) differentially effected
the transcriptome
PM2.5 increased STAT3, which promoted
microRNA-21 expression, leading to decreased
TIMP3 and increased MMP9
PM2.5 reduced intracellular Ca2+ via decreased
RYR2 and increased SERCA2a
PM2.5 exposure with vitamin E and omega-3
polyunsaturated
fatty
acid
administration
decreased inflammation (TNF-α, IL-1β, IL-6)
Increased LINE-1 methylation with increasing
dose of PM2.5
PM2.5 increasing concentration was associated with
decreasing levels of ET-1 (negatively) and PF-4
(positively).

15 local participants

Exercise during DE (PM2.5) exposure decreased
ET-1 and increased NOx, but was not modified by
exercise intensity
PM2.5 increased expression of ICAM-1, VCAM,
and CRP in sedentary mice, and increased VCAM
in exercised mice
PM2.5 decreased VEGF-induced Akt/eNOS
phosphorylation and circulating levels of Flk1+/Sca-1+ cells (EPCs)
PM2.5
reduced
insulin
stimulated
Akt
phosphorylation and circulating levels of Flk1+/Sca-1+ cells (EPCs), elevated oxidative stress
(SOD2,GST-P), caused inflammasome activation
(IL-1β, pro-IL-18 cleavage , activation of Casp-1)
PM2.5 decreased insulin-stimulated Akt/eNOS
phosphorylation and IĸBα, antioxidant treatment
attenuated vascular insulin resistance and
inflammation
PM2.5 increased phospho-EGFR (Tyr1068),
phospho-Akt (Thr308), NLRP3, NF-κB-p52/p100,
and NF-κB-p65 in heart, as well as CXCL1, IL-6,
IL-18, and NLRP12 mRNA
PM2.5 decreased SOS1, CREB, GSK3b, and GRB2
expression, fucoidan treatment rescued all but
CREB levels.
PM2.5
caused
mitochondrial
size/cristae
deformation (increased FIS1, MFN1, MFN2,
DRP1, OPA1), inflammation (increased TNF-α,
IL-6, IL-1β), decreased SOD, increased MDA and
iNOS
PM2.5 increased Caspase-3, Bax, Bcl-2 in heart,
and NF-ĸB in cardiac myocytes
Acute PM2.5 exposure decreased 5-mC methylation
and DNMT1 mRNA expression in heart and blood.
Chronic PM2.5 exposure decreased these factors
only in blood
PM2.5 increased inflammation, high intensity
exercise stimulates reduced inflammation
(eHSP70)
DEP (PM2.5) increased PAI-1, fibrinogen, lipid
peroxidation, IL-6. Nootkatone pretreatment
alleviated all and reduced thrombosis with
increased Nrf2 and HO-1 activation.
PM2.5 exposure in atherosclerosis model increased
MDA and NOX-4 subunits (p22phox, p47phox) in
cardiac tissue
PM2.5 exposure was associated with elevated levels
of CD14+, CD16+, CD4+, CD8+, endothelial
microparticles (annexin V+ /CD41-/CD31+), antiangiogenic (TNFα, IP-10) and pro-inflammatory
cytokines (MCP-1, MIP-1α/β, IL-6, IL-1β), and
sICAM-1, sVCAM-1 as well as decreased proangiogenic growth factors (EGF, sCD40L, PDGF,
RANTES, GROα, and VEGF).
PM2.5 increased fibrosis (Col1a1, Col3a1),
oxidative stress (NOX-4), transcription factor
binding (TGFβ1, SMAD3)

18 male participants

Exposure

PM2.5
(17)

(19)
(30)

(33)

(38)
(39)

(44)
(51)

(56)

(59)

(62)

(63)

(64)

(79)

(93)

(95)

(98)
(99)

(103)

(114)

(123)

(127)

(131)

25 healthy male and female
participants 18-50 years old
48 male participants
63 pick-up and delivery drivers
and dock workers
Male Sprague Dawley rats, 6
wks old
Male Balb/c mice, 6–8 wks old
Sprague Dawley rats, 6–8 wks
old
66 male participants
15 young, healthy,
smoking subjects

non-

Male ob/ob mice, 12 wks old

C57BL/6J male mice, 8–12 wks
old
C57BL/6J male mice, 8 wks old
(control/high-fat
diet),
C57BL/6J male mice, 12 wks
old (control diet, pre-treated
with Metformin/Rosiglitazone
C57BL/6J male mice, 12 wks
old (control/high-fat diet), pretreated with TEMPOL

PM2.5 collected in downtown Toronto. Administered 250
and 200 μg/m3 per session
PM2.5 data obtained from Dearborn, Tecumesh, and Dexter,
MI. 3 sub-acute integrated 5-day-long exposure periods in
Dearborn, MI (mean concentration of 11.5 ± 4.8 µg/m-3)
PM2.5 collected January 2007 to June 2012 in Boilermaker
Union Local 29, Quincy, MA
PM2.5 collected February 2009 and October 2010 from 10
trucking terminals in the northeastern US (CT, MA, MD,
NJ, NY, and PA).
PM2.5 collected in Beijing, China. Trachea drip, 4 mg/kg
b.w. every 3 days for 36 days
PM2.5 collected Hebei, China. Intratracheal instillation of
0.5 mg at Day 0 and Day 2
PM2.5 collected May–September 2015 in Shanghai, China.
Intratracheal instillation every other day, for 6 days at 10
mg/kg b.w or 1.5 mL/kg b.w.
PM2.5 collected (pre and post-welding shift) January 2010–
June 2012 in Boilermaker Union Local 29, Quincy, MA
PM2.5 ambient air concentrations in Utah Valley from 2
monitoring sites (Lindon, North Provo) measured daily
(January–March 2009). Blood collections done during high
(PM2.5 >40 µg/m3), moderate (PM2.5 ~ 20–40 µg/m3), and
low (PM2.5 <10 µg/m3) concentrations.
PM2.5 collected a 5.5-kW diesel engine under a constant 2.5
kW load. Exposure of 300 μg/m3 over 6/30-minute low and
high intensity cycling periods
PM2.5 collected Columbus, OH. Average 32 μg/m3 for 6
hrs/day, 5 days/week for 9 months through a whole-body
inhalation system
PM2.5 collected June 2009 and December 2010 in
Louisville, KY. Whole-body exposure, 6 hr/day for 4-30
days at 30-100 μg/m3
PM2.5 collected June 2009 and December 2010 in
Louisville, KY. Whole-body exposure, 6 hr/day for 9 or 30
days at 30-120 μg/m3

PM2.5 collected June 2009 and December 2010 in
Louisville, KY. Whole-body exposure, 6 hr/day for 9 or 30
days at 30-120 μg/m3

BALB/c mice, 6–8 wks old

PM2.5 collected November 2014 in a major city of central
China. Intratracheal instillation of 4.0 mg/kg b.w. for 5
consecutive days.

C57BL/6J mice, 8 wks old

PM2.5 collected November–December 2016 in Taipei,
Taiwan. 100μg/m3, 28 days, 6 hrs/day

Sprague Dawley rats

PM2.5 collected January 2013 in Taiyuan, China.
Intratracheal instillation of 0.375, 1.5, 6.0, and 24.0 mg/kg
b.w. performed 5 times

Male C57/BL6 mice, 8 wks old

PM2.5 was collected in, Nanjing, China. 10µg PM2.5 (10µl)
twice a week/intranasal instillation.
PM2.5 (collection location not stated), whole-body acute
exposure (24 hrs -PM2.5 dose of 271.8 ± 86.8 µg/m3) and
chronic exposure (140 days-PM2.5 dose of 271.8 ± 86.8
µg/m3)
PM2.5 collected in São Paulo, Brazil, 5 µg nasotropic
instillation daily before exercise 12 wks

C57BL/6J male mice, 7 wks old

Male B6.129SF2/J mice, 30
days old
BALB/C mice, 8 wks old

Male ApoE−/- Tg mice, 8 wks
old

Diesel exhaust particles (DEP) with a geometric mean
aerodynamic diameter of 215 nm from the National
Institute of Standards and Technology, MD, USA.
Intratracheal instillation of 30 μg/mouse
PM2.5 collected June–October 2013 in Shanghai, China
Intratracheal installation at 0 – 30 mg/kg b.w

72 young, healthy, nonsmoking
subjects
(24
individuals per 3 winter/ spring
time periods (2013, 2014, and
2015))

PM2.5 ambient air concentrations in Utah Valley from 3
monitoring sites (Lindon, North Provo, and Spanish Fork)
measured daily. At Lindon and North Provo sites, hourly
PM2.5 concentrations were used to estimate the average
concentration for the ~24-h period before each blood draw

Female C57BL/6, 10 months
and 4 wks old

PM2.5 collected 2012 and 2013 from Taiyuan, Northern
China. 3 mg/kg. b.w. PM2.5 oropharyngeal aspiration every
other day for 4 wks
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CAPs exposure increased 7-KCh in plasma and
aortic plaques, and increased CD36 expression in
plaque-macrophages and CD36 uptake of oxidized
lipids
12.4% decrease in RHI for every 10µg/m3 increase
in PM2.5. IsoP, angiopoietin 1, VEGF, PlGF,
MMP-9, ICAM-1 positively associated with
10µg/m3 increases in PM2.5, decreased VCAM-1.
PM2.5 increased Hsp-70, HO-1, MPO in heart as
well as laminin, collagen, and calcium signaling
proteins (181 upregulated, 178 downregulated
genes)
TRPA1
activation
increases
negative
cardiovascular responses to CAPs exposure
through myocardial dyssynchrony.
PM2.5 exposure increased oxidative stress (PRNP)
and endoplasmic reticulum stress (GRP78).
Nanoparticles found in myocardial ER and in
abnormal mitochondria
PM2.5 increased fibrosis and collagen genes, and
oxidative stress (8-OHdg and 4-HNE), reduced
antioxidant genes (PRDX5)
PM2.5 exposure in hyperlipidemic rats increased
CRP, JNK and P53 phosphorylation, and increased
Bax and Caspase-3 in the heart, decreased SOD
Higher PM2.5 resulted in myosin heavy chain
isoform switch (increased β-MHC) and decreased
SERCA2a
PM2.5 increased MDA, iNOS activity, TNF-α, IL1β, along with NOX4 and NOX subunits as
p67phox, p47phox and p22phox in the heart and reduced
SOD activity
PM2.5 decreased GSH-Px, increased MDA and
sICAM-1. SeY treatment reduced inflammation
markers (TNF-α, IL-1β, sICM-1)
PM2.5 exposure in diabetic model induced NF-ĸB,
COX-2, MAPK in heart, IĸB inhibitor restored
function through NF-ĸB reduction
PM2.5 increased DNA damage (increased OGG1
and GADD153, decreased MTH1and XRCC1) in
the heart and decreased SOD
Higher PM2.5 correlated with increased blood
TLR2 methylation, flavonoid intake decreased
TLR2 methylation

ApoE−/− Tg and LDLR−/− Tg
mice, 8 wks old

Concentrated ambient PM2.5 collected in Columbus, OH.
Mice xposed for 6 months to 9.1±7.3 μg/m3

100
male
and
female
participants (44% had type 2
diabetes, 52% had diagnosis of
hypertension)
Male BALB/c mice, 7–8 wks
old

PM2.5 levels obtained from 5 monitoring stations in
Jefferson County, KY (June 2011–May 2013) with average
concentration of 11.45µg/m3.

PM2.5 exposure increased GATA4, NKX2-5 and
inflammatory markers (TNF-α and IL-1β)
homocysteine exacerbates these effects
DE PM2.5 caused promoter methylation of
microRNA-133a-2 in progeny and cardiovascular
stress decreased microRNA 133a-2 expression
PM2.5
preconception
exposure
increased
inflammatory markers (IL‐6, IL‐15, NFқB, CRP,
CD26E, CD26P, VCAM-1, MCP-1), fibrosis
(Col3a1), Ca2+ regulation (SERCA2a, p‐PLN),
and altered epigenetics (DNMT1↓, SIRT1↑,
SIRT2↑)
PM2.5 induced changes in calcium dynamics by
decreasing NCX and CaV1.2

Female Sprague Dawley rats,
10 wks old, neonatal progeny

PM2.5 decreased SIRT1, SIRT2, increased
DNMT1, DNMT3a, DNMT3b, decreased Ca2+
markers (NCX, p-PLN, SERCA2a) and increased
IL-1 β, IL-6, Col-1, MMP9, MMP13A
PM2.5 caused a dose-dependent increase of OPA1,
MFN1, DRP1, and FIS1 in progeny.

Female FVB mice, 12 wks old
12 wk-old progeny

(174)

PM2.5
increased
histone
acetyltransferase
(H3K9ac), GATA4, and MEF2c. Exposure also
increased histone acetylation of GATA4/MEF2c
promoters

Female C57BL/6 mice, 12 wks
old, 1 day and 16 wk-old
progeny

(4)

UFP exposure increased AT1R protein along with
Acta1 and Col3a1 in the heart, with decreased HO1 expression
UCAPs exposure decreased blood plasminogen
and thrombomodulin, increased CRP and SAA.
GSTM1 null participants had worse outcomes

Male Sprague-Dawley rats

(133)

(135)

(140)

(157)

(161)

(165)

(167)

(170)

(173)

(181)

(185)

(186)

(188)

Trpa1tm1Kykw/J (Trpa1−/−) Tg
female mice
30 children and young adults
~20 years old
Male AMPK α2–/– Tg mice, 6–
8 wks old
Male Wistar rats, 8 wks old, on
high-fat diet
C57BL/6 male mice, 8 wks old

C57BL/6 mice, 6–8 wks old

PM2.5 with high PAH, nitrite, and organic carbon levels
collected winter 2008 in an urban site (Milano, Italy).
Intratracheal instillation on days 0, 3 and 6, at 0.3
mg/mouse
PM2.5 collected November–December of 2014 in Triangle
Park, NC. 3 hrs/day, 2 days/week, 8 total whole-body
exposures
PM2.5 data obtained in Mexico City Metropolitan Area
1997-2012

PM2.5 collected April–October 2016 in Beijing, China.
Intratracheal instillation for 6 months at 10 mg/kg
(64µg/m3).
PM2.5 collected October–December 2012 in Beijing, China.
Endotracheal instillation of suspension at 0, 4, 40 mg/kg
Concentrated PM2.5 in Columbus, OH. Mean daily
concentration of PM2.5 in the exposure chamber was 85.3
μg/m3. Mice were exposed for 6 h/d, 5 d/wk, for 9 months.
PM2.5 collected September 2013 in Zhengzhou, Taiwan.
Instilled with 1.5, 3.0, 6.0 mg/kg BW 5 days/wk for 2 wks

Male Sprague Dawley rats, 7
wks old

PM2.5 collected September-November 2015 in Shanghai,
China. Intratracheal instillation at 40 mg/kg

KKay Tg mice, 7 wks old

PM2.5 collected Polaris in Columbus, Ohio. Intratracheal
instillation for 6 hr/day, 5 day/week, 8 weeks at dose of 1.6
mg/kg
PM2.5 containing PAHs collected Taiyuan, China.
Intratracheal instillation of 1.5 mg/kg b.w. PM2.5,
1.6 × 10− 4 mg/kg b.w. 1-NP, 1.2 × 10− 4 mg/kg b.w. 9-NA
PM2.5 data collected from Harvard School of Public Health

Male Wistar rats

Normative Aging Study, 573
participants

Gestational
(27)

(57)

(153)

(154)

(155)

(164)

Female C57BL/6 12–14 wks
old, 12 wk-old progeny
Paternal and maternal FVB
mice exposure – male 12 wkold progeny

Female FVB mice, 12 wks old
14-day old progeny

Female Wistar rats, 10–12 wks
old, 1-day old progeny

PM2.5 collected Fujian, China. Exposed during gestation
and lactation (~42 days) to 36.5 μg/m3 through a wholebody inhalation system.
PM2.5 collected a single cylinder Yanmar diesel engine,
operating at 82% load ∼300 μg/m3 for 6 hrs/day for a total
of 5 days during pregnancy
PM2.5 collected Columbus, OH. Average 38.58 μg/m3 for 6
hrs/day, 5 days/week for 3 months through a whole-body
inhalation system preconception

PM2.5 collected Columbus, Ohio. Exposed 6 hr/day, 5
days/week, average 91.78 μg/m3 through a whole-body
inhalation system during pregnancy
PM2.5 collected Columbus, OH. 6 hr/day, 7 days/week
throughout pregnancy, average 73.61 μg/m3 through a
whole-body inhalation system
PM2.5 collected September 2014 to March 2016 in Harbin,
China. Administered dropwise, 3 doses (0.375 mg/kg, 1.5
mg/kg, and 6.0 mg/kg) during pregnancy
PM2.5 collected Chongqing, China. Gestational exposure
by ultrasonic nebulization, 2 hours a day during pregnancy,
at ~300 µg/m3

UFP

(36)

34 participants with metabolic
syndrome, ~48 years old
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UFP collected north of Mexico City (May–July 2009).
Acute (3 days, 5 hr/day) and sub-chronic (8 weeks, 4
days/week, 5 hr/day) exposure to varying concentrations.
UCAPs collected at US EPA facility Chapel Hill, NC.
Whole-body exposure for 2-hrs at average particle
concentration of 189,000 particles/cm3.

(70)
(90)

(147)

(159)

UFP exposure cause mitochondrial mPTP deficits,
Cyclosporin A resulted in attenuation
TAA-PNC of UFP was positively associated with
CRP and TNFR2 in white non-Hispanic
participants
Elemental carbon UFP exposure increased platelet
CD40L and vWF, and decreased circulating
CD40L
UFCP exposure increased CRP and fibrinogen in
systemic circulation

Male Sprague-Dawley rats
408 individuals
91years old

aged

40-

UFP collected US EPA facility Chapel Hill, NC. 100 μg
UFP laryngopharynx instillation
UFP (near-highway, long-term exposure) Dorchester,
South Boston, Chinatown (Boston)

19 type 2 diabetics, 30-60 years
old, never smoked

UFP particles were generated at 32nm. Elemental carbon
UFP through mouth piece for 2 hr at 50 μg/m3
UFCP exposure at 180µg/m3 in a 24-hour time frame

(183)

Increasing UFCP concentrations prevented the
beneficial effects of captopril in reducing AngII.

Male
spontaneously
hypertensive rats (SHRs), 12–
13 months old
Spontaneously
hypertensive
rats (SHRs), 10 wks old

(109)

UFP exposure induced placental HSD11B2 DNA
methylation, elevated IL-1β, IL-6 and MCP-1, and
caused increased activation of AT1R and ACE

Female C57BL/6J pun/pun mice,
6 wks old. Gestational Day 17.5
progeny

UFP collected in northern Mexico City (April–June 2016).
Intratracheal instillation of12 μg or 400 μg/kg during
pregnancy

(139)

UFP exposure caused higher serum levels of IL-10
in C67BL/6 progeny

Female C57BL/6 and BALB/C
mice. Progeny 0–4 wks old

UFP generated with average mass concentration of 101.94
µg/m3. 24-h daily mean dose of 25 µg/m3 during pregnancy

(54)

Carbon nanoparticle-inhalation, compared to intraarterial injection, was more detrimental to cardiac
tissue with perturbation of inflammatory and
endothelial/epithelial pathways
Nano-TiO2-exposed microRNA-378a Tg mice had
higher MFN1 levels (fusion), and preserved
metabolic profiles and ultrastructure in the heart
Nano-TiO2 exposure increased inflammatory
markers (NF-κB, TNF-α, IL-4, IL-6, TGF-β, CK,
CRP, IFN-γ) and transcriptional regulators
(STAT1, STAT3, STAT6, GATA3, GATA4)
Nano-TiO2 exposure caused blood specific
activation of C3, and heart-specific activation of
the complement cascade
Nano-TiO2-exposed mPHGPx Tg mice had
reduced ROS and preserved electron transport
chain complex constituents in the heart

Female BALB/cJ mice, 10–12
wks old

Nano-TiO2
exposure
increased
cardiac
mitochondrial proton leak (UCP2), and fatty acid
metabolism (increased CPT1A and PDH
phosphorylation)
Nano-TiO2 exposure increased ROS (H2O2), global
5-mC methylation, DNMT1 protein expression,
and HIF-1α activity and downregulated mPHGPx
in the heart

Female Sprague Dawley rats
10–12 wks,12 wk-old progeny

Nano-TiO2, particle size (21 nm)/surface area (48.08 m2/g).
7.79 ± 0.26 days, 5 hr/day, 10.35 ± 0.13 mg/m3 through a
whole-body inhalation system during pregnancy

Female FVB 12 wks old,
Gestational day 15 fetal
progeny, 11 wk-old adult
progeny

Nano-TiO2, particle size (21 nm)/surface area (48.08 m2/g).
Whole-body inhalation exposure at a dose of
12.09 ± 0.26 mg/m3 for 6 days (over 8-day period), 6hr/day,
starting from gestational day 5

Nano-TiO2 exposure resulted in cardiac
mitochondrial epigenomic remodeling (increased
H3K4Me3) and decreased transcriptomic immune
response
Nano-TiO2 exposure decreased State 3 and State 4
mitochondrial respiration

Female Sprague Dawley rats
10–12 wks old, Gestational day
20 fetal progeny

Nano-TiO2, particle size (21 nm)/surface area (48.08 m2/g).
Whole-body inhalation exposure at a dose of 10.35 ± 0.13
mg/m3 for 7.79 ± 0.26 days during gestation

Female Sprague Dawley rats,
female 11–16 wk old progeny

Nano-TiO2, particle size (21 nm)/surface area (48.08 m2/g).
Whole-body inhalation exposure at a dose of 10.6 ± 0.3
mg/m3 for 6.8 ± 0.5 days during gestation

UFP collected Beijing, China. Intratracheal instillation of
UFCP (0.15 mg/kg, 0.45 mg/kg and 1.35 mg/kg) and
captopril administration.

Gestational
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(65)

(71)

(77)

(116)

FVB
and
miRNA-378a
knockout Tg mice aged 14–18
wks old
CD-1 (ICR) male mice, 4 wks
old

Carbon nanoparticles with primary particle diameter of 10
± 2 nm. Administered through intra-arterial infusion
(30mm2 per animal) and inhalation (lung deposited dose
10,000mm2). Whole body exposure for 4 or 24 hours
Nano-TiO2, particle size (21 nm)/surface area (48.08 m2/g).
Whole-body inhalation exposure at a dose of 11.09 mg/m3
for 4 hrs
Nano-TiO2 prepared through hydrolysis of Ti(OBu)₄.
Administered via nasal instillation of mice every other day
for 6 months. Treatment of 1.25 – 5 mg/kg TiO2 NPs

Female C57BL/6 mice, 8 wks
old

Nano-TiO2, UV-Titan L181. 6.0 mg Ti/m3–10 mg TiO2/m3
administered through intratracheal instillation

Male FVB and male mPHGPx
Tg mice 10–12 wks

Nano-TiO2, particle size (21 nm)/surface area (48.08 m2/g).
11.58 ± 0.27 μg lung deposition, whole-body inhalation
exposure for 6 hrs

Gestational
(66)

(87)

(143)

(145)

Multi-component Exposure
(9)
(10)
(32)

(43)

(48)

Higher PM2.5 BC, and mass PM2.5 exacerbated
hypomethylation of IFN- and ICAM-1
Higher black carbon concentration associated with
12% reduction in F3 methylation
Increases in PM2.5, BC, and UFP concentrations
were positively associated with inflammation
(CRP and fibrinogen) and coagulation, but not
endothelial dysfunction, Delta-C increasing
concentrations assoiciated positively with
fibrinogen and negatively with MPO
PM2.5 levels, but not UFP, were positively
associated with hsa-miR-197-3p and hsa-miR-99a5p

Normative Aging Study, 777
elderly men
Normative Aging Study, 777
elderly men
135 patients undergoing cardiac
catheterization

PM2.5 mass concentration and PM2.5 BC concentration
measured hourly at the Harvard supersite Boston, MA
PM2.5, BC, SO4, and ozone concentrations of ambient air
collected from Boston, MA were measured hourly
Ambient air pollution, Delta-C (wood-smoke), PM2.5, BC,
UFP collected from New York State Department of
Environmental Conservation (DEC) site in Rochester, NY

59 volunteers (20 were healthy,
20 had COPD, 19 had ischemic
heart disease)

SiNP and Pb co-exposure elevated markers of heart
failure (ANP and BNP), inflammation (CRP, IL-6,
TNF-α) in heart and increased ANGII and ET-1in
serum. T-PA, TFPI, AT III decreased while
fibrinogen and D2D increased with co-exposure

Sprague Dawley rats, 6 wks old

Ambient air pollution exposure (personal exposure level
measurements of PM10 and PM2.5, UFP, nitrogen oxides,
BC, CO) during 2-hour walk. Oxford Street or Hyde Park,
London, England
Stöber technique was used to synthesize SiNPs. Intratracheal instillation of 2 mg/kg body SiNPs and/ or 0.25
mg/kg of lead acetate (Pb) for 30 days.
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(84)
(86)

(96)

54 circulating miRNAs were correlated with dose
of exposure and pollution type
UFP, CO, SO2 exposure was associated with
increased inflammatory markers (IL-6, IL-8, ET-1)
in blood
PM2.5 and SO4 increases associated with CRP
levels, NOx positively associated with IL-6, BC,
sulfate, ozone positively associated with TNFR2

24 non-smoking adults
52 men and women 18-34 years
old
3,996 non-smoking participants
Framingham Offspring cohort
cycle 7 and 8 and Third
Generation cohort 1
3,820 non-smoking participants
Framingham Offspring cohort
cycle 7 and 8 and Third
Generation cohort 1
53 healthy participants, 18–
60 years old

(97)

Higher PM2.5 and BC concentrations were
associated with lower P-selectin levels

(101)

Nickel, barium, and silver levels were positively
correlated with VEGF, UCHL1, and cortisol

(102)

Higher BC is associated with decreased
methylation of Alu and both increased SO4 and BC
resulted in decreased methylation of LINE-1
PM2.5 concentration was positively associated with
69 differentially methylated regions, 13 CpG sites,
including altered methylation of KNDC1 and
FAM50B. UFP was also associated with 15
differentially methylated regions
BC was associated with sVCAM-1, sICAM-1, and
vWF. PM2.5 was associated with sVCAM-1 and
sICAM-1 in patients not taking statins. In smokers,
PM2.5 and BC were positively associated with
sVCAM-1
PM2.5 mass concentration shower positive trend
with HDL-oxidant index (HOI). Changes not seen
with ozone co-exposure.
PM2.5 and quasi-ultrafine particles <0.50 µm
dysregulated parasympathetic response and
increased IFN- γ methylation in blood
PM2.5 exposure was associated with higher
inflammation (CRP) and coagulation (platelet
count in blood)
Co-exposure potentiated increases in CRP, IL-6,
CK, LDH, and MDA, and decreased SOD

Normative Aging Study, 706
individuals

BC, CO, NOx, and PAHs positively associated with
IL-6 and TNF-α, quasi-ultrafine particles <0.25 µm
were also associated with IL-6. Associations were
stronger for haplotype H than haplotype U
SiNP and MeHg co-exposure caused cardiac injury
through changes in serum biomarker activity
including increased SERCA2, cTnT, ANP, and
BNP
Co-exposure (PM2.5, SO2, and NO2) causes
endothelial dysfunction (increased ET-1 and
decreased eNOS) and inflammation (increased
COX-2, iNOS, TNF-α, IL-6)

36 participants, ~84 years old

(110)

(118)

(132)

(158)

(160)

(163)

(169)

(176)

(184)

PM2.5, NO2, UFP, BC, PM10 collected on Oxford Street in
London, 2-hour exposure
UFP, CO, SO2 concentrations collected in Sault Ste. Marie,
Ontario, Canada (Summer of 2010). Occupational air
pollution
PM2.5, BC, SO42-, nitrogen oxides, and ozone collected at
the Boston Harvard Supersite and assessed as 7-day
moving average
PM2.5, BC, SO42-, nitrogen oxides, and ozone collected at
the Boston Harvard Supersite and assessed as 7-day
moving average
Particulate matter collected in downtown Toronto, Canada.
130-min exposure to PM10 (213 µg/m3), PM2.5 (238 µg/m3),
and/or concentrated UFP (213µg/m3)
PM2.5, BC, SO4 data collected from Harvard School of
Public Health during January 1995 to November 2007

157 non-smoking adults

PM2.5 and UFP levels collected in personal and ambient air
pollution, measured in 24-hour intervals, part of
EXPOsOMICS project conducted in 4 European countries
(December 2013–February 2015)

60 male and 37 female
participants with type 2
diabetes (smokers and nonsmokers)

PM2.5 (1998–2002) and BC (1999–2002) measured hourly
and SO42- measured daily (1999–2002) at the Harvard
School of Public Health (Boston, MA)

30 participants, 19–37 years old

PM2.5 (149 µg/m3), ozone (221 µg/m3), and PM2.5 and ozone
data collected from Toronto, Canada as part of Clean Air
Research Center Project.
Particulate matter collected Milan, Italy. Inhalation to
mixture (PM10, PM2.5, PM1.0 and PM0.5µm) over 2 sessions

12 healthy participants

3275 participants

Male Wistar rats (age not
defined)

Sprague Dawley rats, 6 wks old

Male C57BL/6 mice, 6–8 wks

Ambient air pollution PM10 and PM2.5 levels from the
German Heinz Nixdorf Recall Study, three adjacent cities
(Essen, Mülheim, Bochum)
PM2.5 (varying doses), ozone (0.81 ppm), PM2.5 and ozone
collected June–October 2011 in Shanghai, China.
Administered as whole-body inhalation exposure (ozone)
and intratracheal instillation (PM2.5)
Particulate matter (PM-varying sizes), nitrogen oxides
(NOx), carbon monoxide (CO), organic and elemental
carbon (OC and EC), collected from four retirement
communities in the Los Angeles air basin
Silica nanoparticles (SiNPs) and methylmercury (MeHg)
administered through intratracheal instillation 10 times
over 30 days at doses of 0.25 mg/kg (MeHg) and 2 mg/kg
(SiNPs)
PM2.5, SO2, and NO2, collected Taiyuan, China. Intranasal
instillation every other day for 6 hrs/28 days. 0.5/3.5 mg/m3
SO2, 0.2/2 mg/m3 NO2, 1/10 mg/kg PM2.5

Table 1.1: Summarized Recent Findings. Summarized findings of the molecular mechanisms contributing to
cardiovascular complications following particle inhalation exposure. Studies are organized by exposure (PM 2.5, UFP,
ENM, and Multi-component), including subsections for gestational and preconception exposures. All abbreviations
are defined in the Glossary of Abbreviations provided.

Cardiac Remodeling
While inhalation exposure directly impacts the lungs, the subsequent downstream
adaptations of the heart can lead to sustained cardiac remodeling. This remodeling can be presented
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in the form of fibrosis, hypertrophy, and other structural changes to both the cardiomyocyte and
the surrounding connective tissue of the heart. In understanding how this process occurs,
examining the biochemical signature linked to cardiac remodeling changes associated with
toxicant inhalation exposure can provide insight for future investigations into prevention and
treatment. The reported cardiovascular adaptations that occur as a result of toxicant inhalation
exposure are depicted in Figure 1.1.

Figure 1.1: Cardiovascular Changes following Exposure.
Cardiomyocyte

Mitral Valve Function

Decreased
Contractility148,149,150,165

Decreased
MPI61
Mitral Inflow165

Increased
Apoptosis26,38,94,159,162,168

Increased
E/E’ Ratio126
E/A Ratio61,62,111

General
Hypertrophy89,169

Left Ventricular Function

Cardiac Injury38,66, 67,94,176, 156,171
Fibrosis

75,89,150,165

Vasculature
Decreased
Blood Pressure179

Increased
Decreased
LV Mass83
Cardiac Output83
Heart Rate82,154,179
Contractility37,152,165
Sys/Dia Diameters57,150
Ejection Fraction126,148,160
Cardiac Repolarization35,89,158
LV Posterior Wall Thickness150
Fractional Shortening83,148,150,165
Heart Rate Variability16,18,153,162,183

Increased
Blood Clotting109
Artery Wall Thickness4
Blood Pressure6,82,104,127,154,162
Endothelial Dysfunction1,32,130
Endothelial-Dependent Dilation140

Figure 1.1: Summary of the cardiovascular changes following particulate inhalation exposures and the associated
studies detailing these findings. Sys = systolic, Dia = diastolic, LV = left ventricular, MPI = myocardial performance
index.

Cardiac fibrosis involves the imbalance of extracellular matrix production and degradation,
which results in accumulation of scar tissue. Cardiac fibrosis, which occurs as a result of PM
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exposure, therefore decreases compliance, impairing the ability of the heart to contract and relax
properly. PM2.5 exposure results in elevation of several genes linked to collagen deposition
(collagen type I alpha 1 (Col1a1) and collagen type III alpha 1 (Col3a1)) and the fibrogenic growth
factor, transforming growth factor beta 1 (TGFβ-1)) (131). Simultaneously, NADPH oxidase
(NOX-4) is increased, matching the resultant cardiac dysfunction and prooxidative environment
found in the heart following PM exposure. Of note, Qin et al. also further demonstrated that the
effects of PM2.5 are worse in older mice, making them more susceptible to prolonged cardiac
systolic dysfunction marked by decreased ejection fraction and increased E/E’ ratio when
compared to juveniles (131). PM2.5-induced fibrosis is also related to cardiac inflammation in the
hearts of mice, which show elevated expression of inflammatory genes including interleukin (IL)
-6, IL-18, and C-X-C motif chemokine ligand 1 (CXCL1) (79). Inflammation and fibrosis in the
heart may be attributed to increased phosphorylation and therefore activation of epidermal growth
factor receptor (EGFR)/Akt signaling and increased expression of nuclear factor-kappa beta (NFĸB) following inhalation exposure. NF-ĸB expression in the heart is likewise increased as a result
of PM2.5 exposure in diabetic mice, along with cyclooxygenase-2 (COX-2) and mitogen activated
protein kinase (MAPK), indicating high oxidative stress and inflammation

(185).

Intracerebroventricular injection of an inhibitor of IκB kinase-2 (IKK) analog (IMD-0354), which
regulates the nuclear translocation of NF-ĸB, can remediate the inflammatory response that occurs
following PM exposure. While NF-ĸB plays an important role in the cardiovascular effects of PM
inhalation exposure, other inflammatory markers contribute to cardiac remodeling. Cardiac injury
and inflammation that occurred following PM2.5 exposure were attenuated with supplementation
of vitamin E and omega-3 polyunsaturated fatty acids prior to the exposure in rats by decreasing
expression of tumor necrosis factor-α (TNF-α), IL-1β, and IL-6 (39). In addition to TNF-α and IL1β, PM2.5 exposure also induces soluble intercellular adhesion molecule 1 (ICAM-1) (181).
Together, these inflammatory markers can form a positive feedback loop with NF-ĸB, amplifying
PM-induced cardiac fibrosis and remodeling. Selenium yeast (SeY) supplementation can similarly
serve as a pretreatment protective strategy, as reported in Sprague Dawley rats that were
subsequently exposed to PM2.5 (181). PM-exposed rats who were administered SeY pretreatment
had lower levels of pro-inflammatory markers and significantly higher total antioxidant capacity,
total superoxide dismutase (SOD) and total glutathione peroxidase (GSH-Px), compared to the
PM2.5-exposed group without pretreatment (181). The ability of antioxidant therapy to thwart the
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perpetuation of inflammatory signaling associated with cardiac remodeling highlights the essential
role of oxidative stress in the development of cardiac pathology following ambient air exposure.
Understanding the proteins involved in the regulation of reactive oxygen species (ROS) may
provide insight into long-term remodeling of the heart. While most population-derived analyses
assess cardiovascular impact in blood samples, a study of the effects of UFP urban air pollution
utilized post-mortem ventricular autopsies of 30 children and young adults to substantiate that
early and prolonged cardiac stress can result in irreversible consequences (161). Compared to clean
air controls, long-term UFP exposure results in significant upregulation of proteins involved in
oxidative (prion protein (PRNP)) and endoplasmic reticulum (ER) (glucose regulated protein 78
(GRP78)) stress. These response markers of stress were disproportionately upregulated in the left,
compared to right, ventricle. Along with abnormal left-ventricular histopathology, increased
oxidative and ER stress markers suggest a compensation by the heart to attenuate the inflammatory
effects of air pollution in response to UFP exposure (161). GRP78 elevation in cardiomyocytes is
sufficient to promote myocyte growth, potentially through stimulation of cardiac-specific
transcriptional factor GATA sequence binding protein 4 (GATA4) (182). Similar to UFP, nanoTiO2 exposure in outbred mice can lead to an increase in cardiac lesions and a significant change
in inflammation markers, including changes in transcription factors (signal transducer and
activator of transcription (STAT) 1/3/6 and GATA 3/4) in the heart (71). The ability for oxidative
and inflammatory proteins to activate transcription factors such as GATA4 is therefore notable,
particularly following UFP/ENM exposure, as they appear to have strong correlations with cardiac
hypertrophy. Fine PM exposures can also lead to sustained detrimental effects in the heart by
altering the transcription factor profile. One example of this has been shown previously in a cohort
of PM2.5-exposed mice (93). Cardiac remodeling through hypertrophy, QT interval prolongation,
and fibrosis were correlated with elevated cAMP response element binding protein (CREB), as
well as SOS Ras/Rac Guanine Nucleotide Exchange Factor 1 (SOS1), and glycogen synthase
kinase 3 beta (GSK3β) expression. Measuring biomarkers associated with myocardial infarction
can also provide information on the extent of cardiac tissue dysfunction and death. An examination
of the cardiovascular effects of a co-exposure model using silica nanoparticles (SiNP) and
methylmercury (MeHg) has shown increases in myocardial edema, myocardial gap expansion, and
myofibril disorder, as well as increases in activities of myocardial enzymes including cardiac
troponin T (cTnT), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) compared
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to the serum of single exposure and sham-exposed rats (176). The authors also report increased
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2), a potential marker of endoplasmic
reticulum stress (69), in the co-exposure cohort along with oxidative stress. Similar to the
preceding studies mentioned, co-exposures can induce cardiac remodeling by increasing oxidative
and ER stress, and elevating prominent markers of heart failure. PM exposures, including UFP,
ENM, and multi-component exposure, all have the ability to alter the transcription factor profile
in the heart and lead to sustained detrimental effects on cardiac structure. The molecular
adaptations to particle exposures that result in cardiac remodeling center around a theme of
inflammation and oxidative stress, which may ultimately be regulated by a greater transcriptional
and epigenetic adaptation following toxicant inhalation exposure.

Cardiac Hemodynamics
The performance of the heart can highlight both the acute and chronic effects of toxicant
inhalation exposure. Although cardiac remodeling provides an informative diagnostic standard for
assessing the impacts of PM exposure, more immediate changes are captured in measures of heart
function. Whether there is a sustained or transient perturbation to the heart is likely determined by
the molecular cascades involved, such as transcriptional or epigenetic reprogramming.
Controlled studies on human exposure to PM allow for the most relevant simulation of
pollutant exposure, while also limiting interference of confounding factors. Measurements of
blood methylation levels in 15 healthy participants revealed that both fine and coarse concentrated
ambient particle (CAP) exposures induce hypomethylation of the Alu repetitive transposable
element and toll-like receptor 4 (TLR4) (6). Decreased methylation of the short interspersed
nucleotide element, Alu, and TLR4 was also associated with higher systolic blood pressure postexposure, which is similar to previous findings that have shown a role for hypomethylation in
atherosclerosis (23). Other studies have reported similar findings with specific components of
PM2.5, including with black carbon (BC). Over a 90-day period, increased BC levels correlated
with decreased methylation of Alu, while both carbon black and sulfate (SO4) were associated with
decreased methylation of long interspersed nuclear emlement-1 (LINE-1) (102). Interestingly, in
a study examining occupational exposure to PM2.5, methylation of LINE-1 was significantly
increased in peripheral blood leukocytes of participants, but was not directly associated with
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declining heart rate variability (HRV) (44). When DNA methylation is altered, it has the potential
to activate pro-inflammatory factors or repress anti-inflammatory factors, and can therefore
activate pathways that are prevalent in the development of cardiovascular diseases. The
discrepancy of whether toxicant exposure results in hypo- or hypermethylation can likely be
attributed to different exposure environments (controlled or ambient), duration and concentration.
The concentration of PM2.5 during exposure was positively associated with toll‐like receptor 2
(TLR2) methylation in older adults, further suggesting potentiation of the inflammatory response
(188). Flavonoid supplementation can potentially limit TLR2 methylation, as correlations indicate,
and ameliorate PM2.5-induced low frequency HRV. Another study that aimed to address the
epigenetic regulation of inflammatory markers by PM exposure utilized young, healthy subjects
who inhaled an array of PM compositions (PM10, PM2.5, PM1.0 and PM0.5) over two sessions (158).
These subjects presented with decreased HRV indicating a stress response, which is consistent
with previous studies of PM exposure. Furthermore, PM2.5 as well as quasi-ultrafine particles
<0.50 µm were significantly associated with increased pro-inflammatory cytokine (interferon
gamma (IFN- γ)) methylation, correlating with alterations in the parasympathetic nervous system
as an adaptive response (158). Bind and colleagues however, reported that both PM2.5 BC and
PM2.5 mass concentrations were associated with significantly lower methylation of
immunoregulatory genes, IFN- and intercellular adhesion molecule 1 (ICAM-1) in individuals
with low methylation levels prior to exposure (9). The main contributing factor that is likely
responsible for these contradictory findings is the population that was studied. While Tobaldini et
al. conducted a more controlled experiment with healthy, young males (n = 12), Bind et al. utilized
a large cohort (n = 777) of elderly men with varying health conditions (9, 158). Other studies
address epigenetic alterations of the cardiovascular system following PM inhalation exposure as
well (99, 110), though without direct functional associations. Although the studies outlined provide
a link between epigenetic mechanisms and cardiac function, specifically HRV, it remains unclear
if epigenetic reprogramming is a primary mechanism for sustaining adaptations to PM exposures
or if it is transiently changed with exposure. MicroRNA-378A, as well as other microRNAs, are
potential molecular mediators of metabolic and cardiac dysfunction that ensue following ENM
exposure (65). Nano-TiO2 inhalation exposure induced diastolic dysfunction, E/A ratio elevation,
and decreased myocardial performance indices, which were preserved in a microRNA knockout
transgenic mouse model (microRNA-378A). The authors pointed to regulation of mitofusin 1
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(Mfn1) expression through microRNA-378A as a mechanism for controlling mitochondrial
dynamics following exposure (65). While the preceding studies examined epigenetic changes, the
mechanisms of action were not elucidated. Multi-faceted assessments of how pollutants impact the
epigenome and inflammation-associated genes are critical as both are implicated in processes
mediating cardiovascular function impairment.
Inflammation plays a key role in pollutant exposure response in both individual particulate
exposures and multi-component exposures. Co-exposure of sulfur dioxide (SO2), nitrogen dioxide
(NO2), and PM2.5, typical air pollutants produced as a result of coal combustion, results in an
enhanced inflammatory response with upregulation of COX‐2, inducible nitric oxide synthase
(iNOS), TNF‐α, and IL‐6 (184). The co-exposure contributed to decreased blood pressure and
increased heart rate when compared to PM2.5 alone. Similarly, IL-6, IL-8, and endothelin-1 (ET1) were significantly associated with rises in carbon monoxide (CO), UFP and SO2 concentrations
in healthy individuals near a steel mill (86). The precursor for ET-1 (BET-1) was positively
correlated with systolic blood pressure, while C-reactive protein (CRP) was correlated with
increased heart rate. Protein ontology revealed a significant elevation of inflammation specific
pathways (86). Combined high-dose PM2.5 and ozone exposure also promotes cardiovascular
functional injuries that are presented as abnormal electrocardiogram (ECG) results (extended QRS
complex and depression of ST-segment) (163). The addition of ozone to the exposure paradigm
propagated inflammatory and oxidative stress responses with elevated CRP, IL-6, creatine kinase
(CK), lactate dehydrogenase (LDH), and malondialdehyde (MDA). These studies highlight the
importance of controlled co-exposure studies for delineating the risk of ambient pollutants and
combustion materials on cardiovascular hemodynamics and the associated inflammatory and
oxidative stress mechanisms.
Co-exposure to CAPs and acrolein causes myocardial dyssynchrony, though through a less
understood mechanism involving the activation of transient receptor potential cation channel A1
(TRPA1), which the authors report may act to increase cardiac risk, specifically in exposures with
heterogeneous compositions (157). Along with channel proteins affecting cardiac conduction,
modifications in the uptake and clearance of calcium can alter contractility within cardiomyocytes,
further dysregulating the cardiac cycle. One of the more studied pathways is through SERCA2a.
PM2.5 exposure increased intracellular free calcium (Ca2+) that was associated with increased
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ryanodine receptor 2 (RYR2) and decreased SERCA2a, which are responsible for shuttling Ca2+
from the sarcoplasmic reticulum to the cytoplasm and back, respectively (38). The changes in
calcium handling may be a direct result of PM2.5-induced oxidative stress, thereby contributing to
contractile dysfunction in cardiomyocytes. In response to long-term exposure to PM2.5, others have
reported decreased fractional shortening, impaired mitral inflow patterns, depressed contractile
reserve, along with decreased peak shortening and relengthening of isolated cardiomyocytes in
C57BL/6 mice (170). Downregulation of SERCA2a in PM2.5-exposed mice revealed abnormal
Ca2+ cycling, as previously seen, but also elevation of β-myosin heavy chain (β-MHC) indicative
of heart failure. Apart from contractility, tone of the vasculature within the heart can alter cardiac
hemodynamics. A study of acute and sub-chronic inhalation exposure of Sprague Dawley rats to
PM2.5 and PM0.1 separately elevated angiotensin II type 1 receptor (AT1R) mRNA (4). The subchronic exposure to both sizes of PM further increased AT1R protein levels, expression of markers
for myocardial adaptive response to damage (actin alpha 1 (Acta1) and Col3a) and IL-6, while
decreasing antioxidant heme-oxygenase 1 (HO-1). The authors suggest that angiotensin
overexpression can promote coronary artery wall thickness, which is likely to influence blood
pressure in exposure models (4). Another study aimed to elucidate the effects of toxicant exposure
on the regulation of blood pressure using 12-13 month-old spontaneously hypertensive rats
(SHRs), which were exposed to ultrafine carbon particles (UFCP) (159). UFCP inhalation
exposure resulted in increased blood pressure and heart rate, which was correlated with increased
levels of serum CRP, plasma fibrinogen, and levels of ET-1 in the heart. UFCP exposure-induced
hypertension in SHRs is also associated with elevated angiotensin II (AngII) in the blood, with
increasing doses of UFCP diminishing the effectiveness of captopril, an angiotensin converting
enzyme inhibitor (183). The diminished effectiveness of captopril suggests that increasing doses
of UFP, may activate a variety of pathways outside of angiotensin to induce changes in blood
pressure. These data suggest that regulation of blood pressure, like other cardiovascular responses,
is a multifactorial pathway that is influenced by other circumstances, including genetic makeup
and various environmental influences.
One of these environmental influences, high-fat diet feeding, is often used to model
hyperlipidemia. Hyperlipidemic rats exposed to PM2.5 are susceptible to higher blood pressure,
lower HRV, and higher levels of cardiomyocyte apoptosis, accompanied by decreased expression
of antioxidant proteins, including SOD (167). Markedly, high-fat diet exposed mice, compared to
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high fat diet alone, also revealed increased myocardial death through increased levels of cardiac
troponin I (cTnI), LDH and CK. Animal models with a high propensity for metabolic dysfunction,
such as AMP-activated protein kinase α2 knockout (AMPKα2-/-) mice that lack this crucial gene
for fatty acid oxidation, are critical for understanding how PM2.5 inhalation exposure impairs
cardiovascular function in vulnerable populations (165). PM2.5 exposure diminished left
ventricular ejection fraction in AMPKα2-/- mice and promoted an oxidative and inflammatory
environment through decreased expression of peroxiredoxin 5 (PRDX5), and increased expression
of NF-ĸB and TNF-α. These studies highlight the importance of understanding the molecular
changes that occur and the downstream effects on oxidative stress regulation in susceptible
populations exposed to PM. UFP inhalation exposure in human subjects with metabolic syndrome
can be specifically detrimental to cardiac repolarization, as demonstrated by the QRS complexity
in those without the glutathione s-transferase mu 1 (GTSM1) protein, a pivotal antioxidant gene
(36). In the complete cohort (participants with and without the GTSM1 mutation), UFP exposure
elevated CRP and serum amyloid A (SAA) with subsequent decreases in plasminogen and
thrombomodulin within blood, indicating an upregulation of inflammatory pathways and the
critical role of antioxidant genes. On the contrary, sub-acute exposure to PM2.5 in healthy adults
was not correlated with increased inflammatory markers or altered vascular function (17).
However, a 10 µg/m3 increase in exposure was associated with decreased HRV, correlating to
increased homeostatic model assessment of insulin resistance (HOMA-IR). This suggests the
possibility that chronic periods of exposure to PM2.5 could reduce insulin sensitivity and thus
potentiate susceptibility to diabetes mellitus, though inflammation may not be the etiology
implicated by this study (17). Particularly concerning is the notion that in obese mice, chronic
exposure to PM2.5 can prevent the beneficial effects of exercise on cardiac function and antiinflammatory pathways (59). Sedentary mice that were exposed to PM2.5 presented with increased
left ventricular diameter (systolic and diastolic) that was not ameliorated in the exercised group.
Moreover, PM2.5 exposure enhanced CRP, ICAM-1, and vascular cell adhesion protein 1 (VCAM1), which were elevated in the PM2.5 exercised group as well (59). These results are similar to those
seen in a previous study that reported the inability of moderate aerobic exercise to provide antiinflammatory protection in mice exposed to PM2.5 (103), which may be linked to expression of
heat-shock protein 70 kilodalton (HSP70) (103, 140). The advantages of moderate exercise on
cardiovascular function in obese mice (111, 126, 149), but not in obese mice exposed to PM2.5
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(59), emphasizes the consequential results of PM2.5 exposure in vulnerable populations. However,
the use of a high-fat diet induced obesity model may be more relevant in substantiating whether
fine particulate exposure hinders the ability of exercise to mitigate the detrimental cardiovascular
effects in diabetic models, as the ob/ob model may have impaired exercise capacity (59).

Coagulation
Within the lungs, the circulatory system provides a necessary pathway for mediation of the
inflammatory response. Due to this close association of the pulmonary and circulatory systems,
changes arising in blood have the potential to alter homeostasis within blood vessels. Alterations
in the coagulation pathway, specifically through fibrinogen, have been reported following PM
exposure.
Levels of a pollutant from wood smoke, Delta-C, are positively correlated with fibrinogen
and negatively correlated with myeloperoxidase (MPO), an enzyme involved in the inflammatory
pathway and platelet activation (32). The study also demonstrated that PM2.5 and UFP retain a
positive correlation with fibrinogen as well as CRP, sharing a similarity in the effects on blood
coagulation with effects of Delta-C. In a co-exposure model of SiNPs and lead acetate (Pb), Feng
et al. reported alterations to the blood clotting cascade evidenced by decreased tissue-type
plasminogen activator (t-PA), tissue factor pathway inhibitor (TFPI), and antithrombin III (AT
III), as well as elevated fibrinogen and D-dimer (D2D) (48). Following co-exposure, serum
analyses revealed leukocytosis and thrombocytopenia, concomitant with increased expression of
inflammatory markers (CRP, IL-6, and TNF-α) and markers of heart failure (ANP and BNP).
Overlap found between studies of varying particle sizes can help identify critical biomarkers of
increased blood clotting that are a product of multi-component exposure in both human and animal
models. Furthermore, others have shown that levels of fibrinogen can be increased by other
ambient air pollution constituents (8). Specific associations between PM2.5 BC and altered
epigenetic modification status of tissue factor III (F3) were later reported by this group, indicating
alterations to extrinsic blood coagulation (10). Decreased methylation of F3, which likely leads to
increased transcription of the gene, can provide the initial stimulus for altering the response of
thrombin and fibrinogen thereby increasing coagulation (29). Similarly, in a meta-population
study, including 3275 participants, long-term rises in PM2.5, but not PM0.1, were matched with
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significantly increased CRP and platelet count (160), suggesting an increased propensity for blood
clotting.
Interestingly, annual average UFP exposure levels and fibrinogen were negatively
associated, though not significantly, in human blood samples (90), which may have been a result
of micro-environment compared to ambient concentrations. To better elucidate the dynamic
relationship between ambient exposure and the time/concentration of the exposure in terms of their
effects on the cardiovascular system, Lane et al. examined biomarkers in patients with varying
levels of microenvironment exposures (time-activity adjusted) in addition to the annual average
particle number concentration of UFPs. There were significant positive associations between
time/concentration of exposure and inflammatory pathway genes in blood, including CRP and
tumor necrosis factor receptor 2 (TNFR2) (90). These findings illustrate the significance of
monitoring personal exposure levels, which may account for the differences seen in fibrinogen
expression between studies that solely use annual outdoor particle concentrations and those that
consider varying levels of individual microenvironment exposure. Modifying the coagulation
pathway in individuals who are continuously exposed to high levels of pollutants through ambient
air may provide a potential a potential prophylactic strategy to prevent the inevitable high risk of
CVD. Nootkatone, a sesquiterpenoid in grapefruit has potential as a pretreatment strategy for PM2.5
diesel exhaust exposure through its ability to reduce blood clotting by decreasing plasminogen
activator inhibitor-1 (PAI-1) and fibrinogen, and restoring thrombotic occlusion time in arterioles
(114). The authors suggest that the pretreatment strategy activated nuclear factor erythroid-derived
2-like 2 (NRF2), which plays a key role in initiating HO-1, to provide protection from oxidative
injury (114). While the studies discussed thus far have primarily utilized healthy cohorts, it is
important to understand how the coagulation pathway is altered in at-risk populations as well.
Elemental carbon UFP inhalation exposure modifies platelet activation in type 2 diabetic patients
by increasing CD40 ligand (CD40L) expression in platelets, with a resulting decrease in soluble
CD40 (sCD40) in blood (147). Higher CD40L levels, as a result of UFP exposure, exerted a
stimulatory role on von Willebrand factor (vWF) and elevated its expression. Though this study
revealed the adaptations of those with diabetes mellitus, it did not provide a control cohort to
elucidate whether these effects of PM on coagulation are exaggerated in the at-risk population.
Nonetheless, genes involved in the activation of pathways involving fibrinogen and platelet
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activation are potential early biomarkers of increased CVD risk in healthy and vulnerable
populations and require further clarification.

Vascular Dysfunction
Along with mediating the blood clotting cascade, particulate exposure has the capacity to
modify the integrity of vascular tissue, thus interfering with blood flow and cellular metabolism
directly within the vasculature. Through direct damage to the vasculature, or mediation of the
inflammatory response, particulate matter can cause blood vessels to become predisposed to
ultrastructural changes. Atherosclerosis, which involves the build-up of fatty acids and cholesterol
within the intima layer of arteries, is linked to PM exposure.
In an atherosclerotic transgenic mouse model (ApoE−/−), PM2.5 exposure causes cardiac
autonomic nervous system dysfunction concomitant with oxidative stress (123). Of note, the highfat diet fed, atherosclerotic mice displayed a greater proclivity for oxidative damage, suggesting,
once again, the impairment of cellular protective mechanisms in those who already have an altered
metabolic profile. Similarly, concentrated PM2.5 exposure significantly altered high-density
lipoprotein (HDL) anti-oxidant and anti-inflammatory capacity (HDL oxidative index (HOI)),
along with increased systolic blood pressure (132). However, ozone exposure in addition to the
PM2.5 exposure in this study did not exacerbate these effects, suggesting that short-term CAP and
ozone co-exposure may not induce overt changes that are suggestive of atherosclerosis
progression. On the other hand, long-term CAP exposure does contribute to the progression of
atherosclerosis. Rao, et al. discovered that PM2.5 exposure increased abnormal accumulation of an
oxidized variant of cholesterol, 7-ketocholesterol (7-KCh), in macrophages and the aortic wall
(133). PM2.5-exposed mice also presented with increased CD36 expression in plaquemacrophages, implicating CD36 in the accumulation of oxidized lipids, promoting atherogenesis.
By reducing the number of CD36-positive macrophages, internalization of 7-KCh can be limited
and therefore the oxidized lipids can be efficiently cleared from the vasculature (133). Along with
altered macrophage clearance, other immune responses have been implicated in vascular
maladaptation following particle exposure including changes to the innate immune response. ENM
inhalation exposure resulted in translocation of nanomaterials to the heart, which initiated the
complement cascade, setting off a local immune response, indicated by global complement factor
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3 (C3) upregulation in the blood (77). This study demonstrates that alterations to the innate immune
response may be a direct effect of translocated particles, but both studies (77, 133) highlight the
importance of the inflammatory response and part of its role in altering vascular function. PM 2.5
exposure can impact vascular endothelial cell permeability pathways by causing an inflammatory
response, which is a hallmark of increased vascular permeability. A recent study has demonstrated
that long-term changes in vascular permeability are promoted specifically by IL-6 and sustained
in-part by STAT3 phosphorylation (1). In rats, PM2.5 exposure induced phosphorylation and
subsequently expression of STAT3, which upregulated microRNA-21 expression (33). Increased
microRNA-21 expression reduced tissue inhibitor of metalloproteinase 3 (TIMP3) expression and
enhanced matrix metalloproteinase 9 (MMP9) expression. Ultimately, vascular endothelial
dysfunction was linked to extracellular matrix remodeling propagated by STAT3 (33), which was
likely promoted by the PM-induced inflammatory response. Changes in the composition of the
vascular matrix could result in alterations to immune cell binding and further changes to diapedesis
leading to vascular dysfunction.
In a 3820 non-current smoking patient population that was part of the Framingham Heart
Study, acute PM2.5 and BC exposure concentrations were inversely correlated with expression of
P-selectin, suggesting decreased endothelial-surface cell adhesion (97). Along with changes to
vascular structure, the ability for the endothelium to regenerate and adapt to pollutant exposure
can be compromised. Typically, this occurs through the production of endothelial progenitor cells
(EPCs) in response to vascular injury (50). However, PM2.5 exposure diminishes circulating EPC
levels, which may occur as a result of vascular endothelial growth factor (VEGF)-induced Akt and
endothelial nitric oxide synthase (eNOS) phosphorylation (50, 62). Short-term CAP exposure in
mice fed a control diet remarkably induced vascular insulin resistance, indicated by decreased Akt
phosphorylation, and suppressed circulating levels of EPCs through activation of the NF-κB
inflammatory pathway (63). Increasing insulin sensitivity prevented activation of these pathways,
substantiating that PM2.5 exposure can lead to insulin resistance and therefore type 2 diabetes in
healthy populations (50). Furthermore, CAP-induced vascular insulin resistance was accompanied
by increased vascular oxidative stress marked by mitochondrial SOD2 and glutathione stransferase-P (GST-P) mRNA levels, and expression of protein-HNE adducts (63). Interestingly,
9-day CAP-exposure did not exacerbate high-fat diet induced changes in vascular insulin
resistance (63), but a 30-day CAP exposure significantly aggravated systemic insulin resistance,
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elevating glucose intolerance and HOMA-IR in high-fat diet-fed mice (64). In aortic tissue, both
9-day and 30-day CAP exposures resulted in decreased insulin-stimulated phosphorylation of Akt
and eNOS, subsequently suppressing inhibition of the transcription factor NF-κB (IκBα) and
promoting an inflammatory response (64). By treating with an antioxidant, 4-hydroxy-2,2,6,6tetramethylpiperidine-1-oxyl (TEMPOL), CAP-induced inflammation and the associated vascular
insulin resistance were alleviated in high-fat diet fed mice leading to the conclusion that short-term
exposure to PM2.5 triggers a pulmonary oxidative stress response that is able to elicit downstream
vascular insulin resistance and inflammation (64).
Compounding environmental factors can further propagate the effects of particulate
exposure. A study in type 2 diabetic Boston residents provided evidence that both PM 2.5 and BC
are significantly associated with increased VCAM-1 and vWF in participants who have smoked in
the past (118). These data indicate that prior exposure to smoking-related particulates, may
exacerbate the inflammatory response seen with ambient PM2.5 exposure, creating a greater risk
for endothelial dysfunction and cardiovascular damage in type 2 diabetic patients. In an attempt to
directly assess the physiological impact of PM2.5 exposure on vasculature in a CVD at-risk
population, Riggs et al. assessed individuals’ reactive hyperemia index as a measure of endothelial
function (135). Increasing concentrations of PM2.5 significantly reduced the reactive hyperemia
index and were associated with angiogenic signaling and inflammation markers, angiopoietin 1,
placental growth factor (PlGF), VEGF, ICAM-1, and MMP9 and negatively associated with
VCAM-1 and urinary F2-isoprostane (Isop), a measure of oxidative stress (135). Interestingly,
incremental increases of PM2.5 by 10 ug/m3, were also associated with increased pro-inflammatory
cytokines including, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory
protein 1α/β (MIP-1α/β) and IFNγ-induced protein 10 (IP-10) in a cohort of young, healthy
individuals with low CVD risk (127). Together, these studies indicate that PM2.5 initiates changes
in cytokines and growth factors, which lead to endothelial injury and an immune response that
may result in acute cardiovascular events in both high-risk and low-risk CVD populations (127,
135). Furthermore, PM2.5 exposure, in a subset of the same cohort, revealed an inverse association
with ET-1, but a positive association with platelet factor 4 (PF-4) (51). Additionally, ET-1 was
negatively associated with PF-4 following PM2.5 exposure, which the authors conclude may be the
result of an anti-angiogenic effect of the exposure that could also suppress endothelial repair (51,
127). Though this is contrary to previous studies reporting positive correlations between PM and
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ET-1 (48, 86, 184), another acute exposure reported similar findings (56). Conversely, chronic
exposure paradigms appear to cause elevated ET-1 levels (48, 86, 184). Current literature provides
convincing evidence that particulate matter exposure causes a remarkable maladaptive vascular
response that can lead to increased risk of CVD. However, understanding the genome-wide effects
of exposure may provide a better understanding of the molecular mechanisms that are responsible
for these alterations.

Cellular Stress and Death
PM inhalation exposure-induced changes to the cardiovascular system can eventually
trigger cell death pathways through varying mechanisms including oxidative stress (94). These
pathways include apoptosis and necrosis, leading to programmed or uncontrolled cell death and
subsequently cardiovascular hypertrophy.
One of the mechanisms that initiates the cell death pathways is damage to nuclear DNA.
Assessment of blood from trucking industry participants revealed that 48 (elemental carbon (EC)),
260 (organic carbon (OC)), and 49 (PM2.5) differentially regulated genes were associated with each
of the exposure; these expression profiles implicate genes regulating apoptosis, DNA and metal
binding, and chronic heart and lung disease pathways (30). Consistent with these findings,
exposure to PM2.5 containing polycyclic aromatic hydrocarbons (PAHs), increased DNA damage
and DNA damage response genes in a rodent model (186). These genes included 8-oxoguanine
DNA glycosylase (OGG1) and growth arrest and DNA damage 153 (GADD153). PM exposure
also altered genes involved in ROS regulation (glutathione S-transferase (GST) and SOD) (186).
An increased expression of GST and decreased expression of SOD may promote a high oxidative
environment with reduced ability to scavenge ROS, which may help propagate the effects of DNA
damage. NOX4 is a prominent contributor of oxidative stress in the failing heart, and is associated
with initiating increased DNA damage through this mechanism (89). PM2.5 exposure in mice
enhances not only inflammatory markers as previously reported (TNF-α and IL-1β), but also
myocardial apoptosis, NOX4, and NOX4 associated subunits, suggesting that the progression of
cardiovascular disease may be dictated by ROS generation and the modification of antioxidant
protein-levels, which are initially regulated by PM2.5 exposure (173). While unregulated levels of
ROS may function through multiple pathways to cause cell death, programmed cell death through
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apoptosis has been linked to PM inhalation exposure through other channels. Hyperlipidemic rats
exposed to PM2.5 are more prone to cardiac apoptosis (167) that is mediated through c-Jun NH2terminal kinase (JNK), P53 phosphorylation and downstream activation of (Bcl-2-associated X)
Bax and Caspase-3 (167). The expression of both GST and JNK are modified following PM
exposure, which implies the presence of an overlap among these pathways that mediate apoptosis
as previously suggested (55). Similar results are seen in other vulnerable models such as mice that
were challenged with myocardial infarction (98). PM inhalation exposure exacerbated left
ventricular dysfunction and increased infarct size, with increased myocardial apoptosis through
Caspase-3, Bax and B-cell lymphoma 2 (Bcl-2). Moreover, PM exposure may not immediately
stimulate cell death, but rather result in reprogramming of the cell, making it susceptible to future
insult. One way reprogramming may be occurring is through changes in microRNAs, which are
associated with PM2.5, but not UFP, in the blood of individuals residing in multiple urban regions
(43). Specifically, PM2.5 is correlated with increased hsa-miR-197-3p and hsa-miR-99a-5p, which
play roles in cell death and cancer (43, 180). PM2.5 inhalation exposure was also linked to
microRNAs involved in cardiovascular function, including decreased expression of microRNA133a, 145-5p, and 499a-5p in plasma (84). Overall, these studies outline some of the potential
mechanisms that initiate myocardial apoptosis and eventually lead to cardiovascular abnormalities
due to particulate exposure.

Mitochondrial Bioenergetics and Ultrastructure
In the cardiovascular system, slight perturbations to mitochondrial health could result in
significant detriments and sustained pathology. The energy needed for the heart to contract is
derived primarily through oxidative phosphorylation of mitochondrion (~95%) (189). Alterations
to mitochondrial function are therefore implicated as a primary pathway for cardiovascular
dysfunction and disease (117).
The integrity of mitochondrial DNA defines its respiratory potential, allowing for
separation of individuals into a variety of haplogroups (138). Ambient air pollution has the
potential to differentially effect individuals with diverse haplotype backgrounds (169).
Haplogroup H (high ROS production) compared to haplogroup U (low ROS production) is more
susceptible to quasi-ultrafine particle <0.25 µm exposure. Quasi-ultrafine particle exposure
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induced inflammation to a greater extent in haplogroup H than U, demonstrated by increased IL6 and TNF-α (169). Furthermore, high doses of PM2.5 result in cardiac mitochondrial ultrastructure
(size and cristae formation) changes in addition to increased inflammation (95). These
ultrastructural changes are supported by increases in mitochondrial fission 1 (FIS1), MFN1,
MFN2, dynamin-related protein 1 (DRP1), and mitochondrial dynamin like GTPase (OPA1),
which suggest alterations to the fission/fusion pathway (95). UFP exposure has also been linked
to mitochondrial dysfunction (70). Exposure to UFP exacerbated ischemia/reperfusion damage in
the isolated hearts of rats. Isolated cardiac mitochondria of UFP-exposed rats displayed decreased
Ca2+ buffering prior to the mitochondrial permeability transition pore (mPTP) opening, which
indicates that exposure can increase mPTP Ca2+ sensitization and therefore mitochondrial
permeability (70). The alterations to fission/fusion proteins (95) and mitochondrial permeability
(70) showcase changes to the composition and functionality of mitochondrion following exposure,
which can propagate oxidative damage and initiate mPTP-associated cell death pathways to
instigate cardiac damage. A single dose of ENM through inhalation exposure in mice, has the
ability to trigger cardiac functional changes and mitochondrial dysregulation (116). However a
transgenic mouse model for mitochondrial phospholipid hydroperoxide glutathione peroxidase
(mPHGPx) was used to restore cardiac function, mitochondrial respiratory function, and abrogate
ROS levels following nano-TiO2 exposure. By increasing antioxidant defense through mPHGPx
overexpression, proteomics revealed that changes in mitochondrial composition, including
individual electron transport chain complex constituents, were protected from the detrimental
effects of exposure (116). This study further validates the importance of antioxidant protection in
preservation of mitochondrial structure and function, and should therefore be investigated as a
potential protective approach.
PM exposure can modify the transcriptional capacity of the mitochondrion and likewise
incite dysfunction through this approach. Boilermakers exposed to PM2.5 were utilized in a study
that aimed to elucidate the exposure-induced changes in methylation of mitochondrial DNA (19).
Methylation of specific mitochondrially transcribed genes involved in ATP synthesis, including
mitochondrially encoded tRNA phenylalanine (MT‐TF) and mitochondrial 12s RNA (MT‐RNR1),
were not associated with PM2.5 exposure. However, methylation of the mitochondrial promoter DLoop was associated with PM2.5 exposure. Participants with mitochondrial DNA hypermethylation
were more vulnerable to the effects of PM2.5 exposure on HRV (19). Inhalation of toxicant particles
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may exert its effects on overall mitochondrial structure and function, and thus cardiovascular
function, through ROS regulated and inflammatory pathways as the preceding studies indicate.
Both increased inflammation and ROS have the ability to recruit methyltransferases, such as DNA
methyltransferase 1 (DNMT1), and alter the methylome of various genes implicated in CVD,
causing repression of the associated genes (83).
Though the molecular mechanisms behind cardiovascular impairment associated with
particulate matter exposure vary based on the particle size, constituents, and physiochemical
properties, there are common overlapping genes that appear to be modulated by multiple toxicants
present in air pollution. Figure 1.2, created using Ingenuity Pathway Analysis (IPA), provides an
interaction network of genes that are dysregulated following particulate inhalation exposure. IPA
included genes that were upregulated, downregulated, or had diverse expression following more
than one type of particulate exposure mentioned throughout this review. These genes can serve as
potential early biomarkers of cardiovascular damage as a result of inhaled toxicant exposure.
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Figure 1.2: Ingenuity Pathway Analysis (IPA).

Figure 1.2: Ingenuity pathway depicting the interaction network of genes that are dysregulated following particulate
inhalation exposure. The genes included in the interaction network were associated with more than one type of
particulate exposure. The interactions represent direct, validated experimental associations between genes that were
increased (red), decreased (green), or found to have a diverse expression profile (yellow) following exposures. All
abbreviations are defined in the Abbreviations section provided.

Gestational Exposures
There has been an increasing volume of literature investigating how particulate exposure
can affect vulnerable populations, including women during pregnancy. Due to the coinciding
metabolic changes prompted by both diabetes/obesity and air pollution, particularly related to
oxidative stress and inflammation, understanding the dynamics of both pathologies is critical in
determining how pollutant exposure can alter the metabolome (117). Particulate exposure during
gestation is a major risk-factor for gestational diabetes (105, 179). However, the effects of pollutant
insult in utero on the offspring remain a critical gap in knowledge (11, 78, 100). This is particularly
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concerning for fine and ultrafine particles that have the ability to enter circulation and reach the
fetal side of the human placenta (12). Recent studies indicate that maternal toxicant inhalation
exposure during gestation is a predisposing factor for CVD in offspring.

Oxidative Stress and Inflammation
PM2 exposure results in activation of oxidative and inflammatory pathways, as has been
described in the previous sections. Preconception toxicant exposure, predisposes future offspring
to the development of cardiac dysfunction (153). PM2.5 preconception exposure in both parents
decreases ejection fraction, fractional shortening, and cardiomyocyte contractility in 3-month old
progeny (153). Inflammatory and oxidative pathways are thereby activated, resulting in increased
IL‐6, IL‐15, NFқB, and CRP along with elevated fibrosis (Col3a1), similar to the results found in
many direct exposure studies. Notably, calcium handling proteins, SERCA2a and phosphorylated
phospholamban (p‐PLN) are elevated in preconception PM2.5 exposed offspring, as increased pPLN loses its ability to inhibit SERCA2a. While PM-induced inflammation and oxidative stress
are common in both direct and preconception exposures, SERCA2a is contrarily decreased in
direct exposures (38, 170). One potential reason for this discrepancy may be that preconception
exposure results in an adaptive response. Similar to direct and preconception exposure, PM2.5
exposure during gestation also results in cardiac remodeling with associated inflammation
(increased IL‐6 and IL‐1ß) (155). Furthermore, extracellular matrix remodeling, marked by
increased collagen‐1, MMP9, and MMP13 expression, is also present in neonates following
gestational exposure, but was not assessed into adulthood. Nevertheless, long-term maternal
exposure to PM2.5, throughout gestation and lactation, enhanced activation of the inflammatory
markers and myocardial apoptosis in both neonatal and weanling Sprague Dawley rats (27). UFP
exposure to pregnant C57BL/6J dams led to fetal reabsorption and increased blood pressure in
adult progeny (109). Increases in maternal serum inflammation during gestation, along with AT1R
and angiotensin I-converting enzyme (ACE) activation in the lungs are suggested to contribute to
progeny cardiovascular dysfunction both short and long-term. The notion that maternal and
paternal exposure activates an inflammatory response in progeny from early life into adulthood is
therefore well established, but whether the changing maternal environment (109), particle
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translocation, or a combination of such factors are culpable in altering progeny development and
metabolic function remains elusive.
In addition to inflammatory pathways, immune responses and oxidative stress pathways
are changed in progeny who are exposed during gestation. Challenging progeny immune systems
with house dust mite (HDM) allergen revealed a decreased immune response through lower IL-13
and IL-17, with higher serum levels of IL-10 following UFP exposure (139). This has also been
demonstrated with UFP containing persistent free radicals (MCP230), which suppressed the T
helper and T regulatory cells found within the lungs of offspring (166). Maternal ENM exposure
during gestation may however, modulate a regulatory axis involving enhanced hypoxia inducible
factor (HIF)-1α activity and decreased mPHGPx expression, which are critical in the regulation of
ROS in fetal and young adult cardiac development (87). Understanding how gestational exposure,
as opposed to direct exposure, effects individuals will contribute in the development of
preventative measures for vulnerable populations, including pregnant women and children, and
promote safer limits of exposure thereby mitigating susceptibility to metabolic diseases and CVD
in offspring.

Cellular Function
Calcium regulated contraction is significantly affected throughout development in progeny
exposed to particulate matter during gestation. Assessment of fourteen-day old progeny whose
dams were exposed to PM2.5 during gestation, revealed decreased cardiomyocyte contractility
through calcium dynamics, with changes to proteins involved in calcium flux in the heart, SERCA2a, p-PLN, Na+/Ca2+ exchanger (NCX), calcium channel, voltage-dependent, L type, and alpha 1C
subunit (CaV1.2) (154, 155). Offspring whose dams were exposed during gestation also present
with major cardiac anomalies present into adulthood as a result of ENM-induced mitochondrial
dysfunction. Nano-TiO2 gestational exposure decreased diastolic cardiac function, marked by a
15% increase in E/A ratio, and diminished mitochondrial respiration in young adult progeny (66).
These results were simultaneous with mitochondrial proton leak and increased uncoupling protein
2 (UCP2), as well as upregulation of mitochondrial metabolism proteins, carnitine
palmitoyltransferase 1A (CPT1A) and pyruvate dehydrogenase (PDH) phosphorylation. ENM
exposure during gestation also affects mitochondrial bioenergetics by limiting state 3 respiration
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in the left ventricle of young adult progeny, coinciding with impaired endothelium dependent
dilation in coronary and uterine arterioles (145). PM2.5 gestational exposure can trigger myocardial
apoptosis in a dose-dependent manner, as has been revealed in one day-old neonatal offspring from
Wistar rats (164). Myocardial cell death likely occurred due to alterations in mitochondrial
fission/fusion through OPA1, MFN1, DRP1, and FIS1 following PM2.5 exposure during gestation
(164). Utilizing functional genomics in addition to mitochondrial structural and bioenergetic
assessment, may provide insight into the mechanisms driving the deficits observed in progeny
whose dams were exposed to particulate matter during gestation.

Epigenetics and Transcriptional Regulation
Studies in progeny exposed to particulate exposure during a critical point in development
such as gestation, reveal that cellular regulatory networks are substantially altered, likely
contributing to sustained detrimental effects into adulthood. These regulatory systems include
epigenetic remodeling as well as non-coding RNA networks, which can act to reprogram the basal
cellular function in progeny and cause predisposition to metabolic disorders that modulate
analogous pathways. Maternal PM2.5 exposure during gestation can promote long-term cardiac
remodeling and causes cardiac hypertrophy in young adult progeny, with an increase in both total
histone acetylation and promoter acetylation of hypertrophy genes, GATA4 and myocyte enhancer
factor 2C (Mef2c) (174). This further suggests the ability of gestational PM exposure to induce
global epigenetic remodeling through transcriptional activation of acetylated regions in offspring.
Supporting these findings, multiple additional studies have reported a cardiac hypertrophic/fibrotic
phenotype, cardiac functional changes, and epigenetic reprogramming in early development due
to gestational PM exposure (153, 155, 174). Preconception exposure in both parents to PM2.5
resulted in progeny with decreased ejection fraction, fractional shortening, and cardiomyocyte
contractility at twelve weeks of age (153). Epigenetic assessments suggested changes that were
indicative of reprogramming induced by the particulate exposure, with decreased expression of the
maintenance methyltransferase DNMT1, but increased histone deacetylase sirtuin (SIRT) 1/2. This
pattern of expression may be explained by the ability of SIRT to regulate DNMTs and alter their
activity. Similar to preconception exposure, PM2.5 exposure during gestation also impaired cardiac
function of progeny at twelve weeks of age, revealed by decreased fractional shortening and left
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ventricular posterior wall thickness, and increased left ventricular systolic/diastolic diameters and
collagen deposition in cardiac tissue (155). Epigenetic regulation likely contributed substantially
to persistent cardiac detriments as seen in the preceding study. In contrast with preconception PM
exposure (153), gestational exposure decreased SIRT1/2 and increased DNMT1, DNMT3a, and
DNMT3b expression (155). Although there are differences in expression profiles of these
epigenetic regulators that likely stem from the time of exposure (preconception vs. gestation), both
are representative of profiles that can cause sustained biological detriments and/or susceptibility
to pathologic insult. ENM inhalation exposure during gestation causes similar changes to DNA
methylation machinery (87). Maternal exposure to nano-TiO2 during gestation decreases cardiac
output and increases left ventricular mass with a subsequent decrease in fractional shortening in
progeny. These functional alterations were linked to elevated levels of 5-methylcytosine (5-mC),
a marker of global DNA methylation, DNMT1 protein expression, and HIF-1α activity (87). Along
with DNA methylation, changes in the histone composition of DNA can contribute to modified
gene expression profiles. Chromatin immunoprecipitation sequencing for histone 3 lysine 4/27
trimethyaltion (H3K4me3 and H3K27me3), coupled with the transcriptomic profiling of fetal
cardiac tissue from dams exposed to ENM during gestation, has revealed significant changes to
major pathways including immune adaption and organismal growth (143). The authors suggest
that cardiovascular outcomes at the young adult stage may actually be linked to liver and fetal
development, evidenced through IPA protein ontology. MicroRNAs have also been implicated in
metabolic changes in offspring as a result of gestational particulate exposure (57). Diesel exhaust
exposure in utero decreased methylation of microRNA133a-2 at the promoter region in isolated
neonatal cardiomyocytes (57). As the progeny aged, introducing stress, such as transverse aortic
constriction, enhanced microRNA-133a-2 and decreased protein tyrosine phosphatase receptor
type F (PTPRF) and peptidase domain containing associated with muscle regeneration 1 (PAMR1)
expression, which mediate adult sensitivity to heart failure by inducing pathologic hypertrophic
signaling or preventing antihypertrophic signaling (57). Currently longitudinal studies on the
effects of maternal exposure to various pollutants on offspring cardiovascular function are limited.
Figure 1.3 provides a summary of the factors involved in epigenetic regulation that have been
discussed in this review, in the context of preconception/gestational particulate inhalation
exposure. Functional genomics studies that combine transcriptomic, proteomic, and metabolomic
data in cohorts presenting with particulate-induced cardiovascular alterations will provide a more
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thorough understanding of early epigenetic remodeling and its involvement in contributing to CVD
predisposition later in life.

Figure 1.3: Epigenetic Alterations.
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Figure 1.3: Epigenetic alterations observed following gestational and/or preconception particulate inhalation
exposures. Gene expression of GATA4 and MEF2C are increased through promoter acetylation at H3K9. MicroRNA133a-2 expression is repressed through elevated 5mC. DNA methyl transferases (DNMT1, DNMT3a, and DNMT3b)
are all increased following exposure, along with increased expression of transcription factors (STAT3 and HIF-1α).
H3K4me3 and H3K27me3 alterations are observed at promoter regions throughout the genome. The histone
deacetylases, SIRT1/2, reveal a dysregulated expression profile in progeny exposed during gestation. All abbreviations
are defined in the Abbreviations section provided.

Future Directions
From a morning commute, to an occupational setting, to our very homes, exposure to
particulates remains a central issue for debate and therapeutic/lifestyle interventions.
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Industrialization and increased urbanization will continue to exacerbate issues concerning air
quality and human health, unless better defined guidelines and limits are introduced. Although we
provide a summary of the molecular mechanisms propagating cardiovascular decline following
exposure in human and animal models, areas of research that are crucial in driving the field of
molecular inhalation cardiovascular toxicology forward, still remain uncharted. Future
investigations should aim to address understudied populations.
There are limited studies investigating whether increased particulate matter exposure is
associated with higher rates of cardiac arrest. One study that aimed to assess this association in
New York City reported that a 10 µg/m3 increase in PM2.5 one day before and day of the event
significantly increased the relative risk for a cardiac arrest in the warm season (141). Similar results
were seen in Melbourne (35), Copenhagen (168), Indianapolis (137), and Houston (42). Contrarily,
a study done in Stockholm (134) and several studies by a group in Washington (25, 92, 151), report
no association between PM exposure and out-of-hospital cardiac arrests. Nonetheless, due to the
high mortality rate associated with cardiac arrests, future studies should attempt to further clarify
these associations through assessment of molecular markers.
There has been a growing body of literature exploring the adverse outcomes of PM
exposure during gestation, including associations with metabolic dysregulation and cardiovascular
deficits. In addition to a necessity for a better understanding of how particles induce specific
changes during embryonic and fetal development, evaluation of the long-term effects is essential.
This is particularly important for determining whether particulate exposure during gestation elicits
alterations to the epigenome of offspring that can cause increased susceptibility to prevalent
metabolic disorders, including diabetes mellitus (100). Notably, recent research has revealed the
ability for prenatal and perinatal PM exposure to alter glucose metabolism (108) and elevate lowdensity lipoprotein cholesterol (LDL-C) (104), suggesting an increased risk of diabetes and
atherosclerosis. However, the molecular mechanisms were not evaluated. In order to address these
gaps in knowledge, focus must turn to the epigenetic effects following particle exposure during
intrauterine and early childhood development concomitantly with metabolic assessments, which
are currently meager (49, 78).
As we continue to shift the paradigm of cardiovascular research in inhalation toxicology,
much of the cellular and molecular mechanisms are yet to be discerned. Cell culture models of
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exposure interactions can help provide a foundational understanding of cell and organelle function
that cannot be fully captured through in vivo inhalation studies. While it remains outside the scope
of this review, in vitro models can provide a very granular, and controlled approach to mechanistic
evaluations. Of note, authors have recently investigated the effects of PM2.5 exposure (20, 34, 46,
73, 177, 178, 184), as well as the toxicology of nanomaterials and advanced materials (47, 75, 76,
176) in cells. Additionally, in vitro studies can provide preliminary data for determining how
complex and dynamic mixtures of particulate and gaseous substances affect cardiomyocytes,
establishing potential molecular mechanisms and thus setting a path for future in vivo experiments
(3, 67, 120).
Most of the current research is focused on ambient PM2.5 exposure, but with standards
being set based on mass, UFP concentration is not accounted for thoroughly due to their low mass.
However, the high surface area of UFP and ENM makes them considerably detrimental to health,
potentially even more than fine and coarse PM (148). As most ambient PM exposures are
performed by collection and monitoring of PM in different regions, the problem of variable PM
composition in these regions also arises. Integration of ENM exposure with UFP and PM multicomponent studies on both humans and mice, will allow for a more thorough interpretation of the
direct molecular mechanisms by which pollutants induce toxicity, while also allowing the most
relevant elucidation of overall health effects (148). Though co-exposure studies are becoming
more common in exploring the effects of present-day air pollution constituents on cardiac function
in healthy and metabolically-challenged systems (21, 45, 88, 119, 162), there is limited research
assessing both cardiac function and the associated molecular mechanisms, leaving a critical gap in
knowledge (3). This is one of the main limitations in many studies that could be addressed with
the identification of altered candidate genes via functional genomic approaches.
A clear necessity exists for more encompassing “omics” based approaches. While
investigators have begun to examine molecular modulators of the responses to inhalation exposure
in the heart, including protein and gene markers for inflammation, few studies have examined the
complete cellular protein, gene, or metabolic regulatory networks that coincide with the functional
and structural changes. The integration of transcriptomics, epigenomics, proteomics, and other
holistic approaches will provide a comprehensive understanding of cellular reprogramming, which
can be impacted by the size, source and duration of particle inhalation exposure (Figure 1.4). The
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implementation of these approaches will outline early biomarkers induced by particulate exposure,
ultimately encouraging exposure limits and standards that more precisely prevent the adverse
effects of inhaled toxicants.
Figure 1.4: Overview of Factors Contributing to Cardiovascular Response to Toxicant
Inhalation Exposure.
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Figure 1.4: An overview of various contributing factors that can differentially alter the cardiovascular responses to
toxicant inhalation exposure is provided. Current gaps in knowledge are outlined, including the lack of systemic
integration of omics data across varying inhalation exposure paradigms.
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Abstract
Background: Nano-titanium dioxide (nano-TiO2) is amongst the most widely utilized engineered
nanomaterials (ENMs). However, little is known regarding the consequences maternal ENM
inhalation exposure has on growing progeny during gestation. ENM inhalation exposure has been
reported to decrease mitochondrial bioenergetics and cardiac function, though the mechanisms
responsible are poorly understood. Reactive oxygen species (ROS) are increased as a result of
ENM inhalation exposure, but it is unclear whether they impact fetal reprogramming. The purpose
of this study was to determine whether maternal ENM inhalation exposure influences progeny
cardiac development and epigenomic remodeling.
Results: Pregnant FVB dams were exposed to nano-TiO2 aerosols with a mass concentration of
12.09 ± 0.26 mg/m3 starting at gestational day five (GD 5), for 6 hours over 6 non-consecutive
days. Aerosol size distribution measurements indicated an aerodynamic count median diameter
(CMD) of 156 nm with a geometric standard deviation (GSD) of 1.70. Echocardiographic imaging
was used to assess cardiac function in maternal, fetal (GD 15), and young adult (11 weeks) animals.
Electron transport chain (ETC) complex activities, mitochondrial size, complexity, and respiration
were evaluated, along with 5-methylcytosine, Dnmt1 protein expression, and Hif1α activity.
Cardiac functional analyses revealed a 43% increase in left ventricular mass and 25% decrease in
cardiac output (fetal), with an 18% decrease in fractional shortening (young adult). In fetal pups,
hydrogen peroxide (H2O2) levels were significantly increased (~10 fold) with a subsequent
decrease in expression of the antioxidant enzyme, phospholipid hydroperoxide glutathione
peroxidase (GPx4). ETC complex activity IV was decreased by 68% and 46% in fetal and young
adult cardiac mitochondria, respectively. DNA methylation was significantly increased in fetal
pups following exposure, along with increased Hif1α activity and Dnmt1 protein expression.
Mitochondrial ultrastructure, including increased size, was observed at both fetal and young adult
stages following maternal exposure.
Conclusions: Maternal inhalation exposure to nano-TiO2 results in adverse effects on cardiac
function that are associated with increased H2O2 levels and dysregulation of the Hif1α/Dnmt1
regulatory axis in fetal offspring. Our findings suggest a distinct interplay between ROS and
epigenetic remodeling that leads to sustained cardiac contractile dysfunction in growing and young
adult offspring following maternal ENM inhalation exposure.
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Background
An elevated risk of postnatal cardiovascular disease has been imputed to a toxic gestational
environment, when the fetus is at a critical point of development (9, 15). The adverse effects of
maternal prenatal disease and environment on future progeny were proposed as early as the 1990’s
with Barker’s contribution of the Developmental Origins of Health and Disease hypothesis (4, 29).
Recent studies have focused on the consequences of a baleful gestational environment, which
include endocrine disruptors, toxic metals, and the subsequent increase in progeny developing
cardiovascular, cancer, reproductive, immunological, and neurological diseases (5, 21, 36, 41, 64).
However, investigation into organ dysfunction and the molecular consequences of maternal
inhalation exposure to engineered nanomaterial (ENM) on developing offspring is lacking.
Titanium dioxide (TiO2) is one of the most widely used ENM, being incorporated into
toothpaste, cosmetic products, food, paint, and in clinical settings for drug delivery due to its
photocatalytic capabilities (47). Although TiO2 has provided a wealth of benefits in these
applications, the potential for adverse effects on manufacturers, consumers, and the environment
raise safety concerns that warrant elucidation. Nano-TiO2 exposure has been shown to have
detrimental effects on mitochondrial bioenergetics and cardiovascular function, which are
associated with increased levels of reactive oxygen species (ROS) (26). Mitochondrial and cardiac
dysfunction are often related due in part to the cardiomyocytes’ dependence on mitochondrial ATP
generation necessary for maintaining contractile function. Mitochondria are a primary target of
oxidant stress due to ROS generation that arises from the electron transport chain (ETC), which
can lead to peroxidation of biomembranes and impairment of ATP production (55). As a result,
antioxidant defenses are critical for mitochondrial functional preservation.
Using transcriptomics, we had previously found that maternal nano-TiO2 inhalation
exposure induces epigenetic remodeling in offspring through histone modifications (56).
Interestingly, an antioxidant defense protein, phospholipid hydroperoxide glutathione peroxidase
(GPx4), was the most significantly downregulated transcript (~9 fold) following exposure, when
evaluating proteins that are involved in mitochondrial functional processes (PRJNA513051).
GPx4 is an antioxidant enzyme that is a primary defense mechanism against oxidation of
mitochondrial biomembranes. We have previously reported that overexpression of a
mitochondrially-targeted GPx4, also known as mPHGPX, in a transgenic mouse model, was
capable of ameliorating H2O2 levels and improving mitochondrial and cardiac function in an acute
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nano-TiO2 inhalation exposure model (39), suggesting that it may be of particular relevance during
ENM exposure.
The adverse health effects of gestational ENM exposure on developing offspring have among
others been attributed to epigenetic alterations (26, 56). DNA methylation of cytosine, forming 5methylcytosine (5mC), was one of the first epigenetic modifications identified and it
predominantly

occurs

at

5-C-phosphate-G-3’

(CpG

sites).

The

maintenance

DNA

methyltransferase, DNMT 1, is responsible for mediating epigenetic memory by propagating the
initial signal, whereas DNMT 3A/3B are responsible for de novo methylation (32). An increase in
5mC at regulatory regions often results in gene repression and silencing (31). The cell alters CpG
methylation in an attempt to respond to environmental factors (28). During maternal ENM
exposure, toxic metals can interact with the uterine environment and cross the placental barrier
causing direct fetal exposure or indirectly eliciting a maternal immune response (9, 24).
Additionally, a direct effect on the fetus may be occurring as a result of changes in maternal-fetal
hemodynamics following maternal ENM inhalation exposure (1). ENM exposure during gestation
may affect fetal cardiac methylation transiently or permanently, resulting in epigenetic
reprogramming.
Previous studies have reported cardiovascular changes and epigenetic alterations in fetalstage offspring of rats exposed to inhaled nano-TiO2 during gestation, though the mechanisms
remain elusive (26, 56). We hypothesized that maternal nano-TiO2 exposure during gestation may
evoke epigenetic remodeling in the fetus initiated through oxidative stress, diminishing cardiac
bioenergetics and contractile function. In the current study, we utilized a mouse model of maternal
ENM inhalation exposure to explicate the interrelation between ROS (H2O2) and pathogenesis to
cardiac bioenergetic and contractile dysfunction at the acute stage (fetal) and chronic stage (young
adult) in progeny. Our study is the first to implement a mouse model in the molecular examination
of cardiac alterations elicited by maternal ENM inhalation exposure and the findings suggests that
the persistent deleterious consequences observed at the fetal stage may involve sustained
epigenetic reprogramming in the heart.
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Methods
Animal Model
The West Virginia University Animal Care and Use Committee approved all animal studies
which conformed to the most current National Institutes of Health (NIH) Guidelines for the Care
and Use of Laboratory Animals manual. Friend Virus B NIH Jackson (FVB/NJ) mice (32 females,
12 males at 7 weeks) were purchased from Jackson Laboratory (Bar Harbor, ME). Because FVB
mice have prominent pronuclei and reliably large litter sizes, this strain is useful in creating
artificial models that are capable of overexpressing or knocking out specific genes, which could
be useful in future investigations (65). Male and female FVB mice were housed in the West
Virginia University Health Sciences Center Animal Facility and given access to a rodent diet and
water ad libitum. Before mating, mice were acclimated for a minimum of 48 hours. Identification
of the vaginal plug was used to verify pregnancy (~5 days) before the pregnant dams were placed
randomly into either the Sham (15 pregnant dams) or nano-TiO2 exposure (11 pregnant dams)
group at approximately gestational day 5 (Sham = GD 4.4, nano-TiO2 = GD 4.7) (6 exposure
times). Echocardiographic assessments were performed on Sham and nano-TiO2 exposed pregnant
dams, as well as in the fetal (Sham = GD 14.4, nano-TiO2 = GD 13.8) and young adult (Sham =
10.6 weeks, nano-TiO2 = 10.5 weeks) offspring. Pregnant dams were euthanized (8 Sham and 6
nano-TiO2 exposed), and the pups were removed from the uterus of the Sham and nano-TiO2
exposed mothers. On average, pups and maternal tissue, were harvested at gestational days 15.4
(average of 9 pups per mom) and 14.8 (average of 10 pups per mom) from Sham and nano-TiO2
dams, respectively. The specific gestational days may vary by +1 due to plug checks being
administered every 24 hours. Each fetal sample contained all of the pooled tissue from one
individual mother separated by heart, lung, and liver. Mothers (7 Sham and 5 nano-TiO2 exposed)
belonging to the portion of the cohort to be used for the young adult study were placed back in
their individual cages after echocardiographic assessment. The offspring were born with the
singly-housed mothers. Lactation was allowed to occur without intervention and offspring were
weaned at 23.9 (Sham) and 22 (nano-TiO2) days, housed with offspring from the same mother,
and separated by male and female, with no more than 5 animals per cage. Young adult offspring
were euthanized, on average, at 10.8 weeks (Sham) and 10.7 weeks (nano-TiO2), followed by
tissue collection. One, randomly selected young adult was assessed from each mother (7 Sham and
5 nano-TiO2 exposed) for both groups, with 4 females, 3 males in the Sham group and 2 females,
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3 males in the nano-TiO2 group. The number of samples used per study may vary due to limitations
in variability of heart size between fetuses, resulting in lower amounts of protein content.

Engineered Nanomaterial Inhalation Exposure
Nano-TiO2 P25 powder containing anatase (80%) and rutile (20%) TiO2 was purchased
from Evonik (Aeroxide TiO2, Parsipanny, NJ) and prepared by drying, sieving, and storing as
previously described (35, 42) . The primary particle size (21 nm), the specific surface area (48.08
m2/g), and the Zeta potential (−56.6 mV) have been previously reported (39, 42, 48). The use of
the nanoparticle aerosol generator for rodent inhalation exposure has been previously described
(25). Aerosol characterization of nano-TiO2 data are shown in Figure 2.1. To model the lung
burden of nano-TiO2 exposure during manufacturing, a target aerosol mass concentration of 12
mg/m3 of engineered nano-TiO2 for a period of 360 minutes per day for 6 non-consecutive days
was chosen. Figure 2.1A shows the mass concentration measurements over a typical exposure
day; final measurements indicated a daily 360-minute equivalent average mass concentration of
12.09 ± 0.26 mg/m3. A high-resolution electrical low-pressure impactor (ELPI+; Dekati, Tampere,
Finland), a scanning particle mobility sizer (SMPS 3938; TSI Inc., St. Paul, MN), and an
aerodynamic particle sizer (APS 3321; TSI Inc., St. Paul, MN) were used to measure the size of
the nano-TiO2 aerosols. A log-normal fit of the data from the ELPI+ indicated an aerodynamic
aerosol size distribution with a CMD of 156 nm and GSD of 1.70 (Figure 2.1B). A log-normal fit
of the combined data from the SMPS and APS indicated a sized distribution with a CMD of 184
nm and GSD of 2.01 (Figure 2.1C). Scanning and transmission electron micrographs (SEM and
TEM) of nano-TiO2 aerosolized particles, sampled from the exposure chamber, are shown in
Figure 2.1D. The dose required to match the appropriate lung deposition was calculated based on
previously described mouse methodology (39). The formula 𝐷 = 𝐹 𝑥 𝑉 𝑥 𝐶 𝑥 𝑇, where F is the
deposition fraction (10%), V is the minute ventilation based on body weight (36.4 ml) (46) , C is
the mass concentration (12.09 mg/m3) and T is the exposure duration (360 minutes), was employed
(42, 57). This resulted in a daily deposited nano-TiO2 lung dose of 15.85 µg (total six exposure
dose =95.10 µg). Bedding material soaked with water was used in the exposure chamber to
maintain a comfortable humidity during the exposure. Control animals were exposed to HEPA
filtered air only with similar chamber conditions in terms of temperature and humidity. The last
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exposure was conducted 48 hours prior to sacrifice and tissue harvesting. A timeline for the study
can be seen in Figure 2.1E.

Echocardiography
Echocardiographic assessments were carried out as previously described (26, 39, 40, 52),
in both nano-TiO2 exposed (n = 11) and Sham filtered-air exposed pregnant dams (n = 15) as well
as in the pups at both the fetal (GD 14) and young adult (11 weeks) time points. Echocardiography
was analyzed for one fetal pup (first pup in either the right or left horn (n = 15 Sham, n = 11 nanoTiO2) and one young adult (n = 7 Sham, n = 5 nano-TiO2) from each mother that was exposed
during gestation. Each mouse was anesthetized with inhalant isoflurane, which was then
maintained at or below 1% isoflurane to ensure a physiologically relevant heart rate throughout
the experiment and reduce the anesthetic-induced effects on cardiac function. Motion mode (Mmode) echocardiographic and Pulse Wave Doppler images were obtained using the Vevo 2100
Imaging System (Visual Sonics, Toronto, Canada).
In maternal and young adult animals, grayscale M-mode parasternal short-axis images at
the mid-papillary level of the left ventricle (LV) were used for conventional echocardiographic
analysis. In M-mode, interventricular septal, inner, and posterior wall measurements were taken
to determine LV thickness on adjacent end-systolic and diastolic peaks in relation to LV trace
analysis. Mitral valve Doppler echocardiography was used to assess diastolic function by taking
measurements

of

E-

and

A-

wave

velocity,

deceleration

time,

intraventricular

relaxation/contraction time, E-wave-to-A-wave ratio, mitral valve area, etc. In fetal pups, cardiac
function was also assessed using M-mode and B-mode stress strain by visualizing individual pups
in the uterine horn (53). Pulse Wave Doppler echocardiography (Vascular Package) was also used
to assess umbilical and uterine flow in pregnant dams using measures of peak systolic velocity,
end diastolic velocity, and velocity-time integral (30). These measurements were calculated over
three cardiac cycles and averaged. All echocardiographic measurements were acquired by one
analyst blinded to the animal exposure group.

Speckle-Tracking-Based Strain
Speckle-tracking-based strain assessments were completed using short and long axis Bmode images as previously described by our laboratory (26, 40, 52). During each cardiac cycle,
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measures of strain (total deformation length divided by the original length of a segment, strain rate,
displacement length, and velocity) were obtained (8, 44). Endocardium walls were traced and
analyzed for three cardiac cycles using a speckle-tracking algorithm in Visual Sonics VevoStrain
software (Toronto, Canada). Time-to-peak analysis for curvilinear data, allowing strain and strain
rate to be determined, were generated. For maternal and young adult cohorts, speckle-tracking was
performed on both long and short axis B-mode images, while fetal groups were only assessed in
the short axis. All speckle-tracking-based strain analyses were completed by the same blinded
analyst.

Fetal Cardiomyocyte Isolation
Pregnant dams were euthanized one day after echocardiographic assessment, and pups
were removed at GD 15 from the nano-TiO2 exposed and Sham mouse uteri. Maternal and fetal
hearts were removed through a midsagittal cut in the thoracic cavity and fetal hearts were pooled
(one fetal heart from each exposed mother; Sham = 6 dams, nano-TiO2 = 5 dams) as previously
described (26, 54). The hearts were chopped up and initially washed with 1X ADS buffer (0.1 M
NaCl, 1.2 mM NaH2PO4, 0.8 mM MgSO4, 5.4 mM KCl, and 5 mM glucose at pH 7.4). Digestive
solution, comprised of 2 mg pancreatin (Sigma Aldrich, St. Louis, MO) and 2 mg of collagen type
II (Worthington Biochemical, Lakewood, NJ), mixed with 2 mL of physiological 1X ADS buffer
per heart digested, was used to isolate cells. The supernatant was removed from the tissue debris
and centrifuged at 180 x g for 7 minutes after each saved digestion. The supernatant was discarded,
and 2 ml of newborn calf serum were added to the cell suspension and stored in a 37°C incubator.
A Percoll gradient was made in a 15 mL conical tube for separation of cardiomyocytes
from other cells of the heart as previously described (26, 54). The Percoll gradient (density = 1.130
g/ml) was made of two layers: clear (top, density = 1.059 g/ml) and red (bottom, density = 1.082
g/ml). After all cell collection steps, cells were centrifuged at 180 x g and resuspended in 2 ml of
1X ADS buffer, per five hearts. The 2 milliliters of cells were added to the top of the Percoll
gradient and centrifuged at 1,620 x g for 30 minutes, with 9-min acceleration and deceleration
time. The non-myocardial mesenchymal cells were aspirated, and the cardiac cells were extracted
from the middle layer, washed with newborn calf serum, and placed in plating media (with fetal
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bovine serum). Two hours after placing in plating media, cells were changed to maintenance media
(no fetal bovine serum). Cells were counted using a hemocytometer.

Mitochondrial Isolation
Young adult mice (one from each exposed mother; Sham = 7, nano-TiO2 = 5)) were
sacrificed, and hearts were excised through a midsagittal cut in the thoracic cavity. Using
differential centrifugation, isolation of mitochondrial, cytosolic, and nuclear fractions was
achieved. Subsarcolemmal and interfibrillar mitochondrial subpopulations were isolated as
previously described (43) with modifications by our laboratory (6, 7, 18). Due to the limited
amount of subpopulation-specific mitochondria, the two subpopulations were combined. The
isolated mitochondria were then resuspended in KME buffer (100mM KCl, 50mM MOPS and
0.5mM EGTA pH 7.4). Protein concentrations were determined using the Bradford method with
bovine serum albumin as a standard (10).

Mitochondrial Respiration
Freshly isolated mitochondria (from young adults) were used to analyze state 3 and state 4
respiration as previously described (16, 60), with modifications by our laboratory (25). Once
isolated, mitochondria were resuspended in KME buffer and protein concentrations were
determined. Mitochondrial protein was added to respiration buffer (80 mM KCl, 50 mM MOPS,
1 mmol/l EGTA, 5 mmol/l KH2PO4 and 1 mg/ml BSA) and placed into a respiration chamber
connected to a multi-unit (8 channel) Oxytherm Peltier Electrode apparatus (Hansatech
Instruments, Norfolk, England). Glutamate (5 mM) and malate (5 mM) were used to initiate
maximal complex I-mediated respiration. State 3 (250 mM ADP) and state 4 (ADP-limited)
respiration data were expressed as nmol of oxygen consumed/min/mg protein.

Cellular and Tissue Bioenergetics
Fetal isolated cardiomyocytes were plated on F96 V3 cell culture microplates and the
Seahorse XF96 was used for analysis (Agilent Technologies, Santa Clara, CA) (26, 51). The
pooled samples of fetal cardiomyocytes from the pups of Sham (one pup from each of 6 dams,
n=1) and nano-TiO2-exposed (one pup from each of 5 dams, n = 1) females were analyzed 5 hours
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after plating and normalized to cell number. With the pooled samples, 5-6 replicates per animal
group were plated. Isolated cardiac tissue from the young adult offspring were plated on F24 V7PS cell culture microplates. Oxygen consumption rate, extracellular acidification rate, and proton
production

rate

were

measured

using

oligomycin,

carbonyl

cyanide-p-

trifluoromethoxyphenylhydrazone, antimycin A, and rotenone as previously described (66).
Mitochondrial respiration measurements included ATP production, proton leak, basal respiration,
maximal respiration, and spare capacity.

Mitochondrial Size and Internal Complexity
Size and internal complexity were analyzed in mitochondria isolated from young adult
offspring hearts using flow cytometry, as previously described (16, 18, 19, 25, 63). Isolated
mitochondria were loaded with the fluorescent probe Mitotracker Deep Red 633 (Invitrogen) for
assessment of mitochondrial size and internal complexity, utilizing the forward scatter (FSC), side
scatter (SSC), and Sphero AccuCount Blank Particles, 2.0 µm (Spherotech Inc., Lake Forest, IL)
sizing beads. Sizing beads allowed for absolute measurement of mitochondrial size through FSC.
All flow cytometric measures were captured using the LSRFortessa (BD Biosciences, Franklin
Lakes, NJ) at the West Virginia University Flow Cytometry & Single Cell Core Facility. To
process data, FCS Express Flow Research Edition (De Novo Software, Glendale, CA) was
implemented.

Electron Transport Chain (ETC) Complex Activities
ETC Complex activities (I, III, IV, V) were measured in maternal, fetal, and young adult
hearts, placenta, and fetal and young adult liver and lung as previously described (6, 16, 26, 51).
For the maternal, fetal, and young adult analyses, whole tissue was homogenized using the
Polytron PowerGen 500 S1 tissue homogenizer (Fisher Scientific, Hampton, NH) in RIPA buffer
(Life Technologies, Grand Island, NY). The Bradford assay provided normalization of samples by
protein content (10). Complex I (reduction of decyclubiquinone), complex III (reduction of
cytochrome c), complex IV (oxidation of reduced cytochrome C), and complex V (pyruvate kinase
and phosphoenolpyruvate and ATP production) activities were measured. Final values were
expressed as nanomoles consumed per minute per milligram of protein, which was equal to the
nanomoles of NADH oxidized per minute per milligram of protein.
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Hydrogen Peroxide (H2O2) Production
Cardiac H2O2 production was analyzed in maternal, fetal, and young adult hearts, placenta,
and in fetal and young adult liver and lung using Amplex Red fluorescent dye in the presence of
Horse Radish Peroxidase (HRP). The Amplex Red fluorescent dye reacts with H2O2 producing
resorufin, a red fluorescent oxidation product. Experiments were carried out using the
manufacturer’s protocol with minor modifications (39). Cardiac protein was incubated with HRP
and Amplex Red dye was added, followed by initiation of mitochondrial H2O2 production using
glutamate and malate as substrates. The Flex Station 3 fluorescent plate reader (Molecular Devices,
Sunnyvale, CA) was used to assess changes in fluorescence over time and allowed for
quantification of H2O2 production normalized per milligram of protein. Due to its electrical
neutrality providing the ability to infiltrate out of the mitochondrial membrane, measuring H2O2
as a method of assessing mitochondrial ROS production is a well-established method, along with
being more quantitative than methods used to detect other ROS (58). Additionally, assessment of
H2O2 levels is particularly important due to its high reactivity towards imperative cellular targets,
as compared to using other methods of determining ROS levels such as measuring superoxide,
which is not as reactive (58).

Western Blot Analyses
4-12% gradient Bis-Tris gels were used in SDS-PAGE as previously described (3, 6, 7, 18,
40, 60). Protein sample concentrations were standardized with bovine serum albumin using the
Bradford method (10). The primary antibodies used included the following: GPx4 (product no.:
10005258, Cayman Chemical, Ann Arbor, MI), Hif1 (product no.: sc53546, Santa Cruz
Biotechnology INC., Dallas, TX), Dnmt1 (product no.: sc271729, Santa Cruz Biotechnology), and
Dnmt3b (product no.: ab2851, Abcam, Cambridge, MA). The anti-GAPDH primary antibody
(product no.: ab8245, Abcam) was used to normalize protein levels for each blot. Secondary
antibodies used included the following: goat anti-mouse IgG HRP conjugate (product no.: 31430;
Pierce Biotechnology, Rockford, IL) and goat anti-rabbit IgG HRP conjugate (product no.:
10004301; Cayman Chemical). Pierce enhanced chemiluminescence Western blotting substrate
(Pierce Biotechnology) was used to detect signal per manufacturer’s instructions. The G:Box
Bioimaging system (Syngene, Frederick, MD) was used to detect signals, and data were captured
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using GeneSnap/GeneTools software (Syngene). Image J Software (NIH, Bethesda, MD) was used
to analyze densitometry. All values were expressed as optical density with arbitrary units.

5-mC DNA Analyses
20 mg of fetal and young adult tissue was cut into ~2 mm3 and the DNeasy Blood & Tissue
Kit (Qiagen, Hilden, Germany) was used, per manufacturer’s instructions, to isolate total DNA.
DNA methylation (5-methylcytosine; 5-mC) levels were quantified in the fetal and young adult
using a 5-mC DNA ELISA kit (Catalog no: D5326: Zymo Research Corp., Irvine, CA), per
manufacturer’s instructions. Briefly, 100 ng of DNA was run per well in duplicate on a 96-well
plate. DNA was denatured and bound to the 96-well plates. An anti-5-Methylcytosine monoclonal
antibody was used with a secondary antibody and HRP developer. Absorbance was measured
using the Flex Station 3 fluorescent plate reader (Molecular Devices, Sunnyvale, CA) at 450nm.
Using a logarithmic second-order regression equation, total percent (%) methylation was
determined.

Hif1 Transcription Factor Analyses
Hif1 transcription factor activity was assessed in maternal and fetal hearts, placenta, and
fetal lung and liver tissue samples using the Hif1 Transcription Factor Assay kit (Catalog no:
10006910: Cayman Chemical, Ann Arbor, MI), per manufacturer’s instructions. Briefly, fetal
nuclear extracts were run, 10 L per well, in duplicate on a 96-well plate, with the Hif1 response
element immobilized. Hif1 binds to the response element forming an active HIF transcription
factor, which was detected using a Hif1 primary antibody and a secondary antibody conjugated
to HRP. Colorimetric analysis was performed using the Flex Station 3 fluorescent plate reader
(Molecular Devices, Sunnyvale, CA) at 450 nm. The Hif1transcription factor activity was
normalized using the Bradford method and reported per microgram of protein (10).

DNMT Activity Analyses
DNMT activity in fetal heart was measured using a colorimetric assay kit (Catalog no: P3009: Epigentek Group Inc., Farmingdale, NY), per manufacturer’s instructions. Nuclear extracts
were loaded onto a 48-well microplate with Adomet, a universal DNMT substrate, and incubated
allowing the DNMT enzymes in the protein sample to transfer methyl groups from Adomet to
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cytosine, methylating DNA. The wells were washed, and the methylated DNA was captured using
an anti-5-mC antibody, then detected using a secondary antibody and enhancer solution.
Absorbance was measured using the Flex Station 3 fluorescent plate reader (Molecular Devices,
Sunnyvale, CA) at a wavelength of 450 nm and DNMT activity was proportional to the optical
density intensity measured. Samples were normalized using the Bradford method and reported per
microgram of protein (10).

Ex Vivo Micro-CT
Microcomputed tomography (micro-CT) was used to examine the anatomy of the fetal
mouse circulatory system as previously described (67). Briefly, one fetus was dissected from a
nano-TiO2 exposed dam and fixed in 10% formalin for 24 hours before being stained with Lugol
(product no.: L6146: Sigma Aldrich) solution containing iodine for one week. The fetus was then
taken out of the Lugol solution and transferred to a 0.1 N iodine solution (product no.: SI861:
Fisher Scientific, Hampton, NH) for one week. After staining, the sample was embedded in agar
to be imaged on a high-resolution micro-CT scanner. Imaging, which took approximately six
hours, was done with the scanner set to a voltage of 100kV and current at 100A.

Transmission Electron Microscopy
Mitochondrial ultrastructure was analyzed in four whole fetal hearts, two from each a Sham
and nano-TiO2 exposed mother, after being processed and imaged at the WVU Electron
Microscopy Histopathology and Tissue Bank. Due to their small size, the whole fetal hearts were
fixed in EM Primary Fixative (3% glutaraldehyde buffered with 0.1 M Cacodylate buffer) for 48
hours. After rinsing in 0.1 M Cacodylate buffer, the samples were fixed in 1% osmium
tetroxide/0.8% potassium ferricyanide solution for 1.5 hours, followed by an additional series of
0.1 M Cacodylate buffer washes. Samples were dehydrated through graded alcohols (50%, 75%,
95%, 100%) and acetone, and tissue were infiltrated with a mixture of acetone/resin for one hour
each at decreasing ratios (2:1, 1:1, 1:2) followed by 2 infiltrations with pure resin for an hour each
under vacuum. The whole fetal hearts were embedded into flat embedding molds and cured at
70˚C overnight. 15. Samples were then cut into 85nm sections on a LEICA UCT 9 Ultramicrotome
(Leica Microsystems, Wetzler, Germany) and mounted on copper-coated 200 mesh VELCO grids
(2 per sample). The grids were stained with uranyl acetate and lead citrate solutions and imaged
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using the JEOL 1010 TEM with side-mount AMT digital camera (JOEL, Akishima, Tokyo, Japan).
Semi-quantitative analyses of mitochondrial size were processed through Fiji (NIH). Six to eight
randomly selected TEM images of mitochondria per group were used to perform analyses.
Mitochondria were quantified through black & white thresholding using the Shanbhag method
(50), through individual tracings, color inversion, and quantification.

Statistics
All statistical analyses were performed using GraphPad Prism SoftwareVersion 7 for
Windows (GraphPad Software, La Jolla CA). To determine statistical significance between Sham
and nano-TiO2-exposed groups, a two-tailed Student’s t-test was used. Statistical difference was
defined by P  0.05 = *, P  0.01 = **, P  0.001 = ***. All data are presented as the mean ± the
standard error (SEM) of the mean.
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Results
Cardiac Function in Maternal, Fetal, and Young Adult Animals
Although nano-TiO2 inhalation exposure has been shown to negatively impact cardiac
function in murine models (26, 56), it is not known if these effects are mimicked following
maternal exposure in the fetus. In pregnant dams and fetal and young adult offspring, M-mode
(Table 2.1) was used to assess cardiac function. Both diastolic diameter and volume were
significantly decreased in the nano-TiO2 exposed pregnant dams as well as stroke volume and
cardiac output. Pulse Wave Doppler indices revealed a significant decrease in the Mitral Valve
(MV)-A velocity and a significant increase in MV deceleration - acceleration, MV deceleration
time, and E/A ratio in the nano-TiO2 exposed mothers (Figure 2.2A-D). Pulse Wave Doppler
revealed no significant changes in uterine flow (Supplemental Table 1), but a significant decrease
in umbilical end-diastolic velocity (Figure 2.2E). This effect may be occurring as a result of
increased vascular resistance in the in utero circulation, which has been shown to reduce placental
perfusion (1) and could increase the rate of perinatal mortality (20).
To better understand how maternal exposure alters fetal circulation, a micro-CT was
performed in a maternal nano-TiO2 exposed progeny (Figure 2.2F). The umbilical vein, whose
diameter can be measured as way of determining vascular resistance, is also illustrated (Figure
2.2F). Figure 2.2G shows a representative image of the uterine horn with two pups closest to the
cervix, as well as an illustration of how fetal cardiac tissue was gated. In order to assess fetal
cardiac function, each individual pup was visualized in the uterine horn and echocardiographic
scans were performed in utero to determine the effects of maternal ENM inhalation exposure. In
the fetal pups, M-mode measurements revealed a significant decrease in cardiac output and a
decrease in LV mass, indicating a decrease in heart size (Table 2.1). Following maternal ENM
inhalation exposure, young adult offspring showed a significant decrease in ejection fraction and
fractional shortening compared to controls, indicating changes in LV pump (Table 2.1). Pulse
Wave Doppler measurements were also taken at the young adult stage and indicated a significant
decrease in MV deceleration - acceleration and deceleration time (Figure 2.2H-I).
Speckle-tracking stress strain assessments of the pregnant dams and fetal and young adult
offspring are included (Supplemental Table 2.2-2.5). The maternal stress-strain measurements
indicated diastolic dysfunction by an increase in long axis diastolic radial velocity and strain rate,
with a significant decrease in long axis systolic radial displacement, radial velocity, and short axis
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circumferential strain. Short axis systolic radial strain rate and circumferential displacement were
both significantly decreased in the fetal offspring of ENM-exposed dams. Short axis diastolic
radial displacement was significantly decreased in the young adult and diastolic longitudinal
displacement was significantly increased.

Mitochondrial Bioenergetics
In order to elucidate whether the cardiac dysfunction seen in the offspring of ENM-exposed
dams was associated with dysregulation of mitochondrial bioenergetics, mitochondrial respiration
was assessed in isolated cardiomyocytes of the fetal pups as well as in isolated mitochondria and
whole tissue from young adult progeny. Basal and maximal respiration and ATP production were
decreased in the fetal pups of nano-TiO2 exposed dams as compared to those of Sham-exposed
dams (Figure 2.3A). No changes in state 3 and state 4 respiration, using both glucose and fatty
acid-mediated metabolism, were observed between the Sham- and nano-TiO2 exposed young adult
offspring (Supplemental Figure 2.1A), though in isolated cardiac tissue from the young adult, an
overall decrease in oxygen consumption rate was observed (Figure 2.3B). ETC complex activities
were evaluated in the fetal (Figure 2.3C) and young adult (Figure 2.3D) progeny heart with
additional measurements made in the maternal heart, placenta, and fetal and young adult lung and
liver (Supplemental Figure 2.1B-E). Interestingly, in the placenta, there was a significant
decrease in complexes III, IV and V activities in the nano-TiO2 exposed dams. ETC complex IV
activity (Figure 2.3C-D) was significantly decreased in both the fetal and young adult offspring
heart of ENM-exposed dams, further supporting alterations to mitochondrial bioenergetics (37).

H2O2-Mediated Pathways
H2O2 production was assessed in maternal, fetal, and young adult hearts, placenta, as well
as in fetal and young adult liver and lung. There was a significant increase in H2O2 content in the
fetal hearts of pups whose dams were exposed to nano-TiO2 (Figure 2.4A), with a decrease in
H2O2 content in the liver (Supplemental Figure 2.2A). There were no significant changes in H2O2
content in the young adult offspring heart (Figure 2.4A) or other young adult tissues
(Supplemental Figure 2.2A). Hif1 activity was measured to assess how H2O2 may influence the
transcription factor activity and binding. Hif1 activity was significantly increased in the hearts
of fetal offspring whose dams were exposed to nano-TiO2 (Figure 2.4B) as well as in the maternal
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heart (Supplemental Figure 2.2B). Intriguingly, there was a decrease in activity in the fetal lung
and liver tissues following nano-TiO2 inhalation exposure (Supplemental Figure 2.2B).
Because Hif1α is a regulator of Dnmt1 expression, we determined whether H2O2, induced
through nano-TiO2 inhalation exposure, was concomitant with increased transcription of Dnmt1
and, ultimately, DNA methylation patterns. Dnmt1 protein expression in the fetal heart reveled a
significant increase in pups whose dams were exposed to nano-TiO2 (Figure 2.4C). Although
there was an increase in Dnmt1 protein expression following exposure, Dnmt activity was not
significantly altered (Supplemental Figure 2.2C). Additionally, we found that Dnmt3b
expression was not changed, following maternal inhalation exposure to ENM in fetal offspring
(Supplemental Figure 2.2D). Global DNA methylation levels displayed a significant increase in
the hearts of the pups whose dams were exposed to nano-TiO2 (Figure 2.4D). While we observed
an increase in 5-mC DNA methylation in fetal pups whose dams were exposed to nano-TiO2,
development into adulthood revealed an inverse relationship, with a significant decrease in global
DNA methylation (Supplemental Figure 2.2E). Augmented 5-mC DNA methylation levels at the
fetal stage indicate that maternal nano-TiO2 exposure during gestation potentially results in the
repression of vital genes, which could lead to detrimental dysfunction. Furthermore, cardiac DNA
methylation at the fetal and young adult stages reveal an aberrant DNA methylation pattern, which
may be attributed to the Hif1α/Dnmt1 regulatory axis.

GPx4 Expression and Mitochondrial Structure
We next determined whether enhanced H2O2 levels are associated with the repression of
GPx4 protein expression. A significant diminution of GPx4 protein expression was revealed in the
fetal hearts of pups whose dams were exposed to nano-TiO2 during gestation (Figure 2.4E), while
GPx4 protein levels were unchanged in the young adult offspring (Figure 2.4F).
To determine if exposure to nano-TiO2 affected fetal mitochondrial ultrastructure, TEM
was implemented to assess mitochondrial size and complexity (Figure 2.5A). Using a semiquantitative approach, mitochondrial area and internal complexity were shown to be similar
between the Sham and nano-TiO2 groups, while mitochondrial roundness revealed a decrease in
the hearts of the maternal nano-TiO2 exposed fetal offspring (Figure 2.5B). To gain insight into
the impact of gestational nano-TiO2 exposure on mitochondrial ultrastructure at the young adult
stage, mitochondrial size (Figure 2.5C) and complexity (Figure 2.5D) were evaluated through
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flow cytometry. FSC (size) and SSC (internal complexity) were significantly increased in young
adult offspring whose dams were exposed to nano-TiO2 during gestation. These data are suggestive
of an alteration to mitochondrial ultrastructure as a result of gestational nano-TiO2 exposure; the
altered shape of fetal mitochondria could potentially influence the chronic changes to
mitochondrial size and internal complexity in the young adults, precipitating sustained
bioenergetic and cardiac dysfunction into adulthood.
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Discussion
The use of nanotechnology continues to increase in both the variety of applicable fields, as
well as the prevalence within those fields. Nano-TiO2’s high refractive index offers high opacity
and resistance to corrosion making it beneficial in the industries of paints, inks, papers, and plastics
(47). Unfortunately, the repercussions of the rampant use of ENMs remain unclear, along with the
mechanisms and solutions to the potential negative consequences. In order to determine how the
current exposure paradigm, which achieved a lung burden of 95.10 µg over 6 days, reflects ENM
occupational exposure in humans in a manufacturing setting, alveolar surface area was used as
previously described (2, 26, 56, 59). The mouse alveolar surface area is 0.05 m2 (59). Therefore,
the mouse lung burden of 95.10 µg would result in 1,902 µg/m2. Since the human alveolar surface
area is 102 m2, the human lung burden with this exposure paradigm would be 194.0 mg.
Furthermore, the number of working days it would take to achieve this lung burden in humans was
calculated:
𝑛𝑎𝑛𝑜 − 𝑇𝑖𝑂2 𝑎𝑒𝑟𝑜𝑠𝑜𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 ∙ 𝑚𝑖𝑛𝑢𝑡𝑒 𝑣𝑒𝑛𝑡𝑖𝑙𝑎𝑡𝑖𝑜𝑛
∙ 𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 ∙ 𝑑𝑒𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛,
with the following values:
194.0 𝑚𝑔 = 𝑛𝑎𝑛𝑜 − 𝑇𝑖𝑂2 𝑎𝑒𝑟𝑜𝑠𝑜𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
∙ 7600 𝑚𝑙/𝑚𝑖𝑛∙ (8ℎ𝑟𝑠/𝑑𝑎𝑦 ∙ 60 𝑚𝑖𝑛/ℎ𝑟) ∙ 14%,
therefore:
194.0 𝑚𝑔 = 𝑛𝑎𝑛𝑜 − 𝑇𝑖𝑂2 𝑎𝑒𝑟𝑜𝑠𝑜𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
∙ 0.51 𝑚3⁄𝑑𝑎𝑦
76 𝑑𝑎𝑦𝑠 = 194.0 𝑚𝑔/((5 𝑚𝑔/𝑚3 ) ∙ 0.51 𝑚3 ) nano-TiO2.

The National Institute for Occupational Safety and Health (NIOSH) Recommended
Exposure Limit for nano-TiO2 aerosol concentration is 0.3 mg/m3, while the Permissible Exposure
Limit set by the Occupational Safety and Health Administration is 5 mg/ m3 (56). Consequently,
it would require 76 days for a human to achieve analogous lung burdens with the exposure
paradigm used in this study. Thus, the findings are of practical relevance for those exposed in an
occupational context. Importantly, our results demonstrate that H2O2-induced stress from maternal
nano-TiO2 inhalation exposure impacts global DNA methylation remodeling, and is associated
with sustained mitochondrial bioenergetic and cardiac contractile dysfunction.
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Functioning mitochondria are necessary for providing the immense energy requirement
that drives cardiac contraction and relaxation. Thus, mitochondrial dysfunction has been widely
implicated as a precipitator of cardiac contractile dysfunction. ROS, such as H2O2, are a by-product
of oxidative phosphorylation, and as a result, the mitochondrion is an initial site of generation and
damage. Pathological conditions, such as those presented by ENM exposure, have been associated
with enhanced ROS production and mitochondrial dysfunction in cardiac tissue that may precede
contractile dysfunction (39). H2O2 accumulation in the heart following maternal inhalation
exposure to ENMs was significantly associated with negative consequences in the growing fetus,
but the direct link between maternal exposure and increased progeny cardiac H2O2 is unknown.
One theory suggests that changes in the placental environment, through changes in circulatory
flow or inflammation, can trigger tissue specific alterations in the progeny (17).
In the current study we have shown that umbilical blood flow, through a reduction in enddiastolic velocity, was significantly altered (Figure 2.2E). Following an ENM exposure paradigm
similar to the paradigm used for the current study, an increase in placental vascular resistance was
reported, substantiating the antagonistic effects of nano-TiO2 exposure during gestation (1).
Valentino et al. further validate placental circulatory remodeling through a significant decline in
placental flow in rabbits, which was observed following gestational exposure to diesel exhaust
(61). Additionally, they report decreased vascularization of the placental bed contributing to the
effect. Along with diminished maternal-to-fetal blood flow following inhaled gases and
particulates, an inflammatory response promoted through the vasculature could also be a
contributing factor in untoward cardiovascular events in the growing progeny. Interleukin 1 beta
(IL-1β), IL-6, and monocyte chemoattractant protein-1 (MCP-1) were shown to be significantly
elevated in maternal serum following inhalation exposure to ultrafine particulate matter (38).
While the direct link between cardiac ROS production/accumulation and alterations to the
placental environment are currently unknown, a strong link between placental mitochondrial
health (Supplemental Figures 2.1C-E) and fetal cardiovascular outcomes is undoubtedly present.
Following maternal ENM inhalation exposure, direct interaction of the ENM with the fetus,
maternal immune responses, or other responses involving alterations in blood supply or content
could all contribute to increased ROS in the cardiac tissue of the growing fetus. This increased
fetal ROS, which is returned to baseline in the young adult, likely contributes to sustained cellular
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consequences, such as abnormal mitochondrial bioenergetics and ultrastructure which have been
observed following ENM exposure, as well as disruption to the epigenome (25, 56).
Under normal conditions, oxygen-dependent prolyl hydroxylases target Hif1 for
proteasomal degradation; however, during hypoxic conditions, such as when ROS levels are
elevated, prolyl hydroxylase activity is limited by the lack of oxygen and therefore results in the
stabilization of Hif1 permitting dimerization with Hif1, which is constitutively expressed (13,
22, 34, 49). This promotes the formation of an active HIF transcription factor complex (14). The
Dnmt1 and Dnmt3b promoter regions contain the hypoxia response element (HRE), a consensus
sequence for a Hif1 binding site (62). We found a significant increase in Dnmt1 protein
expression, but not activity, further substantiating our hypothesis that in a high ROS environment,
elevated Hif1α activity leads to hypermethylation by causing an increase in Dnmt1 protein
expression through promoter binding. DNA hypermethylation can cause enhanced profibrotic
gene expression and the hypermethylation of CpG islands of vital genes, causing loss of gene
expression (62). This could in turn propagate mitochondrial dysfunction and increased size
associated with ENM exposure and increased ROS.
While the direct effects of ROS, such as disruption of protein structure and function, pose
a significant threat to cellular health, indirect effects, such as ROS-mediated epigenetic
remodeling, can have equal, if not more pronounced, ramifications. In melanoma cells, detachment
from the plating surface revealed an increase in ROS, including H2O2, as well as an increase in
global DNA methylation and Dnmt1 expression (11). When introducing an antioxidant, global
DNA hypermethylation and Dnmt1 increased expression was shown to be prevented. Outside of
global methylation, ROS can induce site-specific methylation profiles. H2O2 has been shown to
increase DNMT1 expression, resulting in hypermethylation and decreased expression of runt
domain transcription factor 3 (RUNX3) (33). Additionally, increased H2O2 has been linked to
DNA hypermethylation and silencing of miRNAs, which regulate the expression of multiple genes
and gene pathways in the cell (27). ROS have been linked to epigenetic modification of the
promoter region of other glutathione peroxide family members (GPX3) (45).
The schema provided in Figure 2.6 encompasses the overall mechanism hypothesized
based on the data in the current study. At the fetal stage, cardiac function is negatively impacted
through increased H2O2 levels, which can have negative consequences on mitochondrial function
and bioenergetics. The increased H2O2 can also lead to an activation of Hif1 activity, which is
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then able to transcriptionally activate the promoter region of a variety of genes, including Dnmt1
and other epigenetic machinery. Augmenting Dnmt1 expression would lead to a global or sitespecific increase in methylation, and in turn repress pivotal genes such as GPx4. By decreasing
antioxidant defenses (GPx4), a futile cycle would be propagated through a decreased ability to
scavenge ROS such as H2O2, resulting in a further increase in ROS. Cardiac and mitochondrial
dysfunction are therefore sustained into adulthood due to epigenomic remodeling that occurred at
the fetal stage.
The role of epigenetic remodeling has been investigated in terms of the intrauterine
environment and external stressors may have negative implications on the growing fetus (23, 64).
The offspring of mothers who had diabetes mellitus or were obese during gestation showed
increased incidence of epigenetic changes and an increased risk of type 2 diabetes mellitus and
other metabolic disorders that can lead to cardiovascular dysfunction (12). Alterations in the
epigenome of young adult offspring were also shown as a potential result of ENM exposure in
pregnant rats, which could enhance susceptibility to future insult (56). The demonstration of such
changes in a mouse model, as detailed in this study, opens up the possibility of examining the fetal
and young adult offspring epigenome using genetic manipulations (25, 39).
This study suggests potential mechanisms such as ROS, that can contribute to epigenomic
remodeling of the fetus, in utero, but the study is limited in unveiling larger pathways associated
with increased genome methylation. We provide a mechanism whereby ROS scavenging is
decreased, leading to the accumulation of ROS and ultimately methylation of the genome, but it is
likely that this pathway is more dynamic with other epigenetic machinery and transcription factors
that are altered. Future experimentation into the specific genes and regulatory pathways that are
hypermethylated may provide better insight into the mechanisms contributing to the sustained
mitochondrial and cardiac dysfunction observed.
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Conclusions
This study highlights disruptions in cardiac and mitochondrial function in offspring of
nano-TiO2 exposed mice during gestation. These dysfunctions are sustained into adulthood and
are most likely due to epigenetic reprogramming, mediated through enhanced H2O2 which occurs
during gestation in the growing fetus. Increased methylation and decreased GPx4 levels suggest
repression of important antioxidant proteins, thus perpetuating the inability to control elevated
ROS levels and leading to mitochondrial and cardiac dysfunction.
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Table 2.1: M-Mode Echocardiography
Maternal

Fetal

Young Adult

Parameter

Sham

Ex

Sham

Ex

Sham

Ex

Heart Rate
(BPM)

672.05 ±
8.30

685.39 ±
7.01

134.28 ±
8.72

118.94 ±
3.40

649.49 ±
23.72

601.87 ±
65.46

Diameter;s
(mm)

0.58 ±
0.05

0.59 ±
0.08

0.25 ±
0.02

0.24 ±
0.02

0.38 ±
0.05

0.73 ±
0.13*

Diameter;d
(mm)

2.70 ±
0.08

2.43 ±
0.05*

0.71 ±
0.02

0.69 ±
0.03

1.95 ±
0.13

2.25 ±
0.15

Volume;s
(uL)

0.64 ±
0.16

0.53 ±
0.16

0.05 ±
0.01

0.04 ±
0.01

0.14 ±
0.06

0.58 ±
0.13**

Volume;d
(uL)

27.60 ±
1.92

21.15 ±
1.13**

0.85 ±
0.08

0.79 ±
0.08

12.64 ±
2.21

14.50 ±
0.58

Stroke
Volume
(uL)

26.96 ±
1.83

20.43 ±
1.08*

0.80 ±
0.07

0.74 ±
0.07

12.46 ±
2.17

13.92 ±
0.48

Ejection
Fraction
(%)

97.84 ±
0.43

96.72 ±
0.99

95.16 ±
0.84

94.79 ±
0.67

98.84 ±
0.33

94.65 ±
1.53*

Fractional
Shortening
(%)

78.56 ±
1.67

75.89 ±
2.95

65.68 ±
2.31

65.62 ±
1.56

80.80 ±
1.89

68.38 ±
3.14**

Cardiac
Output
(mL/min)

18.17 ±
1.31

13.79 ±
0.67*

0.10 ±
0.01

0.08 ±
0.01*

8.30 ±
1.68

9.35 ±
0.34

LV Mass
(mg)

88.03 ±
4.89

75.53 ±
8.13

0.42 ±
0.04

0.74 ±
0.13*

83.42 ±
7.13

79.05 ±
5.59
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Table 2.1: M-mode echocardiography imaging following maternal nano-TiO2 inhalation
exposure. Measurements were taken for a minimum of 3 consecutive systolic and diastolic peaks
and troughs for maternal (n = 15 Sham, n = 11 Ex), fetal (n = 15 Sham, n = 11 Ex), and young
adult (n = 7 Sham, n = 5 Ex). Sham = control filtered air exposed, Ex = nano-TiO2 exposed,
Maternal (M) = 12 week old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks,
Diameter;d = diastolic diameter, Diameter;s = systolic diameter, LV Mass = left ventricular mass,
V;d = volume during diastole, V;s = volume during systole. All data are presented as the mean ±
standard error of the mean (SEM). * = P ≤ 0.05, ** = P  0.01, *** = P  0.001 for Ex vs. Sham.
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Figure 2.1: Exposure Paradigm

A

B

C
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Figure 2.1:

D

E
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Figure 2.1: Maternal nano-TiO2 inhalation exposure paradigm. (A) Real-time aerosol mass
concentration measurements of engineered nano-TiO2 during a typical maternal exposure with the
target concentration indicated by the red line (12mg/m3). (B) Aerodynamic diameter of nano-TiO2
(CMD = 156 nm) measured by high resolution electric low-pressure impactor (ELPI+). (C)
Diameter of nano-TiO2 (CMD = 184 nm) measured by combining scanning mobility particle sizer
(SMPS) and aerodynamic particle sizer (APS) measurements. Red line indicates log-normal fit.
(D) Transmission and scanning electron micrographs of nano-TiO2 aerosolized particles. (E) A
timeline of the study. CMD = Count Median Diameter. All data are presented as the mean ±
standard error of the mean (SEM).
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Figure 2.2: Pulse Wave Doppler and the Fetal Environment
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Figure 2.2:

F
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Figure 2.2:

G
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Figure 2.2: Pulse Wave Doppler assessment of Sham vs. nano-TiO2 exposed dams and their
offspring. (A) Maternal (n = 15 Sham, n = 11 Ex) Pulse Wave Doppler-Mitral Valve imaging
illustrating changes in MV-A velocity. (B) Maternal (n = 15 Sham, n = 11 Ex) Pulse Wave
Doppler-Mitral Valve imaging illustrating changes in MV Deceleration speed. (C) Maternal (n =
15 Sham, n = 11 Ex) Pulse Wave Doppler-Mitral Valve imaging illustrating changes in MV
Deceleration time. (D) Maternal (n = 15 Sham, n = 11 Ex) Pulse Wave Doppler-Mitral Valve
imaging illustrating changes in E/A ratio. (E) Pulse Wave Doppler-Flow indices revealed a change
in umbilical EDV. (F) Representative micro-CT image illustrating fetal organ complexity at GD
15 and the umbilical vein (circled in red). (G) Ultrasound image showing uterine horn containing
two fetal pups, a single fetal pup, and echocardiographic gating of the fetal with a representative
M-mode measurement. (H) Pulse Wave Doppler-Mitral Valve of young adult (n = 7 Sham, n = 5
Ex) following maternal exposure indicating changes in MV Deceleration speed. (I) Pulse Wave
Doppler-Mitral Valve of young adult (n = 7 Sham, n = 5 Ex) following maternal exposure
indicating changes in MV Deceleration time. Sham = control filtered air exposed, Ex = nano-TiO2
exposed, Maternal (M) = 12-week-old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) =
11 weeks, MV = Mitral Valve, EDV = End Diastolic Velocity, micro-CT = micro computed
tomography. All data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05,
** = P ≤ 0.01, *** = P ≤ 0.001 for Ex vs. Sham.
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Figure 2.3: Fetal and Young Adult Bioenergetics
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Figure 2.3:
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Figure 2.3: Mitochondrial bioenergetics from fetal and young adult offspring following
maternal nano-TiO2 inhalation exposure. (A) Seahorse analyses of cardiomyocytes at the fetal
stage (n = 1 Sham (one fetal heart from each of 6 dams pooled), n = 1 Ex (one fetal heart from
each of 5 dams pooled) plated as 5-6 replicates) indicating changes in ATP production and basal
and maximal respiration. (B) Seahorse analysis of young adult (n = 7 Sham, n = 5 Ex) animals
demonstrating a significant change in overall OCR. (C) ETC Complex Activities for complexes I,
III, IV, V (ATP synthase) in fetal offspring (n = 6 Sham, n = 5 Ex). (D) ETC Complex Activities
for complexes I, III, IV, V (ATP synthase) in young adult offspring (n = 7 Sham, n = 5 Ex). Sham
= control filtered air exposed, Ex = nano-TiO2 exposed, Maternal (M) = 12-week-old pregnant
dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks, OCR=Oxygen Consumption Rate,
ETC = Electron Transport Chain. Complex V is measured as nmol/min/mg of tissue. All data are
presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤
0.001 for Ex vs. Sham.
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Figure 2.4: Fetal and Young Adult ROS and Methylation
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Figure 2.4:
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Figure 2.4: Mechanisms governing cardiac and mitochondrial dysfunction following
maternal nano-TiO2 inhalation exposure. (A) Hydrogen peroxide (H2O2) concentration in fetal
(n = 6 Sham, n = 5 Ex) and young adult (n = 7 Sham, n = 5 Ex) animals, normalized to protein
content. (B) Hif1α activity was measured in fetal (n = 4 Sham, n = 5 Ex) heart and normalized to
protein content. (C) Dnmt1 protein expression was assessed in fetal (n = 4 Sham, n = 5 Ex) heart
and normalized using anti-Gapdh primary antibody. (D) Global 5-methylcytosine (5-mC) DNA
methylation levels were evaluated in fetal (n = 6 Sham, n = 5 Ex) hearts, normalized to DNA
concentration. (E) GPx4 levels were assessed in fetal (n = 4 Sham, n = 4 Ex) and (F) young adult
(n = 4 Sham, n = 5 Ex) animals and normalized using anti-Gapdh primary antibody. Sham = control
filtered air exposed, Ex = nano-TiO2 exposed, Maternal (M) = 12-week old pregnant dams, Fetal
(F) = GD (15), Young Adult (YA) = 11 weeks, Hif1α = Hypoxia-inducible factor 1-alpha, Dnmt1
= DNA (cytosine-5)-methyltransferase 1, GPx4 = Glutathione peroxidase 4. All data are presented
as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001 for
Ex vs. Sham.
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Figure 2.5: Mitochondrial Ultrastructure
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102

Figure 2.5:

103

Figure 2.5: Mitochondrial ultrastructure following maternal nano-TiO2 inhalation exposure.
(A) Transmission electron micrographs (TEM) of fetal cardiac tissue following Sham and nanoTiO2 maternal inhalation exposure. (B) Mitochondrial area, internal complexity (form factor), and
roundness (0-1, where 1 = perfect spheroid) were assessed through TEM (n = 2 Sham, n = 2 Ex).
(C) Mitochondrial size and (D) internal complexity were determined in young adult (n = 7 Sham,
n = 5 Ex) animals through FSC and SSC gating, staining mitochondria with MitoTracker™ Deep
Red FM/633. Sham = control filtered air exposed, Ex = nano-TiO2 exposed, Maternal (M) = 12week old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks, FSC = Forward
Scatter, SSC = Side Scatter. All data are presented as the mean ± standard error of the mean (SEM).
* = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001 for Ex vs. Sham.
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Figure 2.6: Overview
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ROS

Figure 2.6: Illustration of molecular pathways altered during maternal nano-TiO2 inhalation
exposure and physiological ramifications. Following maternal exposure, increased ROS in fetal
cardiac tissue and decreased mitochondrial ROS scavenging through GPx4 perpetuates a positive
feedback-loop where increased Hif1α activity acts to transcriptionally activate Dnmt1 and
ultimately increase global 5-methylcytosine levels. While ROS returns to control levels in the
young adult animals, fetal insult negatively influences mitochondrial and cardiac function in
maternal nano-TiO2 inhalation exposed progeny into adulthood. Maternal (M) = 12-week-old
pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks, ROS = reactive oxygen
species, GPx4 = Glutathione peroxidase 4, Hif1α = Hypoxia-inducible factor 1-alpha, Dnmt1 =
DNA (cytosine-5)-methyltransferase 1, Me = 5-methylcytosine.
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Supplemental Table 2.1: Pulse-Wave Doppler Maternal Flow

M Sham
Uterine

M Ex Uterine

M Sham
Umbilical

M Ex
Umbilical

Parameters

Units

End-Diastolic
Velocity

mm/s

46.66 ± 4.203 45.31 ± 6.686 9.864 ± 1.287

Peak-Systolic
Velocity

mm/s

129.3 ± 14.26 112.6 ± 11.57

Velocity Time
Integral

(VTI) mm

8.252 ± 0.786 8.296 ± 1.192 9.433 ± 0.907 8.012 ± 0.924

Velocity Time
Integral

(Mean Vel)
mm/s

81.54 ± 8.967 74.12 ± 8.954 36.83 ± 4.997 33.81 ± 3.237

Velocity Time (Mean Grad)
Integral
mmHg

0.025 ± 0.004 0.024 ± 0.005 0.007 ± 0.002 0.005 ± 0.001

Velocity Time
Integral

(Peak Vel)
mm/s

124.8 ± 12.46 118.79 ± 12.88 84.43 ± 10.15 78.14 ± 7.381

Velocity Time
Integral

(Peak Grad)
mmHg

0.077 ± 0.017 0.061 ± 0.012 0.033 ± 0.008 0.026 ± 0.004
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84.04 ±10.20

3.994 ±
0.792**

78.03 ± 7.367

Supplemental Table 2.1: Pulse Wave Doppler-Flow echocardiography for umbilical and
uterine flow following maternal nano-TiO2 exposure. Maternal (n = 12 Sham, n = 8 Ex).
Sham = control filtered air exposed, Ex = nano-TiO2 exposed, Maternal (M) = 12-week old
pregnant dams. All data are presented as the mean ± standard error of the mean (SEM). * = P ≤
0.05, ** = P  0.01, *** = P  0.001 for Ex vs. Sham.
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Supplemental Table 2.2: Stress-Strain Analysis – Short Axis – Diastole

Parameters

Units M Sham

Heart Rate

Radial Velocity
(Endo)

M Ex

F Sham

F Ex

YA Sham

YA Ex

beats/
123.6 ±
670.1 ± 9.4 684.2 ± 9.1
min
8.186

123.9 ±
9.679

632.1 ±
24.78

689.3 ±
8.156

Pk
cm/s

-3.913 ±
0.13

-3.336 ±
0.324

-0.227 ±
0.033

-0.163 ±
0.011

-2.210 ±
0.262

-2.481 ±
0.366

Radial
-0.004 ±
Displacement Pk mm
0.001
(Endo)

-0.008 ±
0.002

-0.005 ±
0.005

-0.011 ±
0.004

-0.0002 ±
0.0001

-0.020 ±
0.009*

Radial Strain
(Endo)

Pk %

-4.192 ±
1.288

-2.497 ±
0.536

-29.80 ±
7.744

-13.28 ±
3.711

-2.687 ±
1.264

-8.834 ±
4.281

Radial Strain
Rate (Endo)

Pk 1/s

-29.26 ±
4.182

-22.28 ±
1.672

-54.07 ±
4.292

-60.89 ±
4.576

-16.58 ±
2.631

-30.13 ±
10.87

Circumferential Pk
Velocity (Endo) deg/s

-698.1 ±
94.69

-811.1 ±
155.1

-444.17 ±
83.60

-398.8 ±
51.49

-608.8 ±
67.48

-473.5 ±
1215.5

Circumferential
-2.101 ±
Displacement Pk deg
0.603
(Endo)

-3.930 ±
1.974

-6.367 ±
1.440

-16.62 ±
3.183**

-6.108 ±
2.036

-6.623 ±
4.394

Circumferential
Pk %
Strain (Endo)

5.644 ±
1.792

2.076 ±
0.646

9.881 ±
4.341

7.888 ±
2.411

22.89 ±
21.61

15.58 ±
8.565

Circumferential
Strain Rate
Pk 1/s
(Endo)

47.67 ±
2.911

51.29 ±
3.699

12.660 ±
1.975

10.58 ±
1.394

38.43 ±
2.817

47.02 ±
11.50
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Supplemental Table 2.2: Diastole cardiac stress-strain in the short axis. B-Mode images
were used to examine radial and circumferential stress-strain parameters in the short axis during
diastole in maternal (n = 11 Sham, n = 15 Ex), fetal (n = 9 Sham, n = 9 Ex), and young adult (n =
7 Sham, n = 5 Ex) animals. Sham = control filtered air exposed, Ex = nano-TiO2 exposed,
Maternal (M) = 12-weekold pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks.
All data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, ** = P 
0.01, *** = P  0.001 for Ex vs. Sham.
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Supplemental Table 2.3: Stress-Strain Analysis – Short Axis – Systole

Parameters

Heart Rate

Units M Sham

beats/min

Radial Velocity (Endo) Pk cm/s

M Ex

YA
Sham

F Sham

F Ex

YA Ex

670.1 ± 684.2 ±
9.4
9.1

123.6 ±
8.186

123.9 ±
9.679

632.1 ± 689.3 ±
24.78
8.156

2.951 ± 2.854 ±
0.133
0.170

0.194 ±
0.035

0.173 ±
0.014

2.404 ± 2.754 ±
0.258
0.317

Radial Displacement
(Endo)

Pk mm

0.769 ± 0.700 ±
0.022
0.049

0.143 ±
0.012

0.128 ±
0.009

0.549 ± 0.629 ±
0.060
0.057

Radial Strain (Endo)

Pk %

39.26 ± 52.37 ±
3.328
4.428*

10.76 ±
0.960

11.82 ±
2.382

35.49 ± 39.28 ±
2.510
19.79

Radial Strain Rate
(Endo)

Pk 1/s

19.35 ± 19.47 ±
2.023
1.664

54.07 ±
9.664

8.464 ±
1.889**

27.10 ± 25.22 ±
6.571
8.153

Circumferential
Velocity (Endo)

Pk deg/s

695.5 ± 810.9 ± 404.25 ±
104.4
113.9
68.07

356.7 ±
37.99

724.9 ± 440.85 ±
143.5
46.91

Circumferential
Displacement (Endo)

Pk deg

6.384 ± 4.883 ±
0.652
0.817

2.954 ±
0.724**

3.190 ± 4.512 ±
0.899
1.424

Circumferential Strain
(Endo)

Pk %

-38.54 ± -54.51 ± -27.86 ± -25.12 ± -39.90 ± -39.94 ±
4.448
2.811*
2.405
3.225
7.110
8.000

Circumferential Strain
Rate (Endo)

Pk 1/s

-44.57 ± -46.94 ± -12.63 ± -8.919 ± -45.53 ± -45.22 ±
4.357
4.056
1.676
0.432
4.426
12.34

111

11.62 ±
2.265

Supplemental Table 2.3: Systolic cardiac stress-strain in the short axis. B-Mode images were
used to examine radial and circumferential stress-strain parameters in the short axis during
systole in maternal (n = 11 Sham, n = 15 Ex), fetal (n = 9 Sham, n = 9 Ex), and young adult (n =
7 Sham, n = 5 Ex) animals. Sham = control filtered air exposed, Ex = nano-TiO2 exposed,
Maternal (M) = 12-week old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11
weeks. All data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, **
= P  0.01, *** = P  0.001 for Ex vs. Sham.
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Supplemental Table 2.4: Stress-Strain Analysis – Long Axis – Diastole

Parameters

Heart Rate
Radial Velocity
(Endo)
Radial Displacement
(Endo)
Radial Strain (Endo)
Radial Strain Rate
(Endo)
Longitudinal Velocity
(Endo)
Longitudinal
Displacement (Endo)
Longitudinal Strain
(Endo)
Longitudinal Strain
Rate (Endo)

Units

M Sham

M Ex

YA Sham

YA Ex

beats/min 681.3 ± 11.66 708.0 ± 11.75 581.9 ± 54.00 679.1 ± 4.952

Pk cm/s -2.640 ± 0.146

-2.152 ±
0.128*

-1.691 ± 0.043 -1.736 ± 0.121

Pk mm

-0.006 ± 0.002 -0.002 ± 0.001 -0.003 ± 0.001 -0.007 ± 0.003

Pk %

-1.047 ± 0.234 -0.782 ± 0.213 -1.413 ± 0.280 -0.725 ± 0.282

Pk 1/s

-14.25 ± 0.980

-10.94 ±
0.933*

-9.768 ± 0.949 -9.205 ± 1.083

Pk deg/s -1.579 ± 0.246 -1.690 ± 0.152 -1.105 ± 0.119 -0.873 ± 0.169

Pk deg

-0.021 ± 0.006 -0.034 ± 0.010 -0.140 ± 0.034

-0.036 ±
0.016*

Pk %

4.654 ± 1.262 0.933 ± 0.352* 2.209 ± 0.737 1.841 ± 0.528

Pk 1/s

9.834 ± 1.207 11.89 ± 1.223 9.890 ± 1.586 9.867 ± 2.347
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Supplemental Table 2.4: Diastolic cardiac stress-strain in the long axis. B-Mode images
were used to examine longitudinal and circumferential stress-strain parameters in the long axis
during diastole in maternal (n = 11 Sham, n = 15 Ex), fetal (n = 9 Sham, n = 9 Ex), and young
adult (n = 7 Sham, n = 5 Ex) animals. Sham = control filtered air exposed, Ex = nano-TiO2
exposed, Maternal (M) = 12-week old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) =
11 weeks. All data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05,
** = P  0.01, *** = P  0.001 for Ex vs. Sham.
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Supplemental Table 2.5: Stress-Strain Analysis – Long Axis – Systole

Parameters

Units

M Sham

M Ex

YA Sham

YA Ex

Heart Rate

beats/min 681.3 ± 11.66 708.0 ± 11.75 581.9 ± 54.00 679.1 ± 4.952

Radial Velocity
(Endo)

Pk cm/s 2.054 ± 0.091 1.787 ± 0.060* 2.003 ± 0.142 1.954 ± 0.070

Radial Displacement
Pk mm 0.574 ± 0.023
(Endo)

0.469 ±
0.022**

0.468 ± 0.037 0.479 ± 0.038

Radial Strain (Endo)

Pk %

33.33 ± 2.797 27.53 ± 2.388 27.39 ± 3.189 27. 33 ±0.595

Radial Strain Rate
(Endo)

Pk 1/s

12.07 ± 1.203 10.94 ± 1.357 9.365 ± 0.809 10.49 ± 0.621

Longitudinal
Velocity (Endo)

Pk deg/s 1.245 ± 0.131 1.466 ± 0.092 0.997 ± 0.215 0.923 ± 0.248

Longitudinal
Pk deg
Displacement (Endo)

0.237 ± 0.040 0.247 ± 0.035 0.065 ± 0.011 0.100 ± 0.022

Longitudinal Strain
(Endo)

Pk %

-7.070 ± 1.597 -10.40 ± 1.741 -12.15 ± 2.510 -16.87 ± 2.052

Longitudinal Strain
Rate (Endo)

Pk 1/s

-7.309 ± 2.845
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-11.80 ±
1.789*

-10.40 ± 1.282 -8.526 ± 1.306

Supplemental Table 2.5: Systolic cardiac stress-strain in the long axis. B-Mode images were
used to examine longitudinal and circumferential stress-strain parameters in the long axis during
systole in maternal (n = 11 Sham, n = 15 Ex), fetal (n = 9 Sham, n = 9 Ex), and young adult (n =
7 Sham, n = 5 Ex) animals. Sham = control filtered air exposed, Ex = nano-TiO2 exposed,
Maternal (M) = 12-week old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11
weeks. All data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, **
= P  0.01, *** = P  0.001 for Ex vs. Sham.
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Supplemental Figure 2.1: Bioenergetics

117

Supplemental Figure 2.1:
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Supplemental Figure 2.1:
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Supplemental Figure 2.1: Mitochondrial bioenergetics of other tissues and organ systems.
(A) In young adult (n = 7 Sham, n = 5 Ex) animals state 3 and state 4 respiration was assessed
using glucose (glutamine) and fatty-acid-mediated pathways (palmitoyl carnitine), normalized to
number of mitochondria. (B) ETC complex activities for complex I in fetal, young adult, and
maternal tissues. (C) ETC complex activities for complex III in fetal, young adult, and maternal
tissues. (D) ETC complex activities for complex IV in fetal, young adult, and maternal tissues. (E)
ETC complex activities for complex V (ATP synthase) in fetal, young adult, and maternal tissues.
Sham = control filtered air exposed, Ex = nano-TiO2 exposed, Maternal (M) = 12-week old
pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks, P-Carnitine = palmitoyl
carnitine. All data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, **
= P  0.01, *** = P  0.001 for Ex vs. Sham.
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Supplemental Figure 2.2: ROS-Mediated Effects
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Supplemental Figure 2.2:
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Supplemental Figure 2.2: ROS-mediated pathways in other tissues and organ systems. (A)
Hydrogen peroxide (H2O2) concentration in fetal, young adult, and maternal tissues normalized to
protein content. (B) Hif1 activity was measured in fetal and maternal tissues and normalized to
protein content. (C) Activity of DNA methyltransferases (Dnmts) in fetal (n = 4 Sham, n = 5 Ex)
heart tissue, normalized to protein content. (D) Dnmt3b expression levels were assessed in young
adult (n = 3 Sham, n = 3 Ex) animals and normalized using anti-Gapdh primary antibody. (E)
Global 5-mC DNA methylation levels were evaluated in young adult (n = 7 Sham, n = 5 Ex) hearts,
normalized to DNA concentration. Sham = control filtered air exposed, Ex = nano-TiO2 exposed,
Maternal (M) = 12-week old pregnant dams, Fetal (F) = GD (15), Young Adult (YA) = 11 weeks,
Hif1α = Hypoxia-inducible factor 1-alpha. Dnmt3b = DNA (cytosine-5)-methyltransferase 3b. All
data are presented as the mean ± standard error of the mean (SEM). * = P ≤ 0.05, ** = P  0.01,
*** = P  0.001 for Ex vs. Sham.
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Abstract
Maternal engineered nanomaterial (ENM) exposure during gestation has been associated with
negative long-term effects on cardiovascular health in progeny. Here we evaluate an
epitranscriptomic mechanism that contributes to these chronic ramifications and whether
overexpression of mitochondrial phospholipid hydroperoxide glutathione peroxidase (mPHGPx)
can preserve cardiovascular function and bioenergetics in offspring following gestational nanotitanium dioxide (TiO2) inhalation exposure. Wild-type (WT) and mPHGPx (Tg) dams were
exposed to nano-TiO2 aerosols with a mass concentration of 12.01 ± 0.50 mg/m3 starting from
gestational day (GD) 5 for a period of 360 mins/day for 6 non-consecutive days over an 8-day
period. Echocardiography was performed in pregnant dams, adult (11-week old) and fetal (GD 14)
progeny. Mitochondrial function and global N6-methyladenosine (m6A) content were assessed in
adult progeny. MPHGPx enzymatic function was further evaluated in adult progeny and m 6ARNA immunoprecipitation (RIP) was combined with RT-qPCR to evaluate m6A content in the 3’UTR. Following gestational ENM exposure, global longitudinal strain (GLS) was 32% lower in
WT adult offspring of WT dams, with preservation in WT offspring of Tg dams. MPHGPx activity
was significantly reduced in WT offspring (29%) of WT ENM-exposed dams, but preserved in
progeny of Tg dams. M6A-RIP-qPCR for the SEC insertion sequence region of mPHGPx revealed
hypermethylation in WT offspring from ENM-exposed WT dams, which was thwarted in the
presence of the maternal transgene. Our findings implicate that m6A hypermethylation of mPHGPx
may be culpable for diminished antioxidant capacity and resultant mitochondrial and cardiac
deficits that persist into adulthood following gestational ENM inhalation exposure.

Keywords: Environmental exposure, GPx4, Mitochondria, N6-methyladenosine, M6A
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Introduction
While engineered nanomaterials (ENMs) and advance materials, have enabled important
innovations in biomedical engineering, the increased potential for their interactions with biological
tissues warrants assessment of their ability to elicit undesirable toxicological effects (11, 15, 52).
The application of nano-titanium dioxide (nano-TiO2), a commonly utilized ENM, escalated by
300% from 2011-2013 in consumer products (72). The primary route of exposure is inhalation,
which allows particles to enter the bloodstream and systemically impact the body (66). The size of
these particles (≥1 dimension that is ≤100 nm in diameter), plays a critical role in their ability to
access systemic circulation and promote cardiovascular damage (32, 36, 52, 55, 66). Nano-TiO2
has been implicated in alterations to cardiovascular hemodynamics and mitochondrial
dysregulation (23, 24, 45). Exposure to ENMs are of particular concern for vulnerable populations
such as the developing fetus (11, 21). Although research relating to particulate matter exposure
during gestational development and the associated detriments are receiving more attention,
therapeutic interventions are limited and the identification of mechanisms responsible for long
term effects remain undefined.
Initial studies from our laboratory have determined that maternal ENM inhalation exposure
during gestation elicits cardiac contractile dysfunction and bioenergetic disruption in the
developing fetus (35), which are sustained into adulthood (24, 35). At the fetal stage, the functional
deficits were attributed to an increased production of reactive oxygen species (ROS) (marked by
hydrogen peroxide (H2O2) levels) and downregulation of mitochondria phospholipid
hydroperoxide glutathione peroxidase (mPHGPx) (35), an antioxidant enzyme that protects cells
from oxidative stress. Because mPHGPx scavenges hydroperoxides, limiting diffusion of H2O2
from the mitochondrion into other cellular regions, its expression is critical for decreasing ROS
influence on nuclear genome regulation. MPHGPx has the ability to mitigate cardiac dysfunction
and bioenergetic dysregulation in several contexts (6, 16, 26) , including acute nano-TiO2 exposure
(45). However, whether enhanced antioxidant capacity can provide a protective role to fetal and
adult offspring following maternal ENM inhalation exposure during gestation remains unexplored.
In a previous study from our laboratory, we reported mitochondrial and cardiac contractile
decrements in the fetal stage that were sustained into adulthood following maternal ENM
inhalation exposure (35). Though the mechanism by which these detriments are sustained is
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unclear, epitranscriptomic modifications resulting from maternal ENM exposure may be
contributing to the persistent cardiac mitochondrial dysfunction observed. Of interest was our
observation of increased ROS and concomitant diminution of mPHGPx protein expression at the
fetal stage which may have been associated with epigenetic reprogramming that occurs following
particulate exposure (11, 21, 29, 33, 35, 63, 71). Specifically, epitranscriptomic mechanisms may
be responsible for degradation of mRNA and/or functional deficits in proteins (19, 37, 44). N6methyladenosine (m6A) is the most prevalent post-transcriptional mRNA modification in
eukaryotes and has been associated with various pathologies (13, 14, 19, 39, 56, 77). Elevated
stress levels have the ability to alter m6A machinery and therefore modulate transcript stability by
adding and removing methylation marks (9, 19, 37, 61, 77). M6A sites are known to be enriched
near stop codons and in 3’-untranslated regions (UTR) of mRNA (73), thereby influencing
translation (43). Investigation of m6A sites in crucial coding regions of nuclear genome-encoded
mitochondrial mRNAs that are pivotal for antioxidant defense maintenance is of particular interest,
as it may provide insight into mechanisms that result in the longitudinal outcomes of maternal
ENM exposure during gestation.
We hypothesize that altered m6A status of the 3’-UTR of mPHGPx in the hearts of adult
offspring contributes to mitochondrial and cardiac functional deficits and that overexpression of
mPHGPx (in the mother or pup) can preserves these functional alterations following maternal
ENM inhalation exposure. Through the use of differential breeding strategies, we were able to
determine that the maternal transgene is protective for the fetus and the benefit is sustained in adult
offspring, regardless of whether the progeny also possessed the transgene. Following gestational
ENM inhalation exposure, mPHGPx enzymatic activity was entirely preserved only in offspring
whose dams were mPHGPx transgenic. M6A methylation was highly enriched in the 3’-UTR of
mPHGPx in wild-type (WT) offspring exposed in utero to nano-TiO2, but maternal mPHGPx
overexpression prevented this modification. Our findings suggest that enhancing antioxidant
defense in the pregnant dam may provide offspring with the most protection from
epitranscriptomic remodeling and subsequent long-term cardiovascular repercussions that arise
following gestational nano-TiO2 inhalation exposure.
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Materials and Methods
Animal Model
The West Virginia University Animal Care and Use Committee approved all animal studies
which conform to the most current National Institutes of Health (NIH) Guidelines for the Care and
Use of Laboratory Animals (8th edition) manual. Male and female transgenic (mPHGPx (+/+)) and
wild-type (mPHGPx (-/-)) mice with a FVB/NJ genetic background were housed in the West
Virginia University Health Sciences Center Animal Facility. All animals were given access to a
rodent diet and water ad libitum. The mPHGPx transgenic mouse model has been previously
described by our laboratory (6, 16). Briefly, to achieve overexpression of mPHGPx, the gene was
placed under the control of the cytomegalovirus promoter, which provides robust transgene
expression. Transgene screening was performed on tail clip DNA of 3-week old mice using a
qPCR approach in which we probed for mPHGPx using a fluorometric probe (Product no.
Mm00515041_m1, Applied Biosystems, Foster City, CA). Increased mPHGPx protein content
and improved scavenging ability for phosphatidylcholine hydroperoxide (PCOOH) and hydrogen
peroxide (H2O2) in the mPHGPx transgenic mice indicated a functionally active enzyme (16).
MPHGPx overexpression as an antioxidant protective strategy was tested in multiple contexts
utilizing complementary breeding strategies (Figure 3.1A-B). Because mPHGPx mice are
heterozygous transgenic, the transgene status of the donor parent (paternal vs. maternal) impacts
the nature of the protective strategy provided to the offspring. Presence of the paternal mPHGPx
transgene (Paternal mPHGPx Maternal Exposure (PPME)) enabled a portion of the litter (~50%)
to be mPHGPx transgenic positive (Figure 3.1A, right panel) and thus presented the opportunity
to determine whether fetal mPHGPx transgene presence is protective in utero and adult offspring.
Presence of the maternal mPHGPx transgene (Maternal mPHGPx Maternal Exposure (MPME))
enabled a portion of the litter (~50%) to be mPHGPx transgenic (Tg) as well, but with the added
benefit of the maternal mPHGPx transgene (Figure 3.1A, left panel). This breeding strategy
allowed us to delineate whether mPHGPx transgene presence in the environment provided by the
dam is beneficial to non-transgenic progeny or additional benefit to transgenic progeny. Pregnancy
was verified by identifying the vaginal plug. Approximately 5 days after identification of the
vaginal plug (gestational day 5 (GD 5)), the pregnant dams were designated into either sham or
nano-TiO2 exposure groups. Echocardiographic assessments were performed on adult offspring
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(11 weeks old), as well as pregnant dams (12 weeks old) and fetal-stage progeny (GD 14). For the
adult offspring study, pups remained with the singly-housed dams until weaning age (19 days) at
which point they were housed with littermates and separated by sex, with no more than 5 animals
per cage. Adult progeny were euthanized at ~11 weeks of age and hearts were excised for further
analyses. From each adult litter, one animal of each genotype (WT/Tg) was randomly selected and
designated N = 1, alternating selection of male and female offspring to control for sex as a
biological variable. All offspring were genotyped using the qPCR method described above.
Pregnant dams were euthanized one day following echocardiographic imaging (GD 15), the pups
were removed and tail clips were collected for genotyping. Adult offspring and pregnant dams
were euthanized through sedation with 5% isoflurane and subsequent cervical dislocation. A
timeline of the study is provided in Figure 3.1C.

Engineered Nanomaterial Inhalation Exposure
The ENM inhalation exposure paradigm utilized in the current study has been previously
described (23). Nano-TiO2 P25 powder containing anatase (80%) and rutile (20%) TiO2 was
purchased from Evonik (Aeroxide TiO2, Parsipanny, NJ) and prepared by drying, sieving, and
storing (23, 34, 47). The primary particle characteristics have been previously reported including
the size (21 nm), the specific surface area (48.08 m2/g), and the Zeta potential (−56.6 mV) (45, 47,
58). Nano-TiO2 was aerosolized with a high-pressure acoustical generator (HPAG; IEStechno,
Morgantown, WV), and has been detailed in previous studies (23) involving rodent inhalation
exposure. Figure 3.2 provides data outlining the aerosol characterization of nano-TiO2. In order
to recapitulate a lung burden typically seen in a manufacturing setting exposure (35), a target
aerosol mass concentration of 12 mg/m3 of engineered nano-TiO2 was chosen, for a period of 360
minutes per day for 6 non-consecutive days over an 8-day period, with a whole-body exposure
chamber. This level was based on human equivalent alveolar doses during pregnancy and is
explained in more detail later in the manuscript. The real-time TiO2 aerosol mass concentration
readings (pDR-1500; Thermo Environmental Instruments Inc., Franklin, MA) over a typical
exposure day were sampled from an exposure chamber (Figure 3.2A) and verified by gravimetric
measurements during each exposure. Final gravimetric measurements indicated a daily 360minute equivalent average mass concentration of 12.01 ± 0.50 mg/m3. A high-resolution electrical
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low-pressure impactor (ELPI+; Dekati, Tampere, Finland), a scanning particle mobility sizer
(SMPS 3938; TSI Inc., St. Paul, MN), and a Nano Micro-Orifice Uniform Deposit Impactor
(MOUDI 115R; MSP Corp, Shoreview, MN) were used to measure the size of the nano-TiO2
aerosols. A log-normal fit of the data from the ELPI+ indicated a geometric count median diameter
(CMD) of 0.163 µm with a geometric standard deviation (GSD) of 1.77 (Figure 3.2B). A lognormal fit of the data from the SMPS indicated a CMD of 0.190 µm with a GSD of 1.97 (Figure
3.2C). A log normal fit of the data from the MOUDI indicated a mass median aerodynamic
diameter (MMAD) of 0.968 µm with a GSD of 2.56 (Figure 3.2D). Transmission and scanning
electron micrographs (TEM and SEM) of nano-TiO2 aerosolized particles, sampled from the
exposure chamber have been previously published (35). The dose required to match the
appropriate lung deposition was calculated based on previously described mouse methodology
modified to reflect alveolar deposition only (45). The formula D=F x V x C x T, where F is the
alveolar deposition fraction (4.40%) ((Multiple Path Particle Dosimetry Model (MPPD v3.04))
(2), V is the minute ventilation based on body weight (36.4 ml) (10), C is the mass concentration
(12.01 mg/m3) and T is the exposure duration (6 hours), was employed (47, 64). This resulted in a
daily deposited nano-TiO2 alveolar dose of 6.92 µg (total six exposure dose = 41.55 µg). When
this alveolar burden is normalized with respect to alveolar surface area (mousesa = 0.05m3, humansa
= 102 m3) and matched to a human breathing the same aerosol, it corresponds to a human alveolar
deposition of 84.76 mg. This is equivalent to an approximately 79 day exposure at the NIOSH
recommended exposure limit (REL) of 2.4 mg/m3 for fine TiO2 established in 2011 (17) (F =
12.24% (MMPD), V = 7.6 L). Since factory workers are exposed to airborneTiO2 levels of ~ 0.65
mg/m3 (51) and the human gestational period is 9 months, we feel that our exposure concentration
levels are highly relevant to the female worker population. To maintain a comfortable humidity
during the exposure, bedding material was soaked in water and placed in the exposure chamber.
Control animals (sham) were exposed to HEPA filtered air, rather than nano-TiO2, in a designated
chamber with similar chamber conditions. The final exposure was administered 48 hours prior to
sacrifice and tissue harvesting.

Echocardiography
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Cardiac contractile function was assessed in adult offspring (11 weeks old) using the
Vevo2100 High Frequency Ultrasound system (Visual Sonics, Toronto, Canada) to obtain Motion
mode (M-mode) images as previously described (35). Anesthesia was induced using inhalant
isoflurane, which was then maintained at ~1.5% in order to achieve a physiologically relevant
heart rate. Images were acquired with a linear array transducer at 32–40 MHz, with a frame rate
of 233–401 frames/second. M-mode images were also obtained for pregnant dams (12 weeks old)
and their fetal progeny (GD 14). For fetal echocardiographic imaging, pups in the right and left
uterine horns were imaged sequentially, which allowed us to correlate the assessed cardiac
function with the genotype of that specific pup. For adult offspring analyses, one animal of each
genotype (WT/Tg) from each exposed (sham/nano-TiO2) dam (PPME (WT mom) or MPME (Tg
mom) was selected at random. Measurements were calculated over three cardiac cycles and
averaged.
Speckle-tracking-based strain evaluations were performed using parasternal long and short
axis B-mode images as previously described by our laboratory (24, 35, 46, 59). A speckle-tracking
algorithm in Visual Sonics VevoStrain software (Toronto, Canada) was employed to trace the
endocardium and epicardium walls. Data were analyzed for three cardiac cycles using time-topeak analysis for curvilinear data. Measures of systolic strain including deformation, strain rate,
displacement, and velocity were obtained. For adult progeny, speckle-tracking was performed on
both long- and short-axis images. For fetal progeny, speckle-tracking was performed on short-axis
images. All echocardiographic measurements were acquired by one analyst blinded to the animal
exposure group and genotype.

Electron Transport Chain (ETC) Complex Activities
ETC Complex activities (I, III, IV, and V) were measured in hearts of adult offspring as
previously described (4, 6, 24). Whole tissue was homogenized using the Polytron PowerGen 500
S1 tissue homogenizer (Fisher Scientific, Hampton, NH) in NP-40 buffer (20mM Tris, 137mM
NaCl, 10% Glycerol, 1% Triton x100, 2mM EDTA) (25). Samples were centrifuged for 10 minutes
at 10,000 xg (4°C) and the supernatant was used for the activity assays. The protein homogenates
were used to measure activities of ETC complexes I, III, IV, and V (ATP synthase). ETC complex
I and III activities were determined by measuring the reduction of decylubiquinone (I) and
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cytochrome c (III) in cardiac protein lysate of adult offspring. ETC complex IV activity was
determined by measuring the oxidation of reduced cytochrome c, while complex V activity was
determined by measuring oligomycin-sensitive ATPase activity through pyruvate kinase and
phosphoenolpyruvate in cardiac protein lysate of adult offspring. The Molecular Devices Flex
Station 3 Multi-Mode microplate reader (Sunnyvale, CA) was used to measure all assays
spectrophotometrically. Protein content was normalized using the Bradford method, with bovine
serum albumin protein assay standards. Final values were expressed as Unit/nanogram (I-IV) or
milligram (V) of protein, where Unit = nanomoles of substrate oxidized ·minute-1.

Total Glutathione Peroxidase (GPx) Activity
Total GPx activity was measured using a GPx Activity Kit from Cayman Chemical (item
no. 703102, Ann Arbor, MI). The Cayman Chemical GPx Activity Kit determines all glutathionedependent peroxidase activity indirectly through a coupled reaction with glutathione reductase
(GR). The cumene hydroperoxide in this assay is reduced by GPx producing oxidized glutathione
(GSSG), which can then be recycled to its reduced state by GR and NADPH. The oxidation of
NADPH results in a decrease in absorbance at 340nm that is proportional to the GPx activity, when
it is the rate limiting factor. The experiment was carried out using the manufacturer’s protocol,
with minor modifications: Heart lysate (in NP-40) samples were diluted with sample buffer and
20 µl of the diluted heart lysate was used for the assay. Absorbance was read once every minute
for 6 minutes at 340 nm using the Molecular Devices Flex Station 3 Multi-Mode microplate reader.
Absorbance values were retrospectively normalized to protein content with the Bradford assay
(12).

MPHGPx Activity
To determine mitochondrial phospholipid hydroperoxide glutathione peroxidase (GPx4)
activity, phosphatidylcholine hydroperoxide (PCOOH), a specific substrate of mPHGPx, was
synthesized as previously described (67). L-α-Phosphatidylcholine Type III/S (PC) (item no.
P3782; Sigma-Aldrich, St. Louis, MO) was slowly added to a Tris/Base buffer (0.2 M, pH 8.8,
3mM sodium deoxycholate (item no. D6750, Sigma-Aldrich)) while stirring at medium-high
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speed. Once a cloudy emulsion of small droplets was visible, additional Tris/Base buffer was
introduced with continuous stirring until the solution was clear. A volume of soybean lipoxidase
Type V (item no. L6632, Sigma-Aldrich) was added that equaled 250,000 U to initiate the
synthesis reaction followed with continuous stirring for 1hour. A Sep-Pak C-18 cartridge (item no.
020515, Waters, Milford, MA) was activated with methanol and equilibrated with ddH2O, then
used to purify the PCOOH with a 30 ml glass syringe (item no. Z314374, Sigma-Aldrich). The
cartridge was washed with water to remove water-soluble substances and the PCOOH was eluted
from the C18 resin with methanol. The concentration of PCOOH was determined at A234 using the
NanoDrop ND-100 (Thermo Fisher Scietific, Waltham, MA) and diluted to a desired concentration
with methanol. The PCOOH was immediately used as the substrate (in place of cumene
hydroperoxide) with the Glutathione Peroxidase Assay Kit (Cayman) as described above, with
absorbance readings every 30 seconds for 6 minutes at 340nm with the Molecular Devices Flex
Station 3 Multi-Mode microplate reader. All samples were blanked with background wells (no
sample) and normalized to protein content.

Mitochondrial Isolation
Adult progeny were sacrificed at 11 weeks of age, and hearts were excised through a
midsagittal cut in the thoracic cavity. Isolation of mitochondrial subpopulations was achieved
through differential centrifugation as previously described (6, 48). The two subpopulations were
combined and utilized as a total mitochondrial fraction for subsequent analyses. KME buffer
(100mM KCl, 50mM MOPS and 0.5mM EGTA pH 7.4) was used to resuspend isolated
mitochondria. Protein concentrations were determined using the Bradford method with bovine
serum albumin as a standard (12).

Hydrogen Peroxide (H2O2) Production
Hydrogen peroxide (H2O2) production was evaluated in total tissue lysate and isolated
mitochondria from adult offspring in order to determine mitochondrial ROS production (35, 45,
65). The Invitrogen™ Amplex™ Red Hydrogen Peroxide Assay Kit (product no. A2218; Thermo
Fisher) was utilized per manufacturer’s instructions and assays performed spectrophotometrically.
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In the presence of horseradish peroxidase (HRP), the Amplex™ Red reagent produces a red
fluorescent oxidation product when the reagent reacts with H2O2. The oxidation product, resorufin,
was detected spectrophotometrically at 560 nm and data were normalized to protein content.

Global M6A Methylation
Total RNA was purified from heart samples that were digested with QIAzol lysis reagent
(item no. 79306, Qiagen, Hilden, Germany) from one adult offspring of each genotype (WT/Tg)
from each dam (PPME/MPME) from each exposure group (sham/nano-TiO2) using the miRNeasy
Mini Kit (item no. 217004, Qiagen). Global m6A methylation was quantified in total RNA using
the EpiQuik™ m6A RNA Methylation Quantification Kit (item no. P-9005; EpiGentek,
Farmingdale, NY) per manufacturer’s instructions. Briefly, total RNA samples were diluted to a
standard concentration of 200 ng with IDTE buffer. Dilution of the provided positive control
allowed for the generation of a standard curve. RNA was bound to the assay wells through
incubation with the binding solution. An optimized m6A capture antibody was added to the wells,
incubated, and washed, followed by addition of the detection antibody and enhancer solution. The
color developing solution was then introduced and incubated for 2 minutes, until the color changed
to blue, at which point the stop solution was added. Absorbance was read at 450 nm using the
Molecular Devices Flex Station 3 Multi-Mode microplate reader. A standard curve was used to
determine global m6A levels in each sample.

Immunoprecipitation (m6A-RIP)
Total RNA was purified from whole heart samples from PPME and MPME WT adult
offspring from each exposure group (sham/nano-TiO2) using the miRNeasy Kit (Qiagen) described
above.

RNA Fragmentation
Before the immunoprecipitation was carried out, the RNA samples were fragmented using
the NEBNext Magnesium RNA Fragmentation kit (item no. E6150s; New England Biolabs) (5,
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76). To determine the necessary length of incubation to achieve desired fragmentation (~130 nt),
samples were incubated for 1-10 minutes at 94°C. The 10 samples were analyzed with the
Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA) to determine the size distribution of
the fragments.

M6A-RIP
The EpiMark N6-Methyladenosine Enrichment Kit (item no. E1610S; New England
Biolabs, Ipswich, MA) was used to enrich m6A modified RNA per manufacturer’s instructions,
with minor modifications. RNA samples were fragmented at 94°C for 3 minutes (5). Dynabeads™
Protein G magnetic beads from Thermo Fisher Scientific (product no. 10003D) were washed and
resuspended in Reaction Buffer. An anti-N6-Methyladenosine (m6A) rabbit monoclonal antibody
(product no. 56593, Cell Signaling Technology, Danvers, MA) was bound to the beads, followed
by the addition of the fragmented total RNA (100ng) and RNasin® Plus RNase Inhibitor (product
no. N2611; Promega, Madison, WI). The normal Rabbit IgG control (product no. 2729, Cell
Signaling Technology), an unconjugated rabbit polyclonal antibody, was used as a non-specific
IgG control for the immunoprecipitation. After the immunoprecipitation, RNA was eluted with
Buffer RLT (product no. 79216; Qiagen) then cleaned and concentrated using Dynabeads™
MyOne™ Silane (product no. 37002D; Life Technologies, Carlsbad, CA). The RNA samples from
both input and immunoprecipitated samples were examined by RT-qPCR to quantify m6A
enrichment.

RT-qPCR
WT adult offspring heart samples (from WT/Tg and sham/nano-TiO2 exposed dams) were
prepared for downstream analysis by reverse-transcribing the input and immunoprecipitated RNA
using the Applied Biosystems High Capacity cDNA Reverse Transcription Kit (product no.
4368814; Thermo Fisher Scientific) per manufacturer’s protocol. RT-qPCR was utilized to
evaluate m6A enrichment of the mPHGPx 3’-UTR, specifically the region containing the crucial
selenocysteine (Sec) insertion sequence (SECIS) (13, 28). Primers for mPHGPx and a control,
GAPDH, were designed using Primer3Plus (7) and the sequences are listed in Supplemental
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Table 3.1 (Additional file 3.1). Quantification was achieved with SYBR® Green master mix
(product no. A25742, Thermo Fisher Scientific) using the Applied Biosystems 7500 Fast RealTime PCR system. Samples were run in triplicate. Enrichment fold was calculated using the ΔCt
value of the IP normalized to the ΔCt of the input, relative to the dilution factor (20% input; dilution
factor = 5), and normalized to GAPDH, as illustrated below (42).

∆𝐶𝑡[𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝐼𝑃] = 𝐶𝑡 [𝐼𝑃] − (𝐶𝑡[𝐼𝑛𝑝𝑢𝑡] − 𝐿𝑜𝑔2(𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟))
∆∆𝐶𝑡 = ∆𝐶𝑡 [𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝐼𝑃(𝑚𝑃𝐻𝐺𝑃𝑥) ] − ∆𝐶𝑡 [𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝐼𝑃(𝐺𝐴𝑃𝐷𝐻) ]
𝐹𝑜𝑙𝑑 𝑒𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡 = 2(−∆∆𝐶𝑡)

Statistics
All statistical analyses were performed using GraphPad Prism Software Version 8 for
Windows (GraphPad Software, La Jolla CA). For adult offspring analyses, from each MPME or
PPME cohort, one animal of each genotype (WT/Tg) from a given exposure (sham and nano-TiO2)
was randomly selected and designated N = 1. For fetal analyses, each pregnant dam that was
exposed (sham/nano-TiO2) was considered one observation, with each genetic group (WT/Tg)
considered as N = 1. Data were analyzed using a two-way analysis of variance (ANOVA) method
to evaluate mPHGPx presence and nano-TiO2 maternal exposure. Normality was determined using
the D’Agostino-Pearson test. Tukey’s multiple comparison method was performed following the
two-way ANOVA to evaluate effects within the PPME and MPME groups. Statistical difference
was defined by P ≤ 0.05. The presence of a letter above a specific group denotes statistical
significance between those two groups as determined by Tukey’s multiple comparisons test. For
functional assays performed using adult hearts, a two-tailed Student’s t-test was also employed to
evaluate whether maternal nano-TiO2 inhalation exposure during gestation elicited a change
between offspring of the same genotype. The presence of a dagger (†) above a given group
indicates statistical significance between WT Sham and WT TiO2 or Tg Sham and Tg TiO2 of the
same maternal genetic group (MPME or PPME). For qPCR data, a one-way ANOVA was
employed followed by a Tukey’s multiple comparisons test to determine significant differences in
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m6A fold enrichment across WT offspring groups. All data are presented as the mean ± the
standard error of the mean (SEM).

137

Results
Cardiac Function
Deleterious changes in cardiac structure and function have previously been identified in
offspring following maternal nano-TiO2 inhalation exposure during gestation (24, 35).
Conventional M-mode evaluations determined that adult offspring of WT dams (PPME) who were
gestationally-exposed to nano-TiO2 presented with higher systolic diameter and volume, as well
as lower ejection fraction and fractional shortening than those whose dams were sham-exposed
(Table 3.1). Additionally, adult offspring whose dams were mPHGPx Tg (MPME) overall had
significantly lower diastolic diameter and volume, stroke volume, and cardiac outputs than PPME
offspring regardless of exposure (Table 3.1). Adult offspring heart rates were unchanged
regardless of exposure or genotype (Additional file 3.1: Supplemental Table 3.2).
When examining the dams, WT nano-TiO2-exposed mice had significantly decreased
diastolic diameter and volume when compared to WT sham-exposed dams, as well as reduced
pump function indicated by stroke volume and cardiac output reductions (Additional file 3.1:
Supplemental Table 3.3). Furthermore, relative wall thickness was significantly increased
following ENM exposure in WT dams, but not in the mPHGPx Tg dams (Additional file 3.1:
Supplemental Table 3.3). Maternal heart rate remained unchanged between all exposure groups
(Additional file 3.1: Supplemental Table 3.4). At the fetal stage, in order to correlate the assessed
cardiac function with the genotype of that specific pup, pups in the right and left uterine horns
were sequentially imaged (Figure 3.3A). A representative trace of the fetal pup’s left ventricle
(LV) in M-mode is shown in Figure 3.3B. A group-dependent effect was found, with the MPME
fetal offspring demonstrating higher diastolic diameter and volume, as well as higher stroke
volume and cardiac output than the PPME offspring (Additional file 3.1: Supplemental Table
3.5). MPME fetal offspring also had significantly higher heart rates (Additional file 3.1:
Supplemental Table 3.2). Decreased function in the PPME WT offspring following gestational
ENM exposure confirms previous findings (35) and substantiate the susceptibility of WT offspring
to cardiovascular changes due to maternal nano-TiO2 exposure, which may be a result of limited
antioxidant capacity.
Speckle-tracking based stress strain assessments were performed during systole in fetal and
adult offspring groups of all dams (Table 3.2 and Additional file 3.1: Supplemental Table 3.6138

7). Long-axis measurements in adult offspring demonstrated that endocardial global longitudinal
strain (GLS) was significantly lower in PPME WT offspring whose dams were exposed to nanoTiO2 compared to sham-exposed (Table 3.2). The PPME WT pups also had a significantly lower
GLS than PPME Tg adults, who were both progeny of nano-TiO2 exposed dams. (Table 3.2). A
group dependent effect was seen with MPME progeny having higher radial and longitudinal strain
rates, and diminished longitudinal displacement compared to PPME progeny. Group dependent
effects were also observed in the parasternal short axis between the MPME (Additional file 3.1:
Supplemental Table 3.6). Figures 3.3 C and D provide representative B-mode images of a fetal
pup in utero during end diastole and end systole, respectively, as well as speckle-tracking traces
correlating to each of these frames (Figure 3.3 E-F). At the fetal stage, short-axis radial and
circumferential strain rates were significantly lower in both the PPME WT and Tg groups whose
dams were exposed to nano-TiO2 than the pups of the same respective genotype whose dams were
sham-exposed (Additional file 1: Supplemental Table 3.7). Further, these data also revealed a
group dependent effect based on maternal genotype (MPME vs PPME). Overall, these changes
appear to suggest that enhanced maternal antioxidant protection may provide sufficient protection
to thwart cardiac maladaptation that is precipitated by ENM exposure.

ETC Complex Activities
ETC complex activity assays were performed on protein lysate samples of adult offspring
(Figure 3.4). Two-way ANOVA analysis revealed no significant difference between PPME and
MPME offspring for complex I (Figure 3.4A) and complex III activities (Figure 3.4B), but
MPME offspring had significantly higher activities for both complex IV (Figure 3.4C) and V
(Figure 3.4D). Individual t-tests were implemented to better delineate exposure specific
differences between offspring of the same genotype (WT or Tg) and same cohort (PPME or
MPME). The PPME WT offspring of ENM-exposed dams had significantly diminished complex
I (Figure 3.4A) and IV (Figure 3.4C) activities than PPME WT offspring whose dams were shamexposed. These findings are consistent with previously published data from our laboratory (35).

GPx Activity and H2O2 Production
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Total GPx enzymatic activity (including all isoforms) was measured in adult offspring.
MPME offspring had a significantly higher level of total GPx activity than the PPME offspring
(Figure 3.5A). Within the PPME group, Tg offspring of sham-exposed dams had elevated
enzymatic activity compared to their WT littermates (Figure 3.5A). To assess specific mPHGPx
activity, phosphatidylcholine (PCOOH) was used as a substrate. Within the PPME group, the Tg
sham adult offspring had the highest level of mPHGPx activity and was significantly higher than
the other three PPME groups, including the PPME Tg offspring whose dams were nano-TiO2
exposed (Figure 3.5B). In the MPME group, the Tg sham and Tg nano-TiO2 groups were both
significantly higher than their littermate controls (Figure 3.5B). Student’s t-tests were used to
delineate exposure specific differences between offspring with the same genotype from the same
cohort (PPME or MPME). These analyses revealed that in the PPME group, gestational exposure
to ENM resulted in lower mPHGPx activity regardless of the offspring’s genotype (Figure 3.5B).
Previously published data from our laboratory have indicated that maternal ENM exposure
during gestation resulted in increased H2O2 levels at the fetal stage, which was not sustained into
adulthood (35). In the current study, H2O2 levels were unchanged in adult offspring (Figure 3.5C),
which was consistent with our previous findings. H2O2 levels were also evaluated in isolated
mitochondria.

H2O2 levels were elevated in PPME WT adult offspring whose dams were

gestationally-exposed to ENM when compared to PPME WT adult offspring whose dams were
gestationally-sham-exposed (Figure 3.5D). These data overall indicate that maternal exposure to
nano-TiO2 during gestation results in decreased hydroperoxide scavenging and increased ROS,
while maternal antioxidant protection has the potential to prevent these detriments.

Global and mPHGPx M6A Methylation
Alterations in the relative abundance of m6A modifications can affect RNA metabolism
and are associated with various diseases, including metabolic diseases affecting the heart (38). The
SEC insertion sequence (SECIS), which is present in the 3’-UTR of mPHGPx and allows for the
insertion of the crucial selenocysteine, contains potential m6A sites (40, 75). To investigate
whether altered total m6A methylation plays a role in the diminished mPHGPx activity in offspring
whose dams were exposed to nano-TiO2, we quantified global m6A in RNA isolated from the
hearts of adult offspring (Figure 3.6A). Initial analyses indicated that global m6A status was
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statistically unchanged between the groups, but individual t-tests revealed that MPME Tg offspring
whose dams were exposed to nano-TiO2 had significantly lower levels of m6A methylation than
MPME Tg offspring whose dams were sham-exposed (Figure 3.6A).
In order to evaluate the SEC region of mPHGPx in WT offspring, RNA was fragmented
and used to perform an m6A RNA immunoprecipitation, followed by qPCR for a specific region
of the mPHGPx 3’-UTR. RNA fragmentation incubation time was determined using the
Bioanalyzer 2100. A 3-minute incubation was deemed the most appropriate in order to achieve
~130 nt fragments (Figure 3.6B) (5). RMBase v2.0 software predicted the presence of m6A sites
at the 3’-UTR of mPHGPx mRNA specifically within the SECIS region (Figure 3.6C). RT-qPCR
revealed that PPME WT adult offspring whose dams were exposed to nano-TiO2 had significantly
higher m6A levels in the 3’-UTR region of mPHGPx than the control group (PPME WT sham)
(Figure 3.6D), as well as both the sham and nano-TiO2 MPME WT groups. These data indicate
that gestational exposure in WT dams, has the ability to modulate epitranscriptome reprogramming
that is present in offspring at adulthood. The increase in m6A enrichment in the PPME WT
offspring of ENM-exposed dams may be responsible for the persistent mitochondrial bioenergetic
and cardiac functional detriments. Additionally enhanced maternal antioxidant capacity may
provide protection from the initial stimuli responsible for the altered m6A status of mPHGPx.

141

Discussion
With the inevitable increase in production and application of ENM-enabled products in
manufacturing, biomedicine, and general consumer use, a thorough understanding of the
longitudinal repercussions is necessary for the development of preventative and protective
strategies for workers and consumers. This is of particular importance during fetal growth, where
a toxicological insult may elicit immediate and long-term deleterious effects. In this study, we
have demonstrated that increased antioxidant defense in the maternal environment is capable of
providing preservation to cardiac contractile function potentially through the maintenance of
mitochondrial bioenergetics. Furthermore, the presence of the maternal transgene preserved m 6A
status at the 3’-UTR of mPHGPx in offspring despite gestational ENM inhalation exposure. Our
data point to a maladaptation in the epitranscriptomic signature as the mechanism responsible for
diminished bioenergetics and cardiac contractile deficits in adult offspring following maternal
exposure.
Left ventricular ejection fraction (LVEF) has been widely used as a key measure of cardiac
contractile function and as a prognostic tool for heart failure (53). The dependence of this
parameter on load, can limit reproducibility, necessitating a more reliable marker of cardiac
function (1, 30). Global longitudinal strain (GLS), a measure of myocardial deformation, is the
most commonly utilized clinical application of strain imaging (20, 41). GLS appears to be a better
predictor of cardiovascular outcomes than LVEF, with better reproducibility (3, 31). Decreases in
GLS, as seen in the PPME WT offspring following exposure, highlight the susceptibility of this
group to future cardiovascular events (Table 3.2). The preservation of GLS in the MPME group
is therefore noteworthy as the antioxidant protective strategy provided by the mother was able to
sufficiently protect her offspring from long-term adverse cardiovascular complications.
Maternal ENM exposure during gestation interferes with fetal development and has longterm consequences for offspring that persist into adulthood (11, 15, 27, 69). The importance of the
maternal environment are outlined by the developmental origins of health and disease (DOHaD)
hypothesis and supported by an increasing number of studies (70). The current study highlights
how amplifying antioxidant capacity in the maternal environment can deter the maladaptive
cardiovascular changes that persist into adulthood, regardless of the progeny’s genotype. Although
transgenic expression provides a limitation to clinical uses of maternal antioxidant protection, we
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establish a basis for investigating other potential antioxidant protective strategies. One example is
mitoquinone mesylate (MitoQ), a mitochondrial-targeted antioxidant that has showed promise in
improving mitochondrial dysfunction, reducing hydrogen peroxide production, and antioxidant
enzyme activity (50, 54). MitoQ also has the ability to prevent the long-term impacts of maternal
cigarette smoke exposure on progeny by mitigating renal total ROS in the mothers and offspring
at adulthood (68). Future investigations should aim to determine whether supplementation with
antioxidant-boosting therapeutics during pregnancy can provide the same protective effect to
progeny as maternal mPHGPx overexpression.
As a relatively new area of research in ENM inhalation exposure toxicology, there are few
studies that investigate the detailed epitranscriptomic mechanisms associated with the exposures.
However, a recent study demonstrated that in A549 cells, global m6A was decreased following
particulate matter exposure as a result of altered m6A modulator genes (14). Although this study
was performed using lung epithelial cells, it is one of the first studies to highlight the concept that
exposure to environmental toxicants has the ability to alter m6A RNA methylation profiles. M6A
has previously been established to preferentially occur around stop codons, with high enrichment
in 3’-UTRs of human and mouse transcriptomes (18, 43). Further, the 3’-UTR of mPHGPx is a
critical region as it is the location of the Sec incorporation machinery, which enables the catalytic
activity of this peroxide scavenging protein (28). To ensure proper function of mPHGPx as a
peroxide scavenger, proper selenocysteine (Sec) incorporation is required, which involves the
recoding of a UGA codon from “Stop” to “Sec” via a complex that is assembled at a specific region
of the 3’-UTR known as the SECIS (28, 60). Recoding occurs through an eEFSec/Sec-tRNASec
complex binding to Sec binding protein 2 (SBP2), which is anchored to the SECIS in the 3’-UTR.
Alterations to the SECIS region, may affect the efficiency of Sec incorporation and thus alter the
catalytic activity and/or expression of mPHGPx by retaining the premature termination codon,
potentially resulting in decay (60, 62). Modulation of this critical region may be the mechanism
that results in the persistent adverse outcomes of maternal ENM inhalation exposure into
adulthood.
Early studies of m6A modifications determined that m6A primarily occurs in two possible
sequences, Gm6AC or Am6AC (74), but have further been specified as RRACH (R = A/G and H
= A/C/U) (8, 18, 75). Interestingly, RMBase v2.0 software, which was utilized as a way of
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scanning for RRACH motifs, predicted m6A sites at the 3’-UTR of mPHGPx mRNA specifically
within the SECIS region (75), as demonstrated in Figure 3.6C. The presence of m6A sites in this
region was also confirmed in a recent study that aimed to assess the methylome of human and
mouse tissue (40). Papp et al. reported that inefficient selenoprotein synthesis can increase
sensitivity to oxidative stress, which is one potential explanation for the alterations seen at the fetal
stage following gestational ENM inhalation exposure (49). Moreover, increased methylation,
shown in Figure 3.6, may alter Sec incorporation by changing the secondary structure of the
SECIS hairpin (57) and preventing SBP2 from anchoring the incorporation complex to the RNA
(22). This in turn may be leading to inefficient mPHGPx hydroperoxide scavenging (28) at the
adult stage. The decrease in mPHGPx protein expression at the fetal stage compared to the
maintenance of expression, but diminution of mPHGPx activity at the adult stage, will require
further investigation. A possible explanation is that the epitranscriptomic remodeling occurring at
the adult stage may differ from the initial reprogramming that occurred in utero following maternal
nano-TiO2 inhalation exposure.
Figure 3.7 provides an overview of the mechanisms involved in the long-term
ramifications of maternal ENM inhalation exposure during gestation on offspring. Overexpression
of mPHGPx in the pregnant dam limits H2O2 (ROS) production, thereby mitigating changes to
mitochondrial bioenergetics and cardiac contractile function in adult progeny. However, without
the overexpression of mPHGPx in the maternal environment, ROS production is not controlled
following nano-TiO2 exposure during gestation, resulting in downstream effects on cardiac
function and mitochondrial bioenergetics. This occurs, in part, as a result of elevated m6A
methylation at the SECIS region of mPHGPx, which disrupts Sec incorporation and diminishes
mPHGPx catalytic activity. The current study highlights the therapeutic potential of enhanced
antioxidant protection in the maternal environment during gestation (Figure 3.7). Increased
hydroperoxide scavenging through this approach can provide protection for offspring into
adulthood from the deleterious effects of maternal particulate exposure during gestation, without
the need for supplementation by the progeny. Overexpression of mPHGPx in the pregnant dam
likely circumvents the initial surge of oxidative stress that is elicited by the xenobiotic exposure,
through a mechanism that involves epitranscriptomic reprogramming.
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At the adult stage, maternal ENM exposure during gestation was associated with altered
m6A methylation of mPHGPx that contributes to diminished enzymatic activity and persistent
cardiac contractile alterations. These findings highlight a specific targeted alteration to the
epitranscriptome that may be mechanistically linked to sustained bioenergetic and cardiac
dysfunction associated with gestational ENM exposure. Alterations to the epitranscriptome
presented in this study provide a new perspective on the role of m6A methylation changes in the
fields of cardiovascular ENM inhalation exposure toxicology. Our study introduces a protective
strategy that can be implemented to safeguard developing progeny against long-term
cardiovascular ramifications.
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Table 3.1: M-mode echocardiography for adult progeny
PPME

PPME

PPME

PPME

MPME

MPME

MPME

MPME

Parameter

WT
Sham a

WT
TiO2 b

Tg
Sham c

Tg
TiO2 d

WT
Sham e

WT
TiO2 f

Tg
Sham g

Tg
TiO2 h

Diameter;s
(mm)

0.61 ±
0.05

0.85 ±
0.08a,d

0.66 ±
0.07

0.51 ±
0.06

0.63 ±
0.05

0.60 ±
0.02

0.57 ±
0.02

0.72 ±
0.06

Diameter;d
(mm)

2.12 ±
0.04

2.27 ±
0.08

2.15 ±
0.09

2.07 ±
0.07

1.98 ±
0.08

1.98 ±
0.07

1.88 ±
0.06

2.07 ±
0.07

Volume;s (uL)

0.58 ±
0.13

1.47 ±
0.35a,c,d

0.73 ±
0.19

0.38 ±
0.11

0.60 ±
0.11

0.56 ±
0.02

0.46 ±
0.05

0.94 ±
0.24

Volume;d (uL)

14. 78
± 0.61

17.85 ±
1.66

15.63 ±
1.56

14.09 ±
1.25

12.61 ±
1.31

12.65 ±
1.11

11.00 ±
0.92

14.21 ±
1.31

Stroke Volume
(uL)

14. 19
± 0.63

16.38 ±
1.34

14.90 ±
1.43

13.71 ±
1.16

12.01 ±
1.21

12.08 ±
1.12

10.54 ±
0.87

13.27 ±
1.50

Ejection
Fraction (%)

96.02 ±
0.94

92.22 ±
1.29a,d

95.55 ±
0.91

97.48 ±
0.59

95.34 ±
0.41

95.43 ±
0.53

95.82 ±
0.13

93.35 ±
2.30

Fractional
Shortening (%)

71.25 ±
2.37

62.99 ±
2.24a,d

69.84 ±
2.37

75.72 ±
2.37

68.64 ±
1.24

69.64 ±
1.92

69.52 ±
0.35

65.40 ±
4.27

Cardiac Output
(mL/min)

10.08 ±
0.56

10.32 ±
0.77

9.67 ±
1.07

9.06 ±
0.81

7.60 ±
1.44

8.00 ±
0.71

6.80 ±
0.78

9.19 ±
1.20

Relative Wall
Thickness

1.23 ±
0.06

1.20 ±
0.06

1.17 ±
0.12

1.36 ±
0.06

1.18 ±
0.06

1.27 ±
0.06

1.35 ±
0.05

1.15 ±
0.10

153

Table 3.1: M-mode echocardiography was performed in adult offspring (11 weeks of age)
following maternal inhalation exposure. Bold text indicates significant data defined by P ≤ 0.05.
A two-way ANOVA determined statistical difference between PPME and MPME denoted with
underlined values for that parameter. A letter next to a given group denotes statistical significance
between the marked group and the group represented by each letter based on a Tukey’s multiplecomparisons test. All data are presented as the mean ± the standard error of the mean (SEM).
PPME WT Sham, n = 7; PPME WT TiO2, n = 6; PPME Tg Sham, n = 6; PPME Tg TiO2, n = 5;
MPME WT Sham, n = 4; MPME WT TiO2, n = 5; MPME Tg Sham, n = 5; MPME Tg TiO2, n =
4. PPME = Paternal mPHGPx maternal exposure, MPME = Maternal mPHGPx maternal exposure,
WT Sham = wild-type offspring whose dam was exposed to control air, Tg Sham = mPHGPx
transgenic offspring whose dam was exposed to control air, WT TiO2 = wild-type offspring whose
dam was exposed to nano-TiO2, Tg TiO2 = mPHGPx transgenic offspring whose dam was exposed
to nano-TiO2, s = systolic, d = diastolic.
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Table 3.2: Adult progeny systolic stress-strain in the long-axis

PPME

PPME

PPME

PPME

MPME

MPME

MPME

MPME

Parameter

Units

WT
Shama

WT
TiO2 b

Tg
Shamc

Tg
TiO2 d

WT
Shame

WT
TiO2 f

Tg
Shamg

Tg
TiO2 h

Radial
Velocity

Pk
cm/s

2.01 ±
0.17

1.89 ±
0.12

1.82 ±
0.10

2.52 ±
0.16c

2.03 ±
0.21

2.46 ±
0.23

2.23 ±
0.15

2.08 ±
0.26

Radial
Displacement

Pk
mm

0.47 ±
0.03

0.43 ±
0.03

0.44 ±
0.04

0.61 ±
0.02a,b,c

0.40 ±
0.00

0.55 ±
0.04

0.47 ±
0.05

0.52 ±
0.03

Radial Strain

Pk %

27.82
± 1.84

25.95
± 2.85

25.54
± 3.37

31.55 ±
2.74

26.48 ±
2.58

32.90 ±
2.72

30.69 ±
3.08

23.67 ±
1.49

Radial Strain
Rate

Pk
1/s

9.10 ±
0.83

8.20 ±
0.67

8.62 ±
1.13

11.12 ±
1.16

11.34 ±
1.55

11.80 ±
1.02

11.31 ±
0.34

8.50 ±
0.97

Longitudinal
Velocity

Pk
deg/s

1.14 ±
0.16

1.19 ±
0.18

1.00 ±
0.18

1.07 ±
0.20

1.16 ±
0.36

1.09 ±
0.28

1.28 ±
0.60

0.95 ±
0.15

Longitudinal
Displacement

Pk
deg

0.18 ±
0.01

0.12 ±
0.04

0.15 ±
0.06

0.11 ±
0.02

0.04 ±
0.01

0.06 ±
0.01

0.06 ±
0.01

0.12 ±
0.04

Longitudinal
Strain

Pk %

-10.99
± 2.13

-9.51
± 2.00

-9.16
± 0.90

-15.81
± 3.41

-5.38 ±
2.61

-7.98 ±
1.52

-12.99
± 2.78

-10.68
± 4.73

Longitudinal
Strain Rate

Pk
1/s

-7.63
± 0.58

-6.86
± 0.76

-7.06
± 1.01

-9.34 ±
0.76

-7.45 ±
0.85

-8.93 ±
1.35

-14.26
±
1.35e,f,h

-7.49 ±
1.18

Global
Longitudinal
Strain (GLS)

AU

24.26
± 1.54

16.49
±
1.97a,d

19.85
± 2.20

28.51 ±
1.88c

20.07 ±
2.25

23.58 ±
3.52

22.67 ±
1.86

22.29 ±
2.44
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Table 3.2: Peak strain and strain-rate values acquired from B-mode images for longitudinal and
radial dimensions in adult progeny (11 weeks of age) following maternal inhalation exposure. Bold
text indicates significant data defined by P ≤ 0.05. A two-way ANOVA determined statistical
difference between PPME and MPME denoted with underlined values for that parameter. A letter
next to a given group denotes statistical significance between the marked group and the group
represented by each letter based on a Tukey’s multiple-comparisons test. All data are presented as
the mean ± the standard error of the mean (SEM). PPME WT Sham, n = 7; PPME WT TiO2, n =
6; PPME Tg Sham, n = 6; PPME Tg TiO2, n = 5; MPME WT Sham, n = 4; MPME WT TiO2, n =
5; MPME Tg Sham, n = 5; MPME Tg TiO2, n = 4. PPME = Paternal mPHGPx maternal exposure,
MPME = Maternal mPHGPx maternal exposure, WT Sham = wild-type offspring whose dam was
exposed to control air, Tg Sham = mPHGPx transgenic offspring whose dam was exposed to
control air, WT TiO2 = wild-type offspring whose dam was exposed to nano-TiO2, Tg TiO2 =
mPHGPx transgenic offspring whose dam was exposed to nano-TiO2, GLS = global longitudinal
strain, Pk = peak.
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Figure 3.1: MPHGPx mouse breeding strategy. (A) Schematic of mPHGPx breeding strategies
with transgene effect on offspring from maternal (left) or paternal (right) transgene. (B) Schematic
of exposure paradigm that was implemented for each group, representing all groups that were
utilized in the study. (C) A timeline of the study. MPHGPx = mitochondrial phospholipid
hydroperoxide glutathione peroxidase.
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Figure 3.2: Maternal nano-TiO2 inhalation exposure characteristics. (A) Real-time (black
line) aerosol mass concentration measurements with the red line indicating the target concentration
(12 mg/m3) of a typical 360 min maternal nano-TiO2 inhalation exposure. (B) Count size
distribution of the nano-TiO2 aerosols measured with a high resolution electric low-pressure
impactor (ELPI+). The red line designates the log normal distribution obtained with the log
probability plot method (CMD = 0.163 µm, with a GSD = 1.77). (C) Count size distribution of
nano-TiO2 aerosols measured with a scanning mobility particle sizer (SMPS) with the red line
representing a log normal fit of the data (CMD = 0.190 µm, GSD = 1.97). (D) Mass size
distribution of nano-TiO2 aerosols measured with a Nano Micro-Orifice Uniform Deposit Impactor
(MOUDI). The red line represents a log normal fit of the data indicating a mass median
aerodynamic diameter (MMAD) of 0.968 µm and a GSD of 2.56. CMD = Count Median Diameter,
GSD = Geometric Standard Deviation.
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Figure 3.3
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Figure 3.3: Assessment of fetal pup cardiac function in utero. (A) Graphical depiction of the
uterine horn and the pup identification system. (B) Representative M-mode echocardiographic
scan of a fetal pup with the short-axis left ventricular trace (blue). (C-D) Representative B-mode
scan of a fetal pup with the left and right ventricles identified by blue arrows at end diastole (C)
and end systole (D). (E-F) Representative B-mode scan in the short-axis of a fetal pup at with
green outlines indicating tracking of the epicardium and endocardium borders through (E) end
diastole and (F) end systole. R = right, L = left.
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Figure 3.4
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Figure 3.4
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Figure 3.4: Electron transport chain (ETC) complex activities of adult PPME and MPME
offspring. (A-D) Electron transport chain (ETC) activities assessed in cardiac protein lysate of
adult offspring for (A) complex I, (B) complex III, (C) complex IV, and (D) complex V (ATP
Synthase). PPME WT Sham, n = 7; PPME WT TiO2, n = 6; PPME Tg Sham, n = 6; PPME Tg
TiO2, n = 5; MPME WT Sham, n = 4; MPME WT TiO2, n = 5; MPME Tg Sham, n = 7; MPME
Tg TiO2, n = 4. Adult = 11 weeks old. Statistical difference was defined by P ≤ 0.05. * = group
difference determined by a two-way ANOVA and ns = no statistical difference. A letter above a
group denotes statistical significance between those groups based on a Tukey’s multiplecomparisons test. A dagger (†) above a group indicates statistical significance between WT Sham
and WT TiO2 or Tg Sham and Tg TiO2 of the same maternal genetic group (MPME or PPME)
based on a Student’s t-test. All data are presented as the mean ± the standard error of the mean
(SEM). Adult = 11 weeks of age, mPHGPx = mitochondrial phospholipid hydroperoxide
glutathione peroxidase, PPME = Paternal mPHGPx maternal exposure, MPME = Maternal
mPHGPx maternal exposure, WT Sham = wild-type offspring whose dam was exposed to control
air, Tg Sham = mPHGPx transgenic offspring whose dam was exposed to control air, WT TiO2 =
wild-type offspring whose dam was exposed to nano-TiO2, Tg TiO2 = mPHGPx transgenic
offspring whose dam was exposed to nano-TiO2, Unit = nanomoles of substrate oxidized ·minute1

.
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Figure 3.5:
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Figure 3.5: Antioxidant activity and H2O2 production in adult offspring following gestational
inhalation exposure. (A) Total GPx activity in cardiac protein lysate determined by cumene
hydroperoxide as substrate and normalized to protein content. (B) Mitochondrial GPx (mPHGPx)
activity in cardiac protein lysate determined by phosphatidylcholine hydroperoxide (PCOOH) as
substrate and normalized to protein content. (C) Total hydrogen peroxide (H2O2) concentration in
cardiac protein lysate normalized to protein content. (D) Hydrogen peroxide (H2O2) concentration
in cardiac isolated mitochondria of adult offspring normalized to protein content. PPME WT
Sham, n = 7 (protein) and n = 6 (mitochondria); PPME WT TiO2, n = 6; PPME Tg Sham, n = 6
(protein) and n = 5 (mitochondria); PPME Tg TiO2, n = 5; MPME WT Sham, n = 4; MPME WT
TiO2, n = 5; MPME Tg Sham, n = 7; MPME Tg TiO2, n = 4. Statistical difference was defined by
P ≤ 0.05. * = group difference determined by a two-way ANOVA and ns = no statistical difference.
A letter above a group denotes statistical significance between those groups based on a Tukey’s
multiple-comparisons test. A dagger (†) above a group indicates statistical significance between
WT Sham and WT TiO2 or Tg Sham and Tg TiO2 of the same maternal genetic group (MPME or
PPME) based on a Student’s t-test. All data are presented as the mean ± the standard error of the
mean (SEM). Adult = 11 weeks of age, mPHGPx = Mitochondrial phospholipid hydroperoxide
glutathione peroxidase, PPME = Paternal mPHGPx maternal exposure, MPME = Maternal
mPHGPx maternal exposure, WT Sham = wild-type offspring whose dam was exposed to control
air, Tg Sham = mPHGPx transgenic offspring whose dam was exposed to control air, WT TiO2 =
wild-type offspring whose dam was exposed to nano-TiO2, Tg TiO2 = mPHGPx transgenic
offspring whose dam was exposed to nano-TiO2.
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Figure 3.6:
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Figure 3.6:
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Figure 3.6: Epitranscriptomic mechanism contributing to diminished antioxidant
scavenging ability following maternal nano-TiO2 inhalation exposure. (A) Global m6A content
was determined as a percentage (%) of total RNA isolated from adult offspring cardiac tissue.
PPME WT Sham, n = 6; PPME WT TiO2, n = 5; PPME Tg Sham, n = 6; PPME Tg TiO2, n = 5;
MPME WT Sham, n = 4; MPME WT TiO2, n = 5; MPME Tg Sham, n = 6; MPME Tg TiO2, n =
4. (B) Isolated RNA with 3 min fragmentation utilized to achieve ~130 nt fragments (top)
compared to no fragmentation (bottom). (C) Schematic of the predicted m6A site in the 3’-UTR of
the mouse mPHGPx mRNA, specifically within the SECIS region. (D) M6A-RIP-qPCR for
mPHGPx (3’-UTR region including potential m6A site). N= 4 per group (ran in triplicate).
Statistical difference was defined by P ≤ 0.05 (ns = no significance) based on a one or two-way
ANOVA, where appropriate. A letter above a group denotes statistical significance between those
groups based on a Tukey’s multiple-comparisons test. A dagger (†) above a group indicates
statistical significance between WT Sham and WT TiO2 or Tg Sham and Tg TiO2 of the same
maternal genetic group (MPME or PPME) based on a Student’s t-test. All data are presented as
the mean ± the standard error of the mean (SEM). Adult = 11 weeks old, mPHGPx = mitochondrial
phospholipid hydroperoxide glutathione peroxidase, M6A = N6-Methyladenosine, PPME =
Paternal mPHGPx maternal exposure, MPME = Maternal mPHGPx maternal exposure, WT Sham
= wild-type offspring whose dam was exposed to control air, Tg Sham = mPHGPx transgenic
offspring whose dam was exposed to control air, WT TiO2 = wild-type offspring whose dam was
exposed to nano-TiO2, Tg TiO2 = mPHGPx transgenic offspring whose dam was exposed to nanoTiO2, RIN = RNA integrity number, SECIS = selenocysteine insertion sequence.
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Figure 3.7:
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Figure 3.7: Physiological and molecular consequences of gestational nano-TiO2 inhalation
exposure in adult offspring. Following gestational exposure, elevated ROS levels in the progeny
are concomitant with cardiac functional alterations that can be mitigated by overexpression of
maternal mPHGPx. Augmented mitochondrial ROS plays a key role in the persistence of deficits
into adulthood (11 weeks of age) characterized by diminished GLS and ETC complex activities.
A mechanism that could promote the sustained consequences is initiated by high oxidative stress,
which increases m6A methylation at the SECIS in the 3’-UTR of mPHGPx. Ultimately, this may
tamper with the SECIS binding region for the SBP2 that is vital for the incorporation of
selenocysteine and the catalytic activity of mPHGPx. Decreased mPHGPx activity then propagates
mitochondrial bioenergetic deficits, limiting overall cardiac performance in the adult offspring.
MPHGPx = mitochondrial phospholipid hydroperoxide glutathione peroxidase, ROS = reactive
oxygen species, GLS = global longitudinal strain, ETC = electron transport chain, m 6A = N6methyladenosine, SECIS = Selenocysteine insertion sequence, SBP2 = SECIS binding protein 2.
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Supplemental Table 3.1: Primer sequences
Gene Name

Forward (5’ – 3’)

Reverse (5’ – 3’)

GPx4

CCUACAAGUGUGUGCCCCUA

AGGCCUCUGGACCUUCCUC

GAPDH

AACTTTGGCATTGTGGAAGG

ACACATTGGGGGTAGGAACA
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Supplemental Table 3.1: Primers were designed for m6A-RIP-qPCR using Primer-BLAST
through NCBI and Primer3. Sequence information was obtained from the University of Santa Cruz
(UCSC) genome browser from the mouse GRCm38/mm10 assembly.
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Supplemental Table 3.2: Adult and fetal progeny heart rates following maternal inhalation
exposure
Heart
Rate
(BPM)

PPME
WT
Shama

PPME
WT
TiO2 b

PPME
Tg
Shamc

PPME
Tg TiO2

MPME
WT
TiO2 f

MPME
Tg
Shamg

MPME
Tg TiO2

d

MPME
WT
Sham e

Fetal

85.67 ±
5.98

127.92 ±
5.85

107.07 ±
17.75

155.22 ±
6.87

140.26 ±
13.73

163.17 ±
41.65

145.040
± 12.40

160.60 ±
26.36

Adult

716.68 ±
13.74

666.99 ±
14.29

666.37 ±
17.91

661.19 ±
21.95

676.38 ±
50.98

676.14 ±
8.66

641.98 ±
39.60

691.58 ±
18.90
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h

Supplemental Table 3.2: Heart rates were obtained for adult (11 weeks) and fetal (GD 14)
offspring during echocardiographic assessment. Bold and underlined values indicate a statistically
significant difference between fetal PPME and MPME offspring heart rates as determined by a
two-way ANOVA and defined by P ≤ 0.05. All data are presented as the mean ± the standard error
of the mean (SEM). Adult offspring: PPME WT Sham, n = 7; PPME WT TiO2, n = 6; PPME Tg
Sham, n = 6; PPME Tg TiO2, n = 5; MPME WT Sham, n = 4; MPME WT TiO2, n = 5; MPME Tg
Sham, n = 5; MPME Tg TiO2, n = 4. Fetal offspring: PPME WT Sham, n = 3; PPME WT TiO2, n
= 7; PPME Tg Sham, n = 3; PPME Tg TiO2, n = 7; MPME WT Sham, n = 7; MPME WT TiO2, n
= 4; MPME Tg Sham, n = 6; MPME Tg TiO2, n = 6. PPME = Paternal mPHGPx maternal
exposure, MPME = Maternal mPHGPx maternal exposure, WT Sham = wild-type offspring whose
dam was exposed to control air, Tg Sham = mPHGPx transgenic offspring whose dam was exposed
to control air, WT TiO2 = wild-type offspring whose dam was exposed to nano-TiO2, Tg TiO2 =
mPHGPx transgenic offspring whose dam was exposed to nano-TiO2, GD = gestational day.
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Supplemental Table 3.3: M-mode echocardiography for pregnant dams
Parameter

WT Shama

WT TiO2 b

Tg Shamc

Tg TiO2 d

Diameter;s (mm)

0.89 ± 0.05

0.82 ± 0.07

0.70 ± 0.04

0.80 ± 0.09

Diameter;d (mm)

2.62 ± 0.08

2.30 ± 0.08a

2.51 ± 0.02

2.46 ± 0.06

Volume;s (uL)

1.58 ± 0.20

1.41 ± 0.30

0.86 ± 0.16

1.41 ± 0.30

Volume;d (uL)

25.60 ± 1.93

18.70 ± 1.57a

22.8 ± 0.54

21.70 ± 1.32

Stroke Volume (uL)

23.30 ± 1.60

17.30 ± 1.36a

21.9 ± 0.41

20.40 ± 1.21

Ejection Fraction (%)

93.00 ± 0.76

92.90 ± 1.15

96.3 ± 0.61

93.60 ± 1.25

Fractional Shortening (%)

64.60 ± 1.58

64.90 ± 2.18

72.40 ± 1.53

67.50 ± 3.55

Cardiac Output (mL/min)

15.50 ± 1.04

11.40 ± 0.98a

14.00 ± 0.37

13.50 ± 0.72

Relative Wall Thickness

0.81 ± 0.03

1.12 ± 0.09a

0.930 ± 0.03

0.97 ± 0.06
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Supplemental Table 3.3: M-mode echocardiography was performed in pregnant dams (GD 14)
following gestational inhalation exposure to control air or ENM aerosols. Bold text indicates a
statistically significant difference between the highlighted group and the group referenced by the
letter next to it, as determined by a one-way ANOVA with a Tukey’s multiple comparisons test
and defined by P ≤ 0.05. WT Sham, n = 11; WT TiO2, n = 12; Tg Sham, n = 11; Tg TiO2, n = 10.
WT = wild-type, Tg = mPHGPx transgenic, s = systolic, d = diastolic, GD = gestational day.
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Supplemental Table 3.4: Maternal heart rates following gestational inhalation exposure
Heart Rate (BPM)

WT Shama

WT TiO2 b

Tg Shamc

Tg TiO2 d

Maternal

667.90 ± 10.50

655.56 ± 13.40

638.44 ± 17.20

667.39 ± 17.80
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Supplemental Table 3.4: Heart rates were obtained for pregnant dams (GD 14) during
echocardiographic assessment, following gestational inhalation exposure. WT Sham, n = 11; WT
TiO2, n = 12; Tg Sham, n = 11; Tg TiO2, n = 10. WT = wild-type, Tg = mPHGPx transgenic. GD
= gestational day.
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Supplemental Table 3.5: M-mode echocardiography for fetal progeny

Parameter

PPME
WT
Shama

PPME
WT
TiO2 b

PPME
Tg
Shamc

PPME
Tg
TiO2 d

MPME
WT
Shame

MPME
WT
TiO2 f

MPME
Tg
Shamg

MPME
Tg
TiO2 h

Diameter;s
(mm)

0.31 ±
0.02

0.27 ±
0.02

0.33 ±
0.07

0.34 ±
0.03

0.29 ±
0.02

0.43 ±
0.08

0.30 ±
0.01

0.35 ±
0.03

Diameter;d
(mm)

0.76 ±
0.04

0.70 ±
0.05

0.78 ±
0.07

0.78 ±
0.04

0.80 ±
0.05

0.87 ±
0.08

0.82 ±
0.06

0.92 ±
0.04

Volume;s (uL)

0.08 ±
0.01

0.06 ±
0.01

0.11 ±
0.06

0.12 ±
0.03

0.07 ±
0.02

0.22 ±
0.08e

0.08 ±
0.01

0.13 ±
0.03

Volume;d (uL)

0.98 ±
0.12

0.83 ±
0.15

1.09 ±
0.26

1.10 ±
0.19

1.18 ±
0.22

1.48 ±
0.32

1.30 ±
0.23

1.72 ±
0.24

Stroke Volume
(uL)

0.89 ±
0.11

0.77 ±
0.14

0.98 ±
0.20

0.98 ±
0.16

1.11 ±
0.20

1.26 ±
0.24

1.22 ±
0.22

1.60 ±
0.21

Ejection
Fraction (%)

91.45±
0.32

92.68 ±
1.22

90.97 ±
3.02

89.85 ±
1.41

94.07 ±
0.70

86.66 ±
3.67e,g,h

93.56 ±
0.44

93.13 ±
1.12

Fractional
Shortening (%)

58.86 ±
.58

61.36 ±
2.20

58.46 ±
5.58

56. 70
± 2.35

63.60 ±
1.34

52.30 ±
5.30e

63.09 ±
1.56

62.040
± 2.21

Cardiac Output
(mL/min)

0.05 ±
0.00

0.05 ±
0.01

0.06 ±
0.01

0.06 ±
0.01

0.09 ±
0.02

0.11 ±
0.02

0.09 ±
0.02

0.10 ±
0.01

Relative Wall
Thickness

0.59 ±
0.11

0.46 ±
0.07

0.35 ±
0.01

0.57 ±
0.09

0.42 ±
0.08

0.40 ±
0.06

0.40 ±
0.08

0.48 ±
0.03
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Supplemental Table 3.5: M-mode echocardiography was performed in fetal offspring (GD 14)
following maternal inhalation exposure. Bold text indicates significant data defined by P ≤ 0.05.
A two-way ANOVA determined statistical difference between PPME and MPME denoted with
underlined values for that parameter. A letter next to a given group denotes statistical significance
between the marked group and the group represented by each letter based on a Tukey’s multiplecomparisons test. All data are presented as the mean ± the standard error of the mean (SEM).
PPME WT Sham, n = 3; PPME WT TiO2, n = 7; PPME Tg Sham, n = 3; PPME Tg TiO2, n = 7;
MPME WT Sham, n = 7; MPME WT TiO2, n = 4; MPME Tg Sham, n = 6; MPME Tg TiO2, n =
6. PPME = Paternal mPHGPx maternal exposure, MPME = Maternal mPHGPx maternal exposure,
WT Sham = wild-type offspring whose dam was exposed to control air, Tg Sham = mPHGPx
transgenic offspring whose dam was exposed to control air, WT TiO2 = wild-type offspring whose
dam was exposed to nano-TiO2, Tg TiO2 = mPHGPx transgenic offspring whose dam was exposed
to nano-TiO2, s = systolic, d = diastolic.
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Supplemental Table 3.6: Adult progeny systolic stress-strain in the short-axis

Parameter

Units

PPME
WT
Shama

PPME
WT
TiO2 b

PPME
Tg
Shamc

PPME
Tg
TiO2 d

MPM
E WT
Shame

MPM
E WT
TiO2 f

MPM
E Tg
Shamg

MPM
E Tg
TiO2 h

Radial Velocity

Pk
cm/s

2.69 ±
0.22

2.82 ±
0.33

2.58 ±
0.14

2.74 ±
0.12

2.35 ±
0.21

2.34 ±
0.27

2.60 ±
0.30

2.62 ±
0.30

Radial
Displacement

Pk mm

0.61 ±
0.04

0.65 ±
0.06

0.57 ±
0.06

0.67 ±
0.05

0.47 ±
0.07

0.47 ±
0.03

0.50 ±
0.08

0.57 ±
0.03

Radial Strain

Pk
%

43.42
± 3.68

45.16
± 3.27

38.74
± 4.65

45.45
± 2.66

37.72
± 2.52

30.35
± 3.13

32.33
± 5.05

35.54
± 5.31

Radial Strain
Rate

Pk 1/s

15.24
± 1.08

17.48
± 1.10

14.21
± 0.79

15.08
± 0.70

15.48
± 0.54

12.35
± 1.86

14.01
± 0.90

14.21
± 2.58

Circumferentia
l Velocity

Pk
deg/s

736.92
±
150.19

506.27
±
32.36

596.50
±
121.12

611.58
±
41.31

867.56
±
154.99

724.07
±
132.03

583.47
±
86.97

612.95
±
43.03

Circumferentia
l Displacement

Pk deg

7.37 ±
1.67

7.24 ±
2.92

7.08 ±
2.87

7.05 ±
1.89

9.43 ±
4.52

8.37 ±
2.07

4.88 ±
1.12

6.30 ±
1.56

Circumferentia
l Strain

Pk
%

-46.81
± 3.53

-55.29
± 2.82

-43.68
± 1.50

-52.79
± 2.88

-38.49
± 8.83

-42.26
± 6.94

-35.29
± 4.32

-42.69
± 6.94

Circumferentia
l Strain Rate

Pk 1/s

-42.28
± 3.95

-52.41
± 7.85

-37.53
± 5.26

-49.63
± 8.50

-38.61
± 1.97

-42.40
± 9.65

-45.37
± 6.64

-51.42
± 3.43
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Supplemental Table 3.6: Peak strain and strain-rate values acquired from B-mode images for
circumferential and radial dimensions in adult progeny (11 weeks of age) following maternal
inhalation exposure. Bold and underlined values indicate a statistically significant difference
between fetal PPME and MPME offspring values for that parameter as determined by a two-way
ANOVA and defined by P ≤ 0.05. All data are presented as the mean ± the standard error of the
mean (SEM). PPME WT Sham, n = 7; PPME WT TiO2, n = 6; PPME Tg Sham, n = 6; PPME Tg
TiO2, n = 5; MPME WT Sham, n = 4; MPME WT TiO2, n = 5; MPME Tg Sham, n = 5; MPME
Tg TiO2, n = 4. PPME = Paternal mPHGPx maternal exposure, MPME = Maternal mPHGPx
maternal exposure, WT Sham = wild-type offspring whose dam was exposed to control air, Tg
Sham = mPHGPx transgenic offspring whose dam was exposed to control air, WT TiO2 = wildtype offspring whose dam was exposed to nano-TiO2, Tg TiO2 = mPHGPx transgenic offspring
whose dam was exposed to nano-TiO2, Pk = peak.
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Supplemental Table 3.7: Fetal progeny systolic stress-strain in the short-axis

Parameter

Units

PPME
WT
Shama

PPME
WT
TiO2 b

PPME
Tg
Shamc

PPME
Tg
TiO2 d

MPM
E WT
Shame

MPM
E WT
TiO2 f

MPM
E Tg
Sham
g

MPM
E Tg
TiO2 h

Radial Velocity

Pk
cm/s

0.23 ±
0.02

0.12 ±
0.02a,c

0.22 ±
0.05

0.12 ±
0.02a,c

0.19 ±
0.02

0.16 ±
0.02

0.16 ±
0.02

0.17 ±
0.01

Radial
Displacement

Pk
mm

0.13 ±
0.01

0.06 ±
0.01a,c

0.12 ±
0.04

0.05 ±
0.01a,c

0.06 ±
0.01

0.05 ±
0.01

0.04 ±
0.01

0.04 ±
0.01

Radial Strain

Pk %

18.95
± 3.65

9.92 ±
2.22

19.96
± 6.92

8.72 ±
1.33

21.03
± 5.08

16.21
± 2.49

14.07
± 3.10

22.38
± 6.19

Radial Strain
Rate

Pk
1/s

13.16
± 3.10

3.75 ±
0.65a

7.58 ±
3.13

3.37 ±
0.34a

9.30 ±
0.67

11.75
± 3.45

11.07
± 1.61

10.55
± 3.12

Circumferentia
l Velocity

Pk
deg/s

389.31
±
62.28

213.06
±
29.75

425.89
±
170.71

298.10
±
67.32

466.39
±
42.24

442.01
±
79.04

401.68
±
65.57

507.34
±
56.69

Circumferentia
l Displacement

Pk
deg

13.47
± 1.97

5.36 ±
1.35a

11.74
± 2.11

7.91 ±
0.84

15.34
± 1.83

11.66
± 1.00

13.86
± 0.91

11.38
± 1.72

Circumferentia
l Strain

Pk %

-36.36
± 3.16

-21.07
±
3.09a,c

-37.92
± 6.78

-20.79
±
0.88a,c

-29.53
± 2.68

-26.04
± 3.70

-23.51
± 0.81

-24.53
± 4.69

Circumferentia
l Strain Rate

Pk
1/s

-16.47
± 1.82

-10.23
± 2.81

-13.68
± 3.19

-9.50 ±
1.77

-18.25
± 1.71

-17.42
± 1.08

-14.70
± 1.54

-18.48
± 2.85
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Supplemental Table 3.7: Peak strain and strain-rate values acquired from B-mode images for
circumferential and radial dimensions in fetal progeny (GD 14) following maternal inhalation
exposure. Bold text indicates significant data defined by P ≤ 0.05. A two-way ANOVA determined
statistical difference between PPME and MPME denoted with underlined values for that
parameter. A letter next to a given group denotes statistical significance between the marked group
and the group represented by each letter based on a Tukey’s multiple-comparisons test. All data
are presented as the mean ± the standard error of the mean (SEM). PPME WT Sham, n = 3; PPME
WT TiO2, n = 7; PPME Tg Sham, n = 3; PPME Tg TiO2, n = 7; MPME WT Sham, n = 7; MPME
WT TiO2, n = 4; MPME Tg Sham, n = 6; MPME Tg TiO2, n = 6. PPME = Paternal mPHGPx
maternal exposure, MPME = Maternal mPHGPx maternal exposure, WT Sham = wild-type
offspring whose dam was exposed to control air, Tg Sham = mPHGPx transgenic offspring whose
dam was exposed to control air, WT TiO2 = wild-type offspring whose dam was exposed to nanoTiO2, Tg TiO2 = mPHGPx transgenic offspring whose dam was exposed to nano-TiO2, GD =
gestational day, Pk = peak.
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Abstract
Background: N6-methyladenosine (m6A) is the most prominent epitranscriptomic modification in
eukaryotes, but it’s implications on adaptive changes within the gestational environment are poorly
understood. We propose that cardiac m6A methylation in fetal offspring exposed gestationally to
nano-TiO2 alters mitochondrial bioenergetics through changes in mRNA and protein stability.
Methods: 10-week-old female FVB/NJ wild type mice (n=14) were purchased. Mice were mated
and on gestational day (GD) 5 underwent 6 non-consecutive days of whole-body inhalation
exposure. Mice were exposed to filtered room air or nano-TiO2 with a target aerosol mass
concentration of 12 mg/m3. At GD 15 mice were sacrificed and cardiac RNA and mitochondrial
proteins extracted. Immunoprecipitation with m6A antibodies was performed followed by
sequencing of immunoprecipitant (m6A) and input (mRNA) on the Illumina NextSeq 2000. Protein
extraction, preparation, and LC-MS/MS was used for mitochondrial protein quantification.
Results: There were no differences in maternal or fetal pup weights, number of pups, or pup heart
weight between exposure groups. Transcriptomic sequencing revealed 3,648 differentially
expressed genes in nano-TiO2 exposed mice (Padj≤0.05). Genes involved in mitochondrial
bioenergetics were significantly downregulated (83 or 85 genes). 921 genes revealed significant
m6A methylation sites (Padj≤0.10). 311 genes were identified to have significantly altered gene
expression (mRNA) as well as differentially methylated sites. Pathway analysis of these genes
revealed that mRNA degradation and ubiquitin-mediated proteolysis were common pathways.
Mitochondrial proteomics showed decreased ATP Synthase expression in the exposed group.
Conclusions: M6A methylation likely affects the longevity of transcripts and translated proteins
in fetal progeny following nano-TiO2 exposure, ultimately affecting mitochondrial function.

Keywords: Epitranscriptomics; Bioenergetics; Heart, 3’ UTR; m6A; Bioinformatics
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Introduction
Epigenetic reprogramming is one of the main mechanisms responsible for adverse effects
on long-term health outcomes following environmental exposure to toxicants (1, 43). While
studies of transient DNA and histone modifications have provided significant insight into the field
of toxicology, the advent of chemical modifications at the level of mRNA has introduced a new
layer of complexity. The study of mRNA chemical modifications, otherwise known as
epitranscriptomics, provides a new perspective for understanding how alterations in the stability
of mRNA transcripts can impact the maternal environment, shaping the health of the offspring.
N6-methyladenosine (m6A) is the most abundant mRNA modification in eukaryotes (52) and has
the capacity to alter the translational capacity of transcripts. There is currently very little
understanding if/how m6A modifications impact fetal development following gestational
particulate or ENM exposure.
The epigenetic modifications that were implicated in the long-term effects of
environmental exposure thus far have centered primarily around oxidative stress, DNA
methylation, and histone post-translational modifications (37, 39). However post-transcriptional
modifications and their role in regulating RNA function have recently gained traction. Methylation
of bases can alter RNA structure, folding, stability, degradation, localization, and thereby its
interactions with other RNAs or proteins (21, 52). Recently, N6-methyladenosine (m6A) has been
suggested to play a prominent role in epitranscriptomic reprogramming following particle
inhalation exposure (7, 8, 23). M6A, which is the most prevalent internal, post-transcriptional RNA
modification, occurs in ~30% of transcripts, and plays a pivotal role in numerous physiological
systems (51). In addition to being highly abundant in mammalian mRNA, it is also vastly
conserved across eukaryotic species including, yeast, plants, and mammals (10, 13).
To understand the effects of m6A in disease, one must first understand the regulators
involved in writing, erasing, and reading these prevalent modifications. The writers are responsible
for the co-transcriptional addition of a methyl group at the N6 position of the adenosine in the
consensus sequence DRACH (D=A/G/U; R=A/G, H=A/C/U) (21, 22, 52). Methyltransferase-like
protein 3 (METTL3) is the main player in the writer complex which also includes adaptor proteins.
The two predominant demethylases in mammals that are responsible for removing the m6A marks
are fat mass and obesity-associated protein (FTO) and α-ketoglutarate-dependent dioxygenase
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homolog 5 (ALKBH5) (52). However, m6A is not the primary target for FTO as has been recently
discovered, rather the primary target of FTO is N6,2′-O-dimethyladenosine (m6Am) (28). Lastly,
the m6A reader proteins include YTH domain (YT521-B homology) containing proteins,
YTHDC1 and YTHDF1/2/3, which appear to each play their own individual role in mRNA
processing based on the presence or absence of m6A marks. When YTHDC1 binds to the m6A
mark (mainly in the nucleus), it can affect splicing and/or mRNA export, whereas YTHDF1
promotes mRNA translation (22). On the other hand, the reader protein YTHDF2 favors mRNA
decay. YTHDF3 works with both YTHDF1 and YTHDF2 to enhance each respective activity (40).
Dysregulation of m6A can thereby alter gene expression that can lead to changes in cellular
function and the onset of cancer, psychiatric disorders, metabolic diseases, and cardiovascular
disease (51, 52).
The overall landscape of m6A remains to be elucidated in offspring hearts following
maternal ENM inhalation exposure during gestation. In this study we implement transcriptomewide mapping of m6A by combining RNA immunoprecipitation and RNA sequencing (m6A-RIPseq) to elucidate the role of m6A methylation on diminished cardiac and mitochondrial function in
fetal offspring following gestational exposure to nano-TiO2 (23, 24). MRNA and m6A analyses
revealed genes with overlapping pathways, such as regulation of RNA degradation and ubiquitinmediated proteolysis. Both transcriptomic and mitochondrial proteomic data highlighted how
significant decreases in mitochondrial genes were found following exposure. Our data emphasize
how gestational exposure to ENMs can alter m6A methylation and indirectly regulate critical
cellular processes, such as mitochondrial bioenergetics.
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Materials and Methods
Animal Model
Friend Virus B NIH Jackson (FVB/NJ) wild type mice (14 females, 7 males at 10 weeks)
were purchased from Jackson Laboratory (Bar Harbor, ME). Animals were housed in the West
Virginia University Health Sciences Center Animal Facility with access to a standard chow diet
and water ad libitum. All animals were allowed a 48-hour acclimation period before being handled.
Females were housed in groups of 4 per cage and introduced to male bedding three days prior to
being introduced to the males for breeding. This was implemented to take advantage of the Whitten
effect, which states that females are most receptive to mating on the third night after exposure to
male pheromones that are found in urine (47). This allows us to synchronize the females’ estrous
cycles prior to mating and therefore increases the number of females becoming pregnant at similar
time points and leading to well age-matched cohorts.
A harem breeding strategy was utilized with two females and one male per cage set up on
the third night following exposure to male bedding. Females were checked for vaginal plugs in the
early morning after they were set-up with the males. Pregnancy was verified with identification of
a vaginal plug at which point females were randomly separated into sham (7 pregnant dams) and
nano-TiO2 (7 pregnant dams) groups. On approximately gestational day (GD) 5, maternal
inhalation exposure was initiated for each respective exposure group (sham or nano-TiO2) that
occurred for 6 hours/day, for 6 days over an 8-day period. Pregnant dams (7 Sham, 7 nano-TiO2)
were euthanized on GD 15 and the pups were removed from the uteri. The dams, pups, and pup
hearts were weighed and weights recorded (Table 4.1). The hearts of fetal offspring were pooled
per each litter which was considered n=1. The hearts of offspring of 3 sham and 3 nano-TiO2exposed dams were saved in RNAprotect Tissue Reagent (Item no. 76105; Qiagen, Hilden,
Germany) in cryotubes, flash frozen, and stored in -80°C for future analysis. The hearts of
offspring of the other 4 sham and 4 nano-TiO2-exposed dams were immediately processed for
mitochondrial isolation as described below. The West Virginia University Animal Care and Use
Committee approved all animal studies which conform to the most current National Institutes of
Health (NIH) Guidelines for the Care and Use of Laboratory Animals (8th edition) manual.
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Engineered Nanomaterial (ENM) Inhalation Exposure
Our laboratory has previously detailed the engineered nanomaterial (ENM) inhalation
exposure paradigm implemented in this study (14, 23, 24). Nano-TiO2 P25 powder was purchased
from Evonik (Aeroxide TiO2, Parsipanny, NJ) which was composed of anatase (80%) and rutile
(20%) TiO2. Prior to aerosolization, the nano-TiO2 powder was prepared by drying, sieving, and
storing (14, 18, 23, 24, 31). Previous studies from our laboratory and colleagues have outlined the
primary particle characteristics including the size (21 nm), Zeta potential (‒56.6 mV), and the
specific surface area (48.08 m2/g) (30, 31, 38).
A high-pressure acoustical generator (HPAG; IEStechno, Morgantown, WV) was utilized
for nano-TiO2 aerosolization as has been previously done for rodent inhalation exposure studies
(14, 23, 24). Figure 4.1 outlines the details of nano-TiO2 aerosol characterization. Using a wholebody exposure chamber, a target aerosol mass concentration of 12 mg/m3 of engineered nano-TiO2
was implemented for a period of 360 minutes per day for 6 non-consecutive days, over an 8-day
period (23). The relevance of this concentration lies in its ability to recapitulate the lung burden of
a person who works in a manufacturing setting, based on the human equivalent alveolar doses
during pregnancy and has been previously detailed by our laboratory (23). Alveolar deposition
fraction (F), minute ventilation based on body weight (V), the mass concentration (C), and
exposure duration (T) were used with the equation D=F x V x C x T. This allowed us to determine
that the daily deposited nano-TiO2 alveolar dose was 6.92 µg (total six exposure dose = 41.55 µg).
The real-time TiO2 aerosol mass concentration readings were sampled from the exposure
chamber during a typical exposure day (Figure 4.1A). These concentrations were verified by
gravimetric measurements during each exposure, which resulted in an average mass concentration
of 12 mg/m3 during the 360-minute period. To determine the size distribution of the nano-TiO2
aerosols, a high-resolution electrical low-pressure impactor (ELPI+; Dekati, Tampere, Finland),
and a scanning particle mobility sizer (SMPS 3938; TSI Inc., St. Paul, MN) were employed. The
ELPI+ data indicated a geometric count median diameter (CMD) of 172 nm with a geometric
standard deviation (GSD) of 1.96 (Figure 4.1B). The SMPS data indicated a CMD of 112 nm with
a GSD of 2.14 (Figure 4.1C). The exposure chamber contained bedding material that was soaked
in water to maintain a comfortable humidity level during exposure. Control animals (sham) were
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exposed to HEPA filtered air with similar chamber conditions in a designated control chamber.
The final exposure was administered 48 hours prior to sacrifice and tissue harvesting.

RNA Isolation and Fragmentation
Total RNA was extracted from pooled fetal heart samples (sham, n =3; nano-TiO2, n=3)
using QIAzol lysis reagent (item no. 79306, Qiagen). Samples were homogenized in QIAzol using
a rotor-stator homogenizer and further processed using the miRNeasy Mini Kit (item no. 217004,
Qiagen) per manufacturer’s protocol. Concentrations were determined for each sample using the
NanoDrop ND-100 (Thermo Fisher Scientific, Waltham, MA). Spike-in controls obtained from
the EpiMark N6-Methyladenosine Enrichment Kit (item no. E1610S; NEB) were prepared
following the manufacturer’s protocol. Briefly, the m6A control RNA contains m6A modified RNA
(Gaussia luciferase), which was transcribed in the presence of 20% m6ATP and 80% ATP and the
unmodified control RNA (Cypridina luciferase) contains no modifications. 1 µL of the m6A
control RNA and 1 µL of the unmodified control RNA were added to each sample prior to
fragmentation. The fetal cardiac total RNA samples (3 µg) were fragmented into ~250-350nucleotide fragments using the NEBNext Magnesium RNA Fragmentation kit (item no. E6150S;
New England Biolabs (NEB), Ipswich, MA) at 65°C for 5 minutes, followed by addition of the
stop solution (26, 53), previously shown (23). The Monarch RNA Cleanup Kit (item no T2030L;
NEB) was performed per manufacturer’s protocol. Samples were eluted with 20 µL of nucleasedree water and concentrations were determined using the NanoDrop ND-100 (Thermo Fisher
Scientific). 2 µL of fragmented total RNA was saved from each sample to be used as input and the
rest was used for m6A RNA immunoprecipitation followed by sequencing (m6A-RIP-seq).

Immunoprecipitation (m6A-RIP) with Low Input Samples
The protocol used in our study was adapted from m6A-RIP protocols described in “Refined
RIP-seq protocol for epitranscriptome analysis with low input materials” (53) and “Landscape and
Regulation of m6A and m6Am Methylome across Human and Mouse Tissues” (26), with
modifications. In a 1.5 mL microcentrifuge tube (per sample), 30 µL of protein-A magnetic beads
(item no. 10002D; Thermo Fisher Scientific) and 30 µL of protein-G magnetic beads (item no.
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10004D; Thermo Fisher Scientific) were mixed, magnetic field applied, and supernatant removed.
The mixture of beads was washed twice with 400 µL of IPP buffer (10 mM Tris-HCl, 150 mM
NaCl, pH 7.5; 0.1% IGEPAL CA-630) and resuspended in 500 µL of IPP buffer. 5 µg of affinity
purified anti-m6A polyclonal antibody (item no. ABE572-I; MilliporeSigma, Burlington, MA) was
added to the beads and incubated overnight at 4°C. An additional tube with the mixture of beads
received 5 µg of the normal rabbit IgG control antibody (item no. 2729; Cell Signaling Technology
(CST), Danvers, MA) and was also incubated overnight at 4°C. The magnetic field was applied
and supernatant removed, followed by washing the antibody-bead mixture twice with IPP buffer.
In a 1.5 mL microcentrifuge tube, a 500 µL mixture was prepared containing 100 µL of 5X IPP
buffer, fragmented total RNA (diluted with nuclease-free water to a volume of 395 µL), and 5 µL
of RNasin Plus RNase Inhibitor (item no. N2611; Promega, Madison, WI).
The antibody-bead mixture was resuspended in the 500 µL mixture containing the
fragmented RNA and incubated with orbital rotation at 4°C for 2 hours, followed by application
of the magnetic field, removal of the supernatant, and two washes with 1,000 µL of IPP buffer.
The bead-antibody-RNA mixture was then washed twice with 1,000 µL of low-salt IPP buffer (10
mM Tris-HCl, 50 mM NaCl, pH 7.5; 0.1% IGEPAL CA-630) and twice with 1,000 µL of highsalt IPP buffer (10 mM Tris-HCl, 500 mM NaCl, pH 7.5; 0.1% IGEPAL CA-630). A competitive
elution buffer was then prepared containing 6.7 mM N6-methyladenosine 5’- monophosphate
sodium salt (item no. M2780, Sigma-Aldrich) in IPP buffer. Each immunoprecipitation (IP)
sample was resuspended in 100 µL of the m6A competitive elution buffer with continuous shaking
at 4°C for 1 hour. The magnetic field was applied, which allowed us to collect the supernatant
(eluted m6A RNA) into a new tube. The eluted RNA was further purified using the RNeasy
MinElute Cleanup Kit (item no. 74204; Qiagen) following manufacturer’s protocol. The m6A
enriched RNA was eluted by adding 14 µL of ultrapure H2O directly to the center of the membrane
and centrifuging for 1.5 mins at full speed. Samples were stored at –80°C until initiation of the
library preparation procedure.

Library Prep and Sequencing
Library preparation was performed on immunoprecipitated (IP) and total (input) RNA
samples from sham (n = 3) and nano-TiO2 (n = 3) gestationally-exposed fetal offspring hearts
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using the NEB® Single Cell/Low Input RNA Library Prep kit for Illumina® (item no. E6420S,
NEB) and Illumina® compatible NEB® UDIs (item no. E6440S, NEB), which mitigate sample
misassignment due to index-hopped reads. The Agilent 2100 BioAnalyzer (Agilent Technologies,
Santa Clara, CA) was employed to determine the size distribution of RNA. Libraries were PCR
amplified for 10 cycles and NEB UDIs were used for indexing by amplifying for 8 cycles. The
RNA sample concentrations were quantified using a Qubit Fluorometer (Thermo Fisher
Scientific). The samples were sequenced using the Illumina NextSeq 2000 (Illumina Inc., San
Diego, CA) at Marshall University as paired end (PE) 2x50 bp reads.

Analysis of RNA-Seq Data
Adapters were trimmed from Fastq files through Flexbar v3.5 (36). The trimmed Fastq files
were processed using paired-end alignment with HISAT2 v2.2.1 and the resulting BAM files were
aligned to the mouse reference genome (Mus musculus, GRCm39, Ensemble version 104) for input
and IP samples. Peaks showing significant enrichment in the IP samples vs. corresponding input
samples for all submitted replicates were detected using RADAR v0.2.1 (56), with a fragment
length of 297 base pairs and bin size of 25 base pairs. Peak reads coverage for transcripts were
visualized with RADAR and the Integrative Genome Browser (IGV) browser (5, 12, 25, 35).
Input mRNA samples were further processed for full decoy-aware transcriptomic analyses
using Salmon v1.5.2 (33) on the mouse reference genome (Mus musculus, GRCm39, Ensemble
version 104) and processed in R using tximport v1.22.0 (41). Differential gene expression was
performed through DESeq2 v1.34.0 (27). Visualization of data was accomplished through ggpolt2
v3.3.5 (48) and pheatmap v1.0.12. Pathway analysis was performed through PathFindR v1.6.3
(44).

Mitochondrial Isolation
Fetal pups were sacrificed at GD 15 and their hearts were excised through a midsagittal cut
in the thoracic cavity. Mitochondria were isolated as previously described (32), with modifications
by our laboratory (2, 3, 9). The two subpopulations of mitochondria (subsarcolemmal and
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interfibrillar) were combined at the end of the protocol to achieve a total mitochondrial population.
Samples were resuspended in KME buffer (100mM KCl, 50mM MOPS and 0.5mM EGTA pH
7.4) with protease inhibitor cocktail (PIC).

Sample Preparation for Mitochondrial Proteomics
Label-free proteomics sample preparation was performed on fetal cardiac isolate
mitochondria (sham, n=4; nano-TiO2, n=4) based off the “Plasma protein digestion” protocol
described by Valentine et. al. with several modifications (45). 37 µL, containing about 24 µg of
protein, as measured by the Bradford assay, of isolated fetal cardiac mitochondria (in KME+PIC)
was placed in a SpeedVac for 3.5 hours to dry out the sample. Samples were resuspended in 20
µL of Dissolution buffer (8 M Urea, 50 mM Tris-HCl - pH 8.2)) and their protein concentrations
were determined using the NanoDrop™ One Microvolume UV-Vis Spectrophotometer (Thermo
Fisher Scientific). 12 µg of protein per sample was used for the rest of the sample preparation
procedure. 1.2 µL of DTT reducing agent (100 mM DTT (item no. V3151, Promega) in 8 M urea
and 100 mM ammonium bicarbonate – pH 8.2) was added to each sample followed by a 2-hour
incubation at 37°C, with gentle agitation. After reducing the disulfide bonds, samples were placed
on ice. Protein alkylation was then achieved using 1.2 µL of iodoacetamide (225 mM
iodoacetamide (item no. I6125, Sigma-Aldrich) in 8 M urea and 100 mM ammonium bicarbonate
– pH 8.2), which was made fresh.
The reaction was allowed to proceed in darkness, on ice for 2 hours. Next, 1.2 µL of
cysteine blocking reagent (100 mM L-cysteine (item no. 168149, Sigma-Aldrich) in 8 M urea and
100 mM ammonium bicarbonate – pH 8.2) was added to the mixture to remove any remaining
reagent, followed by a 30-minute incubation at room temperature with gentle agitation. Following
this reaction, enough Dilution solution (100 mM ammonium bicarbonate – pH 8.2) was added to
each sample to bring the urea to a 2 M concentration. Protein digestion was initiated by the addition
of Trypsin solution (appropriate amount of trypsin in 2 M urea, 100 mM ammonium bicarbonate
– pH 8.2) to a final concentration of 50:1 protein:trypsin and incubated for 24 hours at 37°C, with
gentle agitation. Peptide cleanup was performed using Thermo Scientific Pierce™ C18 Spin
Columns (item no. 89873) per manufacturer’s instructions and samples were eluted using
acetonitrile. Samples were dried using a centrifugal concentrator (Labconco) and stored at -20°C
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for LC-MS/MS analysis. Prior to LC-MS/MS analysis, each sample was resuspended in 100 µL
of formic acid buffer. Due to limited quantities of protein, the four samples in each group were
pooled to produce sham (n=2) and nano-TiO2 (n=2).

LC Separation
20 μL of digest solution was injected onto a reversed phase liquid chromatography (column (10
cm × 2.1 mm ID, 5 μm particle dia). A flow rate of 300 μL/min was employed for the reversedphase separation. Gradient elution was performed using two buffers. Buffer A consisted of HPLCgrade water with 1% formic acid and Buffer B was acetonitrile with 1% formic acid. During LC
separations the solvent contribution from Buffer B was 0.1%, 0.1%, 25%, 80%, 90%, 90%, and
0.1% at 0, 2, 27, 37, 42, 52, and 57 minutes, respectively.

Mass Spectrometer
Data were collected on an orbitrap mass spectrometer (Q-Exactive, Thermo Scientific).
Experiments were conducted in positive ion mode and data dependent analysis was employed.
Throughout the LC separation, a full MS scan was collected followed by 5 MS2 scans. Resolving
power settings of 70,000 and 17,500 were utilized for the precursor and MS2 scans, respectively.
The respective AGC settings were 1E6 and 1E5. A normalized collision energy of 30 was
employed for MS2 analyses. Finally, a dynamic exclusion time of 10 s was employed for the
separations.

Data Processing
Raw data files from the Q-Exactive mass spectrometer were imported into the Proteome
Discoverer software suite (Thermo Scientific). The SEQUEST search engine was employed for
peptide identification. The SwissProt (v2017-10-25) database for Mus musculus was employed for
peptide ion identification. The search employed a minimum peptide length of 5 residues and
allowed for 3 missed cleavages using Trypsin as the enzyme used for digestion. A precursor mass
tolerance of 12 ppm and a fragment ion mass tolerance of 0.03 Da was employed. A static
200

modification of 57.021 Da (C, carbamidomethyl)) was employed in the searches. A value of 0.1
was used for protein and peptide validation settings.

Proteomic Analysis
After the results were obtained, analysis was performed using an exponentially modified protein
abundance index (emPAI) to estimate absolute protein amounts based on the number of sequenced
peptides per protein (16). Briefly, only high quality peptides were selected based on the Score
Sequest HT: A Sequest HT and mitochondrial proteins were identified using MitoCarta3.0 (34).
The protein abundance index (PAI) was calculated with Equation 1 using the “total peptides”
count per protein for Nobserved and the Nobservable was determined using ExPASy server (49). The
emPAI was then calculated as shown in Equation 2. The emPAI values for the two samples per
group was averaged for each respective group (sham and nano-TiO2) and compared.
𝑁observed

Equation 1

𝑃𝐴𝐼 =

Equation 2

𝑒𝑚𝑃𝐴𝐼 = 10PAI − 1

𝑁observable

Data Code Availability
All

code

used

in

the

bioinformatic

processing

of

samples

is

provided

https://github.com/qahathaway/mRNA-m6A-Proteomics. Additionally, supplementary data files
are included as XLSX files included in the manuscript, as well as provided on the GitHub account.
Raw sequencing files have been uploaded to Gene Expression Omnibus (GEO) under accession:

Statistics
Statistical analyses were conducted in the R v4.1.1 environment. DESeq2 implements the
Wald Test, using the Benjamini-Hochberg procedure. The FDR for this study was set to 0.05 for
the transcriptomic analyses and 0.10 for m6A peak calling. All measures of significance are
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reported as adjusted P-values (Padj). The RADAR package used for peak calling implements a
Gamma-Poisson Distribution Model, which is a type of random effect model.
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Results
Study Design
The study design (Figure 4.1D) highlights the use of mRNA and m6A sequencing on whole
heart tissue and proteomics on isolated mitochondria. Maternal dams were euthanized at
gestational day (GD) 15. Each dam was considered an n=1. No significant differences were
observed between maternal and fetal pup weights, pup number, or pup heart weights (Table 4.1).

Transcriptomics
In performing the m6A-RIP-Seq, the input controls provided overall transcript abundance,
which showcases the changes to mRNA seen following gestational nano-TiO2 exposure in fetal
offspring. Sample distances were projected both using multidimensional scaling (MDS) (Figure
4.2A) as well as distribution with variance stabilizing transformation (VST) (Supplemental
Figure 4.1A). Both techniques illustrate distinct stratification between the two groups. An
illustration of the VST, as well as Log2 normalized counts and regularized-logarithm (rlog)
transformations, are provided (Supplemental Figure 4.1B). Differential expression analysis was
performed and revealed a total of 3,648 genes that were significantly changed following exposure
(Figure 4.2B). Examining the top 1,000 genes, sorted by Padj value, we see that two-thirds are
upregulated, while 1/3 is downregulated between groups (Figure 4.2C). Additionally, Figure 2C
shows that the sham and nano-TiO2 groups hierarchically cluster separately.
Our previous investigations have shown that mitochondrial dysfunction, specifically
alterations to bioenergetics, have correlated with cardiovascular functional impairments, such as
reduced ejection fraction, changes to left ventricular size, and alterations of strain of the heart (15,
23, 24). Electron transport chain proteins were significantly decreased for all mitochondrial
complexes (Figure 4.2D). When examining all mitochondrial genes, decreased expression was
seen across most categories of mitochondrial genes (Supplemental Figure 4.2). Interestingly,
mitochondrial electron transport chain genes (Figure 4.2D) and mitochondrial ribosomal
metabolism (Supplemental Figure 4.2) were the two pathways most significantly impacted
following nano-TiO2 exposure. Also of interest, mitochondrial glutathione peroxidase 4 (Gpx4)
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(Supplemental Figure 4.1C) was significantly decreased, which we have previously shown to be
an important mediator of ROS levels in gestationally and directly exposed mice (23, 30).

Epitranscriptomics through N6-methyladenosine (m6A)
Using both the input (unmodified mRNA) and immunoprecipitated RNA with our m6A
antibodies, we wanted to examine if specific sites were being methylated, or demethylated,
following nano-TiO2 exposure (Figure 4.3). Principal Component Analysis (PCA) revealed
distinct separation of the sham and nano-TiO2 groups (Figure 4.4A). Through differential peak
analyses, we were further able to determine that the majority of m6A sites were occurring in the 3’
untranslated regions (UTRs) (Figure 4.4B), which is supported by previous literature (29). We
then plotted all the differentially methylated sites, revealing significant upregulating of m 6A
methylation following exposure (Figure 4.4C).
Our next step was to assess if the mRNA identified in the input samples and the
differentially methylated sites overlapped. Of the 3,648 differentially expressed genes and 921
unique genes containing significant m6A modifications, 311 overlapped (Figure 4.4D). The
mRNA expression was primarily increased in these genes, suggesting a predominately activating
effect of m6A on gene expression/transcript longevity.
mRNA/m6A Shared Features
We next wanted to understand how the 311 genes identified in both mRNA and m6A were
related to cellular and molecular pathways. Using gene ontology through KEGG, we hierarchically
clustered the pathways and represented the top genes within the pathways for the 3,648
differentially expressed genes (Figure 4.5A) as well as the 311 shared genes (Figure 4.5B). The
shared pathway revealed significant overlap with the pathway containing all genes in a few notable
ways, including ubiquitin-mediated proteolysis, RNA degradation, spliceosome, and HIF-1
signaling. Interestingly, we see that in the all-gene ontology pathway (Figure 4.5A), oxidative
phosphorylation is one of the top pathways, though not represented in the shared analysis (Figure
4.5B).
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The common pathways between the two groups are mainly larger regulator pathways,
controlling the transcription, translation, and turnover of proteins. We include the detailed
molecular pathway for RNA degradation in the all-gene (Supplemental Figure 4.3A) and shared
(Supplemental Figure 4.3B) analyses that highlight genes, such as CCR4-NOT transcription
complex subunit 1 (Cnot1) and 5'-3' exoribonuclease 2 (Xrn2), likely upregulated through m6A
modification. We also provide an illustration of the entire gene (Supplemental Figure 4.4A-B)
and specific region (Supplemental Figure 4.4C-D) that are differentially methylated.

Mitochondrial Proteomics
Our last objective was to analyze the mitochondrial proteome to define if transcriptional
alterations directly aligned with protein level expression. Our workflow included isolating
mitochondrion from fetal heart tissue, isolating the protein, and processing the peptides through
LC-MS/MS (Figure 4.6A). The protein abundance index (emPAI) was calculated only for
mitochondrial proteins identified with a high confidence in both the sham and nano-TiO2 groups.
Of the mitochondrial proteins, those belonging to ATP Synthase, including Atp5a1, Atp5b,
Atp5c1, Atp5pb, and complex I, Nudufs1 and Nudufv2, showed the most consistent
downregulation in the nano-TiO2 exposure group (Figure 4.6B). Additionally, peroxiredoxin 3
(Prdx3), a critical mitochondrial antioxidant, revealed the largest decrease between the sham and
exposed groups (Figure 4.6B).
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Discussion
Fetal development is an intricate process that requires a significant number of regulatory
processes. A baleful gestational environment can result in disease predisposition, in addition to
immediate consequences of fetal development. M6A methylation can transiently alter cellular
function and may play a significant role in the response to toxicants during gestation. The results
of our study emphasize the impact of m6A methylation on regulatory pathways within the heart,
largely involved with the transcription, translation, and longevity of proteins within the cell. Along
with changes to oxidative phosphorylation, acute changes to the m6A methylome may predispose
offspring to future adverse outcomes.
Exposure to environmental toxicants is associated with developmental reprogramming that
alters normal physiological responses and thereby leads to disease susceptibility including
metabolic diseases (43, 46). Specifically, prenatal maternal exposure to benzene, diesel exhaust,
and fine particulate matter lead to glucose intolerance and elevated insulin resistance (20), weight
gain (6), and metabolic syndrome (50), respectively, in adulthood. As cardiovascular disease
remains the leading cause of death worldwide, researchers have begun investigating whether m6A
mRNA modifications can serve as diagnostic or therapeutic targets (19, 42). Transcriptome-wide
assessments of cardiac samples from human and murine models of dilated cardiomyopathy were
assessed by Kmietczyk et. al (17). They found that hypermethylation was prominent in failing
human hearts and confirmed the dynamic and regulatory capabilities of m6A in this diseased state.
Furthermore, research has also shown that m6A is a novel stress-response mechanism in
the heart that attempts to maintain normal cardiac function (11). Specifically, Dorn and colleagues
implemented genetic tools to modulate m6A levels via METTL3 levels, thereby generating
cardiac-restricted gain- and loss-of-function mouse models that allowed them to identify m6A
methylation by METTL3 as a dynamic response that is enhanced with cardiac hypertrophy.
Contrarily, they determined that m6A hypomethylation drives eccentric cardiomyocyte remodeling
and dysfunction (11). Another group examined the m6A landscape in heart hypertrophy and heart
failure as well (4). In addition to confirming that cardiac hypertrophy and failure are accompanying
by m6A methylation changes, the authors found that hypomethylated transcripts played a role in
mitochondrial function and metabolic processes, while hypermethylated transcripts were also
associated with metabolic processes as well as response to growth factor and muscle stretch (4).
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Similarly, in patients with heart failure with preserved ejection fraction, the m6A landscape and its
regulators were altered such that the several methyltransferase complex constituents, including
METTL3, were up-regulated, in addition to demethylase FTO, and reader YTHDF2 (54). Despite
an increased interest in the role of m6A methylation in cardiovascular disease, studies have mainly
focused on heart failure specifically and have yet to elucidate in depth the contribution from
ALKBH5 (22).
Although recent studies have determined that m6A is easily altered by stress and other
external stimuli (11), its status particularly in the heart, following exposure to environmental
toxicants remains to be elucidated. Following exposure to fine particulate matter (PM2.5), there
was a global decrease in m6A methylation, concomitant with elevated expression of
methyltransferase complex components (METTL3 and WTAP), demethylases (FTO and
ALKBH5), and the reader protein HNRNPC (7). However, this study involved a short-term
exposure on A549 cells, which still leaves the question of how different tissue types respond to
environmental exposures and how long-term exposure may alter this response. Recent work from
our laboratory has demonstrated that maternal inhalation exposure to ENM during a critical point
in fetal development results in cardiac dysfunction, mitochondrial bioenergetic disruption, and an
increase in global m6A content (23).
Notably, m6A levels were ameliorated in the presence of enhanced antioxidant capacity
that was mitochondrially targeted in the pregnant mother. It is has become clear that a specific and
balanced m6A RNA distribution is crucial to maintain homeostasis and evade disease, though the
precise mechanisms underpinning the process remain unknown. Zhang et. al. similarly
investigated the effects of carbon black nanoparticle exposure during pregnancy on m6A status in
offspring, but specifically in the case of neurobehavior deficits (55). The authors determined that
the exposure decreased m6A modification in the cortex, along with neurobehavioral deficits and
cortex injuries in the offspring. These studies substantiate the idea that m6A methylation status is
likely disease and tissue specific.
Our current study forwards the concept that differential m6A methylation of genes can have
untoward effects of cardiac function. While our model uses transcriptomics, epitranscriptomics,
and proteomics to provide a multi-omics approach toward mechanistically detailing fetal cardiac
changes, the approach was limited by the amount of tissue available. In our proteomics approach,
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we needed to pool our groups to further condense the protein for adequate analyses, losing the
ability to make true statistical inferences on the data. Additionally, the proteins found to be
decreased in both the ATP Synthase complex and complex I do not consist of the same transcripts
shown to be decreased in the transcriptomic analyses. Though, there is evidence to support that
m6A methylation is acting at an indirect, rather than direct, level to modify transcript and protein
expression.
The analyses indicate that m6A methylation is predominately occurring in pathways
altering transcription of mRNA (spliceosome pathway), stability of transcripts (RNA degradation
pathway), and protein longevity (ubiquitin-mediated proteolysis pathway). While the same mRNA
and protein changes may not completely align, this could be explained through these different
indirect mechanisms decreasing abundance. Further, of the differentially expressed mRNA genes,
Mettl14, a key regulatory writer of m6A methylation marks, is shown to be increased and supports
the findings of significantly increased m6A methylation overall in the nano-TiO2 group.
We provide for the first time a comprehensive, multi-omics approach that includes
epitranscriptomics in the investigation of fetal progeny following toxicant exposure. This
framework helped to identify how m6A methylation can be globally increased in the heart
following exposure, and how the pathways, such as RNA degradation and ubiquitin-mediated
proteolysis, play a role in regulating mitochondrial bioenergetics. These data substantiate the need
to further investigate RNA modifications as a mechanism for adaptive fetal responses. Future work
should seek to identify the persistence of these marks, and whether other RNA modifications also
contribute to modifying the fetal transcriptome and proteome.
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The current study helps to expand our understanding of how environmental exposures
impact our health. Importantly, this study uses a gestational model where we want to understand
how exposure to toxicants during pregnancy can impact the developing fetus. We know that
changes to the fetus can occur at the level of DNA, through temporary modifications known as
“epigenetics”. What is unknown, is whether other changes, outside of DNA modifications, can
also cause the growing fetus to have adverse outcomes. One of the major adverse outcomes of
environmental exposure is cardiovascular complications. We have previously shown that these
cardiovascular complications can be linked to changes at the level of mitochondria, with decreased
ability to produce energy. “Epitranscriptomics” is a term used to described temporary changes at
the level of mRNA. Our goal in the current study was to fully detail the impact of these RNA
modifications on shaping fetal health following exposure. Our novel approach inspected both
mRNA abundance as well as the amount of mRNA modifications present. We then coupled this
information with protein level changes in the mitochondrion. Our result suggests that RNA
modifications can influence expression of RNA and protein of mitochondrial genes.
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Table 4.1: Maternal and Fetal Pup Characteristics

Sample

Maternal
Weight (g)

Number of Pups
in Litter

Average Pup
Weight (g)

Average Pup Heart
Weight (g)

Sham Exposure
1

31.9

8

0.61

0.0038

2

34.1

10

0.56

0.0030

3

34.1

10

0.56

0.0026

4

33.8

10

0.60

0.0036

5

32.0

9

0.39

0.0023

Average

33.2 ± 0.51

9.4 ± 0.40

0.54 ± 0.04

0.0031 ± 0.0003

Nano-TiO2 Exposure
1

34.7

10

0.61

0.0038

2

36.0

10

0.66

0.0043

3

35.6

9

0.66

0.0039

4

31.7

10

0.34

0.0026

5

35.7

9

0.61

0.0037

Average

33.7 ± 0.79

9.6 ± 0.24

0.58 ± 0.06

0.0037 ± 0.0003
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Table 4.1: Maternal and fetal pup characteristics. Dams from sham (n=5) and nano-TiO2 (n=5)
inhalation exposure were assessed. All weights given are wet weights.
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Figure 4.1: Characteristics of maternal whole-body inhalation exposure. (A) A target aerosol
mass concentration of 12 mg/m3 of engineered nano-TiO2 was implemented for a period of 360
minutes per day for 6 non-consecutive days, over an 8-day period. These concentrations were
verified by gravimetric measurements during each exposure, which resulted in an average mass
concentration of 12 mg/m3 during the 360-minute period. (B) High-resolution electrical lowpressure impactor (ELPI+) indicated a geometric count median diameter (CMD) of 172 nm with
a geometric standard deviation (GSD) of 1.96. (C) Scanning particle mobility sizer (SMPS)
indicated a CMD of 112 nm with a GSD of 2.14. (D) Exposure model paradigm including the
allocation of tissue on gestational day (GD) 15.
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Figure 4.2: Transcriptomic analysis of fetal cardiac tissue. (A) Multidimensional Scaling
(MDS) plot of sham (n=3) and nano-TiO2 (n=3) gestationally exposed fetal progeny. (B) Volcano
plot depicting the Log2 fold change observed following differential expression analysis. The top
gene (lowest Padj value) is listed. (C) Heatmap depicting the top 1,000 genes, as sorted in
ascending order by Padj value. The provided scale is in Log2 fold change. (D) Heatmap of
differentially expressed mitochondrial genes within the electron transport chain oxidative
phosphorylation pathway. Genes were classified based on MitoCarta3.0 (34). The provided scale
is in fold change. Genes were differentially expressed if Padj≤0.05, FDR=0.05. Differences are
illustrated as nano-TiO2 (n=3) compared to sham (n=3). Sham = fetal progeny of maternal dams
exposed to filtered air, Nano-TiO2 = fetal progeny of maternal dams exposed to 12 mg/m3 of nanoTiO2 for 360-minute periods for 6 days, Complex I = NADH:ubiquinone oxidoreductase, Complex
II = succinate dehydrogenase, Complex III = coenzyme Q – cytochrome c reductase, Complex IV
= cytochrome c oxidase, ATP Synthase = mitochondrial electron transport chain complex V.
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Figure 4.3: Schematic overview of N6-methyladenosine (m6A) analyses. First, RNA was
isolated from fetal pup hearts. Next, RNA was fragmented, with an average fragment size of 297
base pairs. 10% of each sample was saved as an input control while 90% of the sample was
immunoprecipitated with m6A antibodies. RNA was barcoded and reverse transcribed into cDNA.
Sequencing was performed on the Illumina NextSeq with paried-end (PE) 2x50 reads. Adapters
were trimmed from Fastq files, files were aligned to the mouse genome, and differential peak
calling was performed. Sham = fetal progeny of maternal dams exposed to filtered air, Nano-TiO2
= fetal progeny of maternal dams exposed to 12 mg/m3 of nano-TiO2 for 360-minute periods for 6
days, Input = unprocessed mRNA, IP = mRNA derived from immunoprecipitation with m6A
antibodies.
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Figure 4.4: Epitranscriptomic analysis of fetal cardiac tissue. (A) Principal Component
Analysis (PCA) plot of sham (n=3) and nano-TiO2 (n=3) gestationally exposed fetal progeny. (B)
Pie chart depicting the distribution of m6A sites identified by location across genomic space. (C)
Heatmap of the 1,135 differentially m6A methylated sites across 921 genes. Z-Score is defined as
(gene expression value in sample of interest) – (mean expression across all samples)/standard
deviation. Bins were defined as 25 base-pair regions. (D) Heatmap of the shared 331 genes that
were both identified in the transcriptomic and epitranscriptomic analyses. The provided scale is in
fold change. Genes were differentially expressed if Padj≤0.10, FDR=0.10. Sham = fetal progeny
of maternal dams exposed to filtered air, Nano-TiO2 = fetal progeny of maternal dams exposed to
12 mg/m3 of nano-TiO2 for 360-minute periods for 6 days, 3’ UTR = 3’ untranslated region of a
gene, 5’ UTR = 5’ untranslated region of a gene, CDS = coding DNA sequence, ncRNA = noncoding RNA, Other = other regions in genomic space not specified.
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Figure 4.5: Pathway analysis of differentially expressed genes. (A) Pathway analysis of the
3,648 genes differentially expressed in the transcriptomic analysis. (B) Pathway analysis of those
genes (311) that also coincided with differentially methylated sites. Both pathways are presented
as hierarchically clustered pathways, with the top (A) six and (B) four pathways represented along
with other similar pathways within each clustered group. Genes were differentially expressed if
Padj≤0.05, FDR=0.05
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Figure 4.6: Mitochondrial proteomics. (A) Schematic depicting the processes of mitochondrial
isolation, protein extraction, peptide preparation, and peak identification. (B) Mitochondrial
proteins that were identified with high confidence in the analyses. The provided scale is the
difference between emPAI values between the sham and nano-TiO2 groups. Proteins are organized
based on MitoCarta3.0 designations (34). Sham = fetal progeny of maternal dams exposed to
filtered air, Exp = fetal progeny of maternal dams exposed to 12 mg/m3 of nano-TiO2 for 360minute periods for 6 days, LC-MS/MS = liquid chromatography with tandem mass spectrometry.
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Supplemental Figure 4.1: Transcriptomic processing and pre-processing. (A) Sample
distribution heatmap using variance stabilizing transformation (VSD) normalized counts. (B)
Multidimensional Scaling (MDS) of counts that are Log2 transformations of normalized counts
(left), VST (middle), and regularized-logarithm (rlog) transformations (right). (C) An example of
normalized counts for Gpx4 in the sham (n=3) and nano-TiO2 (n=3) groups. Genes were
differentially expressed if Padj≤0.05, FDR=0.05. Sham = fetal progeny of maternal dams exposed
to filtered air, Nano-TiO2 = fetal progeny of maternal dams exposed to 12 mg/m3 of nano-TiO2 for
360-minute periods for 6 days, Gpx4 = mitochondrial glutathione peroxidase 4.
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Supplemental Figure 4.2: Differentially expressed mitochondrial genes not belonging to
oxidative phosphorylation. (A) Heatmap of differentially expressed mitochondrial genes. Genes
were classified based on MitoCarta3.0. The provided scale is in fold change. Genes were
differentially expressed if Padj≤0.05, FDR=0.05. Differences are illustrated as nano-TiO2 (n=3)
compared to sham (n=3). Sham = fetal progeny of maternal dams exposed to filtered air, NanoTiO2 = fetal progeny of maternal dams exposed to 12 mg/m3 of nano-TiO2 for 360-minute periods
for 6 days.
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Supplemental Figure 4.3: RNA Degradation pathway identified through PathFindR. (A) Of
the 3,648 genes differentially expressed in the transcriptomic data between sham (n=3) and nanoTiO2 (n=3), the highlighted genes were identified in the RNA degradation pathway. (B) Of the
shared 311 genes between the mRNA and m6A peak analysis, the highlighted genes were identified
in the RNA degradation pathway. “Other” indicates genes not shown to be differentially expressed
between sham and nano-TiO2. Genes were differentially expressed if Padj≤0.05, FDR=0.05. Sham
= fetal progeny of maternal dams exposed to filtered air, Nano-TiO2 = fetal progeny of maternal
dams exposed to 12 mg/m3 of nano-TiO2 for 360-minute periods for 6 days.
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Supplemental Figure 4.4: N6-methyladenosine (m6A) peak calling of RNA Degradation
pathway genes. The entire gene region of (A) Cnot1 and (B) Xrn2 reveals m6A methylation across
the gene. Normalized coverage to input samples was gated across samples to display regions were
m6A was significantly increased for (C) Cnot1 and (D) Xrn2. IP expression is designated by filled
boxes while input samples are represented by lines. The x-axis represents the genomic location.
Genes were differentially expressed if Padj≤0.10, FDR=0.10. Sham = fetal progeny of maternal
dams exposed to filtered air, Nano-TiO2 = fetal progeny of maternal dams exposed to 12 mg/m3
of nano-TiO2 for 360-minute periods for 6 days, Input = unprocessed mRNA, IP = mRNA derived
from immunoprecipitation with m6A antibodies.
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Chapter 5: General Discussion
The work within this dissertation aims to ascertain the repercussions of inhalation exposure
to engineered nanomaterials (ENM), particularly nano-TiO2, during gestation on offspring cardiac
function, the epigenetic and epitranscriptomic mechanism that contribute to these detriments, as
well as the potential for therapeutic prevention with the implementation of an antioxidant defense
strategy. With the proliferative increase in nanoparticle applicability in multiple industries, comes
also the necessity for thorough evaluation and understanding of any adverse effects that such
ubiquitous exposure can emanate. The research herein, attempts to ascertain these adverse effects
through approaches that include examination of functional cardiac effects, down to the organelle
that plays a pivotal role in heart contraction, the mitochondrion, and furthermore the chemical
modifications that likely contribute to sustained dysfunction into later stages of life in a mouse
model. The long-term goal of the research performed was to identify mechanisms contributing to
the pathological effects of xenobiotic exposure as a prerequisite to developing strategies for
reducing risks to public health.
The central hypothesis is that changes in the m6A methylome, concomitant with an altered
mitochondrial proteome at the fetal stage, precipitate cardiac contractile dysfunction that is
sustained into adulthood following maternal ENM inhalation exposure. Sustained dysfunction may
be averted through limiting ROS via overexpression of mPHGPx. The particularly intriguing
aspect of this central hypothesis is the idea of epitranscriptomic remodeling and the implications
this holds. Within my research, the focus really does not stray from understanding the effects of
maternal toxicant inhalation exposure during gestation on the offspring heart function and
mitochondrial function. However, the concept of reprogramming may have even more detrimental
outcomes that include inclining the system to be more susceptible to diseases that also alter similar
pathways such as metabolism. To date, this possibility has not been explored, but may, in part,
explain the simultaneous increasing rates of childhood obesity and applications of nanoparticles
and increased air pollutants. The changes seen in mitochondrial function, specifically with
decreased electron transport chain complex activities, in both fetal and adult progeny of dams
exposed to nano-TiO2 during gestation, is similar to what our laboratory has previously seen with
a type 2 diabetic mouse model (6). It is therefore plausible that even if ETC complex activities are
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only diminished as an immediate response (at the fetal stage) or minimally altered at the adult
stage following gestational ENM exposure, the offspring’s capacity to manage a secondary insult,
such as high-fat diet-(HFD) induced obesity, is significantly limited. This may result in a more
severe and rapidly progressing type 2 diabetic phenotype. Nevertheless, the research described
within this dissertation lays the basic groundwork necessary for further research in the field of
inhalation toxicology and both the short and long-term repercussions of it.
The objective of Specific Aim 1 was to elucidate the effects of maternal nano-TiO2
inhalation exposure during gestation on cardiac contractile function and mitochondrial function in
fetal offspring and whether these detriments persist into adulthood. The evidence provided in this
study pointed towards a connection between elevated ROS, specifically hydrogen peroxide (H2O2),
levels and cardiac bioenergetic and contractile dysfunctions at the acute (fetal) and chronic (adult)
stages. Based off the data acquired during this project, we postulated that elevated ROS in the
maternal gestational environment affected the fetal epigenome such that when combined with a
decrease in mitochondrial ROS scavenging capacity via diminished GPX4 protein levels, results
in a positive feed-back loop. The mitigation of antioxidant capacity thus perpetuates increased
ROS levels in fetal mitochondria and is concomitant with an increase in Hif1α, which can
transcriptionally activate Dnmt1. Through augmented Dnmt1 levels, global 5mC methylation in
the fetal offspring is increased and thereby may be further diminishing GPX4 levels, resulting in
a sustained effect into adulthood. The chronic effect seen however cannot be explained by the
same epigenetic modification nor diminished GPX4 protein levels that are seen at the fetal stage.
Notably however, mitochondrial bioenergetics, size, and internal complexity were all affected
negatively. This brings to light the potential of mitochondrial reprogramming as a result of
enhanced ROS, which although not discussed or investigated in this work, is a plausible
hypothesis. It is also unlikely that 5mC methylation of GPX4 is solely responsible for the changes
in mitochondrial structure and function and ultimately cardiac dysfunction that persist long-term.
Moreover, evaluating the role of selenium is also critical in explicating diminished GPX4 content
at the fetal stage.
As a result of the maternal inhalation exposures occurring at a critical timepoint in fetal
development, the consequential phenotype may therefore be pathological. During mouse
embryonic cardiac development, the mitochondrial permeability transition pore (mPTP) closes
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when the cardiomyocyte is maturing, which occurs between embryonic day 9.5 and 13.5 (45). The
purpose of this closure is to increase mitochondrial membrane potential to promote aerobic
respiration and to decrease ROS levels in the cardiomyocytes. It is possible that the increased ROS
levels seen in the fetal progeny may be occurring as a consequence of a high-stress state in the
maternal environment as the nano-TiO2 inhalation exposure occurs during this specific time in
gestation. This may alter the ability of the mPTP to close as is necessary, making it unable to lower
the ROS levels which instead remain high for an extended period. In turn, the mitochondria may
be reprogrammed in an attempt to overcompensate for the deficiency, which could alter heart
development in the vulnerable population (22).
It is important to note that the mechanism by which the effects of gestational nano-TiO2
exposure are being transferred to the fetus and sustained into adulthood remains relatively elusive.
While our studies are able to establish the presence of mitochondrial and cardiac changes,
concomitant with a high ROS environment in the cardiac tissue, there are a multitude of
possibilities in terms of how this occurs. While the research presented in this dissertation mainly
investigated H2O2 and mitochondrial dysfunction as the key source of ROS, there are other cellular
mechanisms that may play a role in the resultant oxidative stress seen following exposure. Some
of those pathways include xanthine oxidase, NADPH oxidase, and uncoupling of NO synthase.
Nano-sized particulate matter can exert its effects through both direct and indirect mechanisms.
Recent studies have proposed the ability of certain particles including black carbon (28) and
nanopolystyrene (2) to cross the placental barrier and potentially induce direct effects to the
developing fetus. However, the prevailing theory suggests that the consequences of particle
exposure generally arise from lung inflammation and an associated ROS increase, in conjunction
with other indirect effects elicited by the maternal exposure (5, 31). On the other hand, if particles
are indeed translocating across the placental barrier, the quantities are likely incredibly limited and
practically inconsequential. It is therefore unlikely that such minimal amounts could be behind
such a significant impact on the progeny at both the acute and chronic stages. Consequently, one
of the main possibilities goes back to inflammation (17, 25, 27). A case could be made that there
is an initial interaction between the particles and lung tissue that precipitates an inflammatory
response that causes both free radical and inflammatory cytokine release, along with other
mediators of inflammation into the circulation. Even though primary inflammation occurs in the
lungs, there are immune cells and inflammatory mediators that regain access to the blood and
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continue perpetuating an inflammatory reaction. Higher amounts of macrophages, neutrophils, and
other immune cells may then increase ROS levels in the blood and furthermore result in a hostile
gestational environment due to the maternal systemic distribution of ROS (17, 25). Previous
studies have determined that nano-TiO2 inhalation exposure during gestation results in impaired
vascular reactivity of the umbilical vein, umbilical artery, as well as increases placental vascular
resistance (1, 9, 10). This may be another consequence of the perpetuating inflammatory reaction
that can occur when alveolar macrophages interact with particulate matter is a change in
endothelial cells. Particularly, studies of ENM inhalation exposure during gestation have shown
altered endothelium-dependent placental hemodynamics, while endothelium-independent
placental hemodynamics were not impacted. It is possible that a kisspeptin-dependent mechanism
is the culprit when it comes to disruption of the normal gestational endocrine vascular axis
following gestational ENM exposure. Specifically, nano-TiO2 exposure augmented the effects of
kisspeptin on vasoconstriction (3). Kisspeptin is a neuropeptide that binds to its respective Gcoupled receptor (Kiss1R) and triggers a cascade that results in release of intracellular calcium,
leading to smooth muscle contraction. Therefore, a potential repercussion of these findings is an
increase in reactivity to this vasoconstrictor, which may be responsible for insufficient placental
perfusion and increased resistance, mitigating oxygen availability for the pups in utero. Notably,
unpublished data from our laboratory showed a decrease in Prdx1 mRNA expression (Padj =
0.002), which has been established as a form of protection against excessive endothelial activation.
Diminished Prdx1 levels in mice resulted in a model that is susceptible to chronic inflammation
(18). These studies emphasize the real possibility that there are several pathways that work in a
cooperative manner to ensue the damage that is seen in offspring following maternal ENM
inhalation exposure. Nevertheless, it is clear that more work remains to fully elucidate the source
of the ROS and the connection between the elevated levels and sustained cardiac and mitochondrial
effects in mice gestationally exposed to nano-TiO2. As this field of research continues to grow, the
truth will likely lie in the possibility that multiple pathways are simultaneously at play.
Regardless of the mechanism by which the fetus is impacted, we still recognize the
importance of the sustained alterations that are carried into adulthood. Unlike at the fetal stage,
young adult offspring whose dams were gestationally exposed to ENM presented with a decrease
in 5mC methylation (21). This is an interesting finding such that it suggests that other epigenetic
and/or epitranscriptomic mechanisms are involved. While the research presented in Specific Aim
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1 of this dissertation investigated Dnmt levels and global 5mC methylation status, other
investigators have looked at histone modifications associated with disease following
environmental exposure as well as altered miRNA and other non-coding RNA levels (13). The
first evidence that maternal ENM inhalation exposure contributes to modifications to the fetal
epigenome identified changes in histone 3 lysine 4 tri-methylation (H3K4me3) and histone 3 lysine
27 tri-methylation (H3K27me3) in the fetal offspring hearts (37). Our laboratory has also
published data that indicates changes to miRNA levels following inhalation exposure, specifically
miRNA-378a that were associated with mitochondrial functional diminutions (11). The possibility
of other non-coding RNAs however has not been investigated in this dissertation or otherwise. As
mentioned earlier, it is highly unlikely that one specific DNA modification is responsible for both
the fetal and adult mitochondrial and cardiac detriments that are associated with maternal
inhalation exposure to particulate matter during gestation. Further research is required to determine
whether long non-coding RNA (lncRNA) distribution, for example, is altered as lncRNA has
multiple regulatory roles including regulating translation, miRNA sequestration, guiding
chromatin remodeling, and inhibiting or promoting binding of transcription factors and cofactors
to gene promoters and thus control the transcription of target genes (16). It is thereby possible that
several of these mechanisms are working together to result in a globally altered and sustained
mitochondrial profile and ultimately chronically diminished cardiac function.
Although the focus of our research and others in the field of inhalation toxicology has
prominently been epigenetics, there is an increasing amount of interest surrounding the
epitranscriptome (4, 24, 44). While both epigenetics and epitranscriptomics play a role in
influencing gene expression, there is a distinct difference between the two. Epigenetics
encompasses DNA modifications, histone modifications, and nucleosome occupancy, which can
influence the structure of chromatin as well as the function of the genes that are affected (8). The
most prevalently studied epigenetic modification is 5-methylcytosine (5mC), which was studied
in Specific Aim 1 as mentioned previously. Epitranscriptomics, on the other hand, refers to posttranscriptional modifications in both coding and non-coding RNAs, with the most prominent
modification being N6-methyladenosine(m6A) (7). The study of the epitranscriptome is gaining
traction as discoveries have verified that post-transcriptional modifications such as m6A have their
own set of writers (responsible for addition of the methylation mark(s)), erasers (responsible for
removal of the methylation mark(s)), and readers (responsible for determining the fate of the
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mRNA with the methylation mark(s)). This has initiated a burgeoning field of possibilities in terms
of researching and elucidating the effects that modifications have on gene expression, regulation,
and furthermore their roles in diseases. This provides a new opportunity to understand not only the
role of DNA modifications or RNA modifications individually, but the combined role they may
be playing in disease and how one may influence the other (15). Because recent discoveries have
established the link between environmental toxicant exposure and the most abundant mRNA
modification, m6A, in the second part of my dissertation we wanted to determine whether this
modification played a role in the acute and chronic repercussions on progeny gestationally exposed
to ENM.
The objective of Specific Aim 2 was to determine whether enhanced mPHGPx expression
preserves cardiac contractile function and bioenergetics in adult offspring following maternal
ENM inhalation exposure, and whether m6A methylation contributes to altered antioxidant
capacity. Our study specifically focused on the mPHGPx mRNA and whether m6A modifications
played a role in the diminished mPHGPx activity found in adult offspring hearts following
maternal ENM inhalation exposure. The reasoning behind the focus on the 3’UTR of mPHGPx
specifically is two-fold; (1) the 3’UTR of mPHGPx contains the selenocysteine (Sec)
incorporation machinery, which is vital for the catalytic activity of this enzyme to promote H2O2
scavenging and evade damage to the mitochondrial membrane, and (2) m6A is highly enriched in
the 3’UTR and around stop codons. Notably, this is of interest as changes to the Sec incorporation
sequence (SECIS), the critical region located in the 3’UTR of mPHGPx, can alter the binding
ability for the complex that recodes a “Stop” codon to a “Sec” codon and allows for the catalytic
activity to be viable (14, 35). M6A-RIP-qPCR for this particular region determined that there in
fact was an increased amount of m6A methylation occurring in wild-type offspring gestationally
exposed to nano-TiO2, concomitant with decreased mPHGPx activity. These findings, though
limited in terms of sample size, highlight the value of understanding the role of m6A as it relates
to epitranscriptomic reprogramming associated with sustained effects. However, a more broad
scale approach would be beneficial in detailing other aspects of mPHGPx that may be altered
through this prominent modification and whether these modifications are detrimental (as in the
case presented in Specific Aim 2) or the possibility that the modification is actually necessary for
proper function as is the case with the Sec tRNA. The epitranscriptomic writer, alkylation repair
homolog 8 (ALKBH8), is a tRNA methyltransferase that adds methylation marks to the wobble
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uridine of the Sec tRNA to allow for synthesis of selenoproteins. (40) Without this methylation
mark, selenoprotein levels are diminished and mitochondrial reprogramming ensues. Not
investigated in this study is the likelihood that modulator proteins (readers and writers) are altered,
but other studies have shown that environmental exposure to toxicants alters expression of RNA
methylation modulator genes including METTL3, WTAP, FTO and ALKBH5. It is also of utmost
importance that other genes be investigated that are required for mitochondrial function and ROS
regulation. This can provide new targets for the prevention or treatment of ROS-induced cardiac
effects in fetal and adult offspring of mother exposed to nanoparticulate matter during pregnancy.
As the importance of antioxidant defense and limiting ROS levels became abundantly clear
through our preliminary studies, the potential of alleviating the adverse effects on fetal and adult
offspring gestationally exposed to nano-TiO2 became of interest. Based off our laboratories
previous work with the mPHGPx mouse models, this model was chosen at it increases H2O2
scavenging and thereby decreases mitochondrial ROS levels. This endeavor required
implementation of a novel breeding strategy that would allow us to test the benefits of increased
antioxidant capacity from several points of origin; (1) fetal, (2) maternal, as well as (3) fetal and
maternal. Interestingly, our original prediction that the combined maternal environment mPHGPx
overexpression and fetal pup mPHGPx overexpression protection would be the most protective
profile, as compared to wild type pups from wild type mothers that were gestationally exposed to
ENM was not supported. We did not expect to see that there was a trivial difference between the
protection provided by just the maternal environment providing increased antioxidant defense and
the combined maternal and fetal mPHGPx overexpression. This was therefore the first study to
show that enhancing antioxidant defense in the mother during pregnancy may suffice for limiting
cardiac and mitochondrial deficits associated with gestational nano-TiO2 inhalation exposure.
Furthermore, the offspring of mPHGPx ENM-exposed mothers did not present with increased m6A
methylation in the mPHGPx 3’UTR region, unlike the offspring of wild type ENM-exposed dams.
Despite the limitations associated with using a transgenic mouse model, this study unlocks the
possibility that supplementation with a mitochondrially-targeted antioxidant therapeutic during
pregnancy may be able to provide the same beneficial protection in humans, in regards to avoiding
the repercussions of acute and sustained cardiac detriments, in offspring gestationally exposed to
ENM. Mitigating ROS in the mother and gestational environment using a supplement, such as
mitoquinol (a mitochondrially targeted form of CoQ10), is the next step in protecting future
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generations from the consequences of particulate matter exposure (30, 39). Furthermore, other
antioxidant supplements may be of benefit, however, our study supports the beneficial role of
targeting the mitochondrion specifically to protect from dysregulation and diminished bioenergetic
function.
The objective of Specific Aim 3 was to determine whether disruption of mitochondrial
bioenergetics and cardiovascular dysfunction elicited by maternal exposure can be attributed to
epitranscriptomic remodeling that is associated with an altered mitochondrial proteome that is
incapable of managing high levels of ROS. To gain a better understanding of the broad-scale m6A
changes that may be occurring at the fetal stage that result in long-term dysfunction, we performed
m6A-RIP-sequencing as well as label-free mitochondrial proteomics on fetal cardiac samples
obtained following maternal inhalation exposure of sham air and nano-TiO2 aerosolized particles.
The novelty of this study lies in the application of multi-omics approaches including
epitrasncriptomics, transcriptomics, and proteomics. Such an approach is vital in moving the field
forward, towards a more integrative approach that allows researchers to see the bigger picture
while also understanding the detailed mechanisms involved with pathologies of not only the heart
but all the organ systems. The connection between mitochondrial bioenergetic dysregulation and
the mRNA expression levels presented in Figure 4.2D is apparent. All, but 2, mRNAs that are part
of the electron transport chain complexes were significantly decreased in the nano-TiO2
gestationally exposed offspring. The possibility that this was an experimental fluke is rejected by
the data presented in Supplemental Figure 4.2 which demonstrates the dynamic expression
changes seen within other pathways. These data further substantiate the notion that there is a
dysregulation of expression levels to pivotal genes, which then results in mitigation of
mitochondrial activity previously reported by our laboratory (12, 20, 21, 26). Markedly, GPX4
mRNA expression was significantly decreased in fetal offspring gestationally exposed to ENM
(Supplemental Figure 4.1). This is consistent with previously published data from our laboratory
which determined that GPX4 activity (20) and GPX4 protein expression (21) were decreased in
fetal and adult offspring , respectively, that were gestationally exposed to ENM.
As GPX proteins are selenoproteins, it is a reasonable assumption that the diminishment
of GPX4 may be attributed to a decrease in selenium. Notably, unpublished data from our
laboratory determined that following gestational ENM exposure, the only glutathione peroxidase
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proteins that were altered were GPX1 (Padj = 0.005) and GPX8 (Padj = 0.024). Although this is
interesting, it leads us to believe that a limitation in selenium is likely not responsible for
diminished GPX4 levels. The reason for that lies in the discovery that selenium is prioritized for
synthesis of GPX4, therefore if selenium concentrations were the issue in this situation, we would
expect all of the other GPX proteins to be decreased significantly as well (33). However, based on
our unpublished data mRNA expression of other selenoproteins were significantly decreased
including selenoprotein M (Padj = 0.001), selenoprotein H (Padj = 0.029), and selenoprotein W
(Padj = 0.005), but others were increased such as selenoprotein T (Padj = 0.025), suggesting
dynamic changes that are likely unrelated to selenium availability. This further indicates that a
potential limited availability of selenium was not responsible for decreased GPX4 mRNA and
activity. Other constituents of the oxidative stress pathway that should be considered are
glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), and peroxiredoxins (PRDX).
Environmental stress, such as exposure to particulate matter can derive free radicals that react with
oxygen, thereby producing superoxide, which can then result in either production of peroxynitrite
(superoxide interacting with nitric oxide) or H2O2 via a dismutase reaction catalyzed by SOD (29).
The antioxidant activities of CAT and GSH/GPX are then responsible for detoxifying the H 2O2
produced in the previous step, otherwise hydroxyl radicals are produced via the Fenton reaction.
It is therefore necessary to understand whether expression of these antioxidant enzymes is
diminished following gestational ENM exposure, or if this suppression is only limited to GPX4.
Unpublished data from our laboratory indicated that mRNA expression of the catalase was not
changed (Padj = 0.060), while glutathione synthetase expression (Padj = 0.004) and SOD1
expression were significantly decreased (Padj = 0.017). These data may therefore suggest that
decreased GPX4 is not the only contributor to elevated ROS in offspring maternally exposed to
ENM. However, protein expression levels of these members of the oxidative stress pathway were
not examined due to the limitation that our proteomic assessments were performed on isolated
mitochondria from cardiac tissue of fetal offspring. Nevertheless, protein expression data,
presented in Chapter 4, highlights the apparent decrease in PRDX3 (Figure 4.6), which also
scavenges H2O2 in mitochondria, as well as lipid peroxides and peroxynitrites, and is required to
maintain normal mitochondrial function (41, 43). It is necessary that this pathway be further
examined in order to truly be able to delineate if there is one specific antioxidant enzyme that can

258

be supplemented in a mother during pregnancy to avoid the detriments to mitochondrial and
contractile function seen in offspring.
Evaluation of the shared pathways seen between the genes with altered mRNA expression
and m6A levels determined that ubiquitin mediated proteolysis was the top pathway. This
unexpected finding is intriguing as a recent study reported that YTHDF3 is involved in ubiquitin
mediated proteolysis (42). As mentioned earlier, YTHDF3 affects translation and decay of
methylated mRNAs depending on whether it is interacting with YTHDF1 (translation) or
YTHDF2 (decay) (36). Modulating expression of YTHDF3 can therefore affect the RNA binding
activity of the other two proteins, changing the fate of the m6A methylated mRNA by altering
stability. As part of the study done in Chapter 4, we found that YTHDF3 mRNA expression was
significantly increased (Padj = 0.002) in offspring whose dams were exposed gestationally.
Although this mechanism is far from elucidated, our research as well as research from other
laboratories mentioned herein, suggest that explicating this connection may be valuable in better
understanding how the fate of m6A methylated mRNAs is regulated.

Limitations
The work presented within this dissertation contributes to the understanding of the
shortcomings associated with increased ENM utilization and the possibility of circumventing these
shortcomings using an accessible supplement during pregnancy. Nevertheless, there are limitations
that must be taken into consideration. The inhalation exposure protocol utilized in all three Specific
Aims involve a whole-body exposure, which results in not only inhalation exposure, but also
dermal exposure. Additionally, as the mice continue to groom themselves throughout the exposure,
ingestion of nano-TiO2 becomes a concern. Future studies should attempt to compare the
difference in lung burden between a nose-only and whole-body exposure, as well as the presence
of particles in the gastrointestinal tract. Furthermore, working with fetal samples presents the
limitation of fetal tissue size. Tissue size resulted in restrictions in terms of the experiments we
were able to run principally for understanding mitochondrial bioenergetics with the mPHGPx
transgenic and wild type offspring.
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In Specific Aims 2 and 3, m6A RNA immunoprecipitation (m6A(me)-RIP) was employed
in order to capture m6A modified mRNAs. M6A-RIP is one of the most used methodologies for
this purpose, but comes with limitations of its own. In general, this method does not have the
ability to differentiate N6-methyladenosine (m6A) from 6,2’-O-dimethyladenosine (m6Am) (19).
Although m6Am is very limited, it still introduces an aspect of uncertainty as to what we are
actually capturing with the RNA immunoprecipitation procedure. Future studies would benefit
from utilizing m6A individual-nucleotide resolution cross-linking and immunoprecipitation
(miCLIP), which can accurately differentiate between the two modifications. This method still
requires further development to accommodate for small sample sizes though. Lastly, m6A-RIPqPCR, which was used in Specific Aim 2, is restricted by the fact that the it has high variation
among biological replicates and therefore requires a greater number of replicates for reliable data
(19). Similarly, m6A-RIP-seq, which was used in Specific Aim 3, is limited by the high risk of
false positive results. Further validation of the results with either a more reliable method such as
miCLIP or with a greater sample size is needed in ordered to definitively be able to confirm the
reprogramming phenotype seen in the fetal offspring.
The proteomics analysis performed in Specific Aim 3, though interesting, is limited by
sample size and therefore statistical analyses were not possible. To achieve the protein
concentrations necessary to perform label-free proteomics, fetal cardiac mitochondrial samples
were pooled from 2 mother’s litters per each exposure group (sham/nano-TiO2). In order to verify
the findings presented in our study, it is of utmost importance that these studies be repeated with
a greater sample size that will allow for more tangible answers.

Future Directions
In the US between 2011 and 2012, 5,300 children and adolescents (10-19 years old) were
diagnosed with type 2 diabetes and ~90% of adults diagnosed with type 2 diabetes were overweight
or obese (38). With the growing prevalence of obesity and metabolic syndromes such as type 2
diabetes, assessment of prominent environmental risk factors must be elucidated. Like the
suggested effects of ENMs on m6A, recent studies have reported that in type 2 diabetic patients,
m6A was significantly reduced in peripheral blood RNA, concomitant with an upregulation of the
demethylase FTO (34). Based on the similarities in metabolic pathways that are altered by both
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inhaled particle exposure and high-fat diet-induced obesity (27), future investigations should focus
on understanding whether maternal exposure to inhaled particles during pregnancy predisposes
offspring to type 2 diabetes in young adulthood. A potential starting point for such studies would
likely include “omics” based approaches that include epitrasncriptomics, proteomics,
metabolomics, and epigenomics profiling which will allow for a better understanding of the
mechanisms (i.e. inflammation and oxidative stress) that are activated due to inhaled particle
exposure and play instrumental roles in eliciting cardiovascular deficits. Specifically, future
studies should investigate the role of NF-ĸB in offspring whose dams were gestationally exposed.
NF-ĸB is associated with insulin resistance, obesity, and atherosclerosis, which have overlapping
pathways with what is seen following exposure (23). H2O2 has the ability to result in translocation
of NF-ĸB so understanding how ROS influences this pivotal mediatory of inflammatory responses
and how the two work hand in hand, will allow for a better understanding of different mechanisms
driving ROS accumulation and long term mitochondrial and cardiac health effects.
As previously discussed, blood flow to the placenta may plays a critical role in initiation
of the series of events that occur leading to long term cardiac contractile and mitochondrial
dysfunction. Future studies should attempt to assess blood flow and the inflammatory pathways
that likely contribute to elevated ROS levels as well as potential endothelial dysfunction. A
thorough examination of other forms of ROS such as nitric oxide and xanthine oxidase may also
provide more insight into the mechanisms involved. Understanding these key aspects will allow
for a more complete picture of the mechanisms in place, thereby making a more clear path for
treatment and prevention.
As indicated by the findings from our laboratory and others, enhancing antioxidant defense
is a plausible route to investigate as a prophylactic and/or therapeutic strategy. Although our
studies used genetic modification to overexpress the ROS scavenging antioxidant protein,
mPHGPx, there are other forms of mitochondrially targeted antioxidants that should be evaluated
in the context of inhaled particle exposure and its associated mechanisms. As indicated by our
recent study (Chapter 3) (20), increasing maternal antioxidant defense was sufficient to protect the
offspring from long-term adverse cardiac and mitochondrial functional alterations. The clinical
relevance of this study is one that is highlighted by the suggestion that a antioxidant strategy that
is delivered to the pregnant mother may allow for complete evasion of pollutant-associated long-
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term cardiovascular defects in offspring. One example of a deliverable antioxidant strategy that
has recently gained traction is mitoquinone mesylate (Mito-Q). A recent study that investigated
the effects of vehicle exhausted exposure as a form of toxicological stress that leads to behavioral
deficits utilized Mito-Q to ameliorate oxidative stress levels that were triggering mitochondrial
impairment in the brain (32). Treating the mother during pregnancy with Mito-Q may serve a
similar protective profile for the progeny as the mPHGPx overexpression, thereby limiting ROS
upsurges during inhaled particle exposure and avoiding mitochondrial bioenergetic dysregulation.
This would likely allow for the maintenance of normal cardiac function at both the fetal and adult
stages in progeny.

Conclusions
Overall, the data presented within this dissertation strongly support the idea that maternal
inhalation exposure to ENM results in differentially altered epigenetic and epitranscriptomic
methylation status in progeny cardiac tissue at both the fetal and adult stages of life. These changes
culminate in a mitochondrial phenotype that is associated with a high ROS environment,
bioenergetic dysregulation, and ultimately, cardiac dysfunction. These studies also demonstrate a
potential supplemental preventative measure that can be administered to mitigate the effects of
gestational toxicant inhalation exposure. Based on the data presented within this dissertation, we
accept the hypothesis that changes in the m6A methylome, concomitant with an altered
mitochondrial proteome at the fetal stage, precipitate cardiac contractile dysfunction that is
sustained into adulthood following maternal ENM inhalation exposure. The novelty of
epitranscriptomic and epigenetic modifications studied herein advances the field such that it
provides a stepping stone for future studies to assess the interactions of these modifications and
how they can be exploited for therapeutic strategies. A summary of the overall conclusions and
findings within this dissertation is illustrated in Figure 5.1.
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Figure 5.1: Specific Aims Overview
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Abstract

We utilized segmental stress strain analysis to evaluate whether intrinsic (diet-induced
obesity (DIO)) and extrinsic (unpredictable chronic mild stress (UCMS)) stressors can alter
deformational patterns of the left ventricle and act as a unique “fingerprint” for characterization.
6-week-old, male C57BL/6J mice were randomized into lean or obese groups (N = 24/group). The
obese group underwent 12 weeks of DIO with a high-fat diet (HFD). At 18 weeks, lean and obese
mice were further randomized into UCMS and non-UCMS groups to elicit a chronically stressed
phenotype (UCMS; 7 hrs/day, 5 days/week, for 8 weeks). M-Mode, Pulse-Wave Doppler, and
speckle tracking echocardiography were assessed at baseline (6 weeks), post-HFD (18 weeks), and
post-UCMS (26 weeks). Supervised machine learning with 10-fold cross validation was applied
to the DIO and UCMS groups. Comparing obese to lean mice, the machine learning model
provided robust prediction (AUC: 0.921), radial strain of the lateral wall and anterior free wall
being most important. Changes in radial strain of the lateral wall (-64%, P≤0.001) and anterior free
wall (-53%, P<0.001) were more dramatically altered than ejection fraction (-9%, P<0.001) and
global longitudinal strain (-16%, P=0.08). The ability to predict mice that underwent UCMS,
irrespective of diet, was assessed (AUC: 0.886) revealing longitudinal strain rate of the anterior
mid wall and radial strain of the posterior septal wall as the top features. The wall segments indicate
a predilection for changes in deformation patterns to the free wall (DIO) and septal wall (UCMS),
indicating disease-specific alterations to the myocardium.
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Introduction
Cardiovascular diseases contribute to nearly one-third of all deaths in the world, accounting
for 17.9 million deaths in 2019 (2). Left ventricular (LV) dysfunction plays a major role in
precipitating mortality in the context of cardiovascular diseases, which heightens the need for a
better understanding of LV pathology. In general, overt functional and/or structural modifications
of the LV begin as subclinical modifications at the molecular and cellular level that further
culminate into adverse clinical outcomes (5). Being able to predict how stressors will modify the
LV is important in both a basic understanding of the disease and how to model treatment options.
The initial clinical findings of pathological changes to the LV can be observed using stressstrain parameters. Speckle tracking stress-strain can identify deformation patterns across a variety
of regions within the LV, including the longitudinal, circumferential, and radial axes. Global
longitudinal strain (GLS) has been used as a marker for predicting outcomes, such as all-cause
mortality (24) and morbidity (4), as well as cardiovascular disease (22). The measurement of
stress-strain parameters, such as GLS, has also been shown to be more reproducible than left
ventricular ejection fraction, regardless of the level of expertise of the technician (11). While GLS
is a powerful measurement for modeling the early changes in deformation patterns of the LV, it
does not address how varying insults could preferentially affect certain areas of the LV
myocardium, and if these regions can act as a “fingerprint” in the identification of an insult
retrospectively.
The current study investigates a novel concept that suggests a role for different forms of
physiological stressors to cause unique deformational patterning of the LV. We investigate how
diet-induced obesity (DIO) and unpredictable chronic mild stress (UCMS) alter stress-strain
parameters in the murine LV and if they can be differentiated from one another. Our findings
highlight how segmental stress-strain parameters, when compared to other common
echocardiographic techniques, provide superior predictive power in correctly identifying DIO and
UCMS animals. Additionally, segmental patterns of deformation are unique across these
physiological insults, with changes in segmental stress-strain clearly identifiable even in animals
that have already undergone LV remodeling (i.e., DIO).
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Methods
Murine Model and Diet-Induced Obesity (DIO) Protocol
6-week-old male C57BL/6J mice (Stock No: 000664; The Jackson laboratory. ME, USA)
were randomized into lean (N=24) or obese (N=24) groups. Mice in the obese group underwent
12 weeks of diet induced obesity (DIO) (Research Diet D12492; NJ, USA) with a caloric
composition of 20 kcal% protein, 20 kcal% carbohydrate, and 60 kcal% fat. To elicit a chronically
stressed phenotype at 18 weeks of age, mice in the lean and obese groups were further randomized
into unpredictable chronic mild stress (UCMS) and non-UCMS groups. The final groups reflect
lean non-UCMS (N=12), lean-UCMS (N=12), obese-non-UCMS (N=12), and obese-UCMS
(N=12) at 26 weeks old. Body weight was measured in the morning at 6, 18 and 26 weeks of age.
At 26 weeks of age, mice were euthanized. All experiments used only male mice. All animal
studies, including animal housing, sedation, euthanasia, and experimentation were approved by
The West Virginia University Animal Care and Use Committee and conformed to the most current
National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals
manual.

Unpredictable Chronic Mild Stress (UCMS) Protocol
The UCMS protocol is a well-defined model to induce a depressive state in rodents (29).
Rodents undergoing UCMS manifest with clinically relevant depressive symptoms such as
anhedonia and learned helplessness (29) with alterations in brain structure and function parallel to
clinical depression (16). Mice were singly housed in UCMS groups, and exposed to the following
mild environmental stressors in randomly chosen sequences for 8 hours each day, 5 days/week,
over the course of 8 weeks:
1. Damp bedding – 10 oz. of water was added to each standard cage.
2. Bath – all bedding was removed and ~0.5 inches of water was added to empty cage. Water
temperature was room temperature, ~24°C.
3. Cage Tilt – cage was tilted to 45 degrees without bedding.
4. Social stress – each rat was switched into a cage of a neighboring mouse.
5. No bedding – all bedding was removed from the cage.
6. Alteration of light/dark cycles –turning lights off/on in random increments for scheduled
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period.

Echocardiography
Mice were anesthetized with inhaled isoflurane at 2.5% in combination with 100% oxygen
(25). Imaging was performed while mice were maintained under anesthesia using 1% isoflurane.
Vital signs were measured using a rectal probe to monitor temperature and limb leads for
electrocardiogram. A 32–55 MHz linear array transducer was used to acquire ultrasound images
with the Vevo2100 Imaging System (Visual Sonics, Toronto, Canada) at a frame rate of 200–425
frames/second. A trained, ultrasound technician at the West Virginia University Animal Models
and Imaging Facility performed all imaging. M-mode images were acquired at the mid-papillary
level of the LV in the parasternal short axis, with LV volumes and masses calculated through the
Vevo2100 system. Measurements in M-mode were calculated over four consecutive cardiac cycles
and averaged. M-Mode and pulse-wave (PW) Doppler tracings were divided between two skilled
technicians who were blinded to the assigned groups.

Speckle Tracking Echocardiography
Strain analysis was applied to B-Mode videos captured in the parasternal short and long
axes using the Visual Sonics VevoStrain software (Toronto, Canada) (25). Using speckle tracking
software, points were designated along with endocardium and epicardium of the LV. The LV in
parasternal short axis was segmented into six regions of interest: anterior free (AF), lateral (L),
posterior (P), inferior free (IF), posterior septum (PS), and anterior septum (AS). Additionally, the
LV in parasternal long axis was segmented into six regions of interest: anterior base (AB), anterior
mid (AM), anterior apex (AA), posterior apex (PA), posterior mid (PM), and posterior base (PB).
All of the individual segments were used in the proceeding analyses. Strain and strain rate were
used for subsequent analyses. Doppler tracings were divided between two skilled technicians who
were blinded to the assigned groups.

Machine Learning Pipeline
Features from M-Mode (N=14), PW Doppler (N=13), strain analysis (N=57), as well as
features including heart rate, root mean square of successive difference between heart beats
(RMSSD), and dyssynchrony were used for analyses. Multicollinearity of features were assessed
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using corrplot (v.0.90) (27) in R (v4.0.3). Machine learning was performed using BigML
(https://bigml.com.

BigML,

Inc.

Corvallis,

Oregon,

USA,

2011)

using

a

mixed

supervised/unsupervised platform (AutoML). A 75% training/testing and 25% holdout spilt was
implemented to separate the data along with 10-fold cross validation. The top 3 most predictive
models built on the 75% training/testing set were combined into a fusion model that was evaluated
on the 25% holdout data. The evaluation data was extracted from BigML and used in the R
environment to generate receiver operating characteristic (ROC) curves using pROC (v1.17.0.1)
(21) and ggplot2 (v3.3.3) (28). Feature importance was assessed using packages randomForest
(v.4.6-14) (12) and rfUtilities (v.2.1-5) (9) in R. All code can be found here:
https://github.com/qahathaway/DIO_and_UCMS.

Statistics
All statistical analyses were performed using GraphPad Prism v9.1.0 (GraphPad Software).
Outliers were first removed using a ROUT test prior to analyses. On clean data, the D’AgostinoPearson omnibus (K2) test was implemented to determine whether the data were normally
distributed. Correlation tests were implemented to determine whether normalization of
hemodynamic parameters using body weights or LV mass was necessary. For normally distributed
data, the Pearson correlation coefficients were computed whereas the nonparametric Spearmen
correlation was applied to non-normally distributed data. Normally distributed data were then
analyzed using either a one-way analysis of variance test (ANOVA) (Tukey’s post hoc test) or a
two-sided unpaired Student’s t-test. Data that did not follow Gaussian distribution were analyzed
using either a Kruskal-Wallis test (Dunn’s post hoc test) or a Mann Whitney test, depending on
the number of groups being compared. Significant differences between paired ROC curves were
evaluated using DeLong’s test (7, 21, 26). Results were considered statically significant if P ≤
0.05. All data are reported as the means ± the standard error of the mean (SEM).
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Results
Study Paradigm
An overview of the study design is provided to illustrate the three timepoints that were
assessed in our analyses (Figure 6.1A). Briefly, echocardiography was performed at weeks 6, 18,
and 26. High fat diet (HFD) was administered for 12 weeks followed by 8 weeks of unpredictable
chronic mild stress (UCMS). Body weights were assessed at each time point (Figure 6.1B). As
expected, in the presence of a 12-week HFD regime the obese group gained 18.72 grams while the
lean group only gained 7.33 grams compared to their baseline assessments. In the presence of
UCMS, the HFD mice failed to gain more weight, unlike their non-UCMS counterparts.
Additionally, the weight lost by the lean group of mice was statistically significant in the UCMS
group, but not the non-UCMS group (Figure 6.1B).

Traditional Echocardiographic Assessments
First, we wanted to understand if functional and structural changes of the LV would be
observed following HFD. Measures of systolic and diastolic function for the baseline (6-week-old)
and post-diet (18-week-old) animals are provided for M-Mode (Table 6.1) and PW Doppler
(Table 6.2). The lean group of animals (18-week-old) compared to their baseline assessments (6week-old) revealed increased ejection fraction (EF) (88.33% vs. 81.80%) and fractional shortening
(FS) (60.11% vs. 50.88%) and decreased systolic volumes (3.828 µl vs. 7.997 µl) (Table 6.1), but
did not exhibit significant changes in left ventricle (LV) mass (120.5 mg vs 109.8 mg). The obese
group of animals (18-week-old) presented with a significantly decreased EF (76.38% vs. 88.33%)
and FS (45.32% vs. 60.11%) compared to the lean cohort (18-week-old) with a significantly
elevated LV mass (150.7 mg vs. 120.5 mg) and stroke volume (38.35 µl vs. 26.72 µl) (Table 6.1).
PW Doppler also revealed other poorly adaptive functional changes in the obese group (Table
6.2). This included decreases in the obese groups MV A (333.0 mm/s vs. 395.6 mm/s) and
increased E/A ratio (1.869 vs. 1.583) compared to their baseline. These data suggest that the obese
cohort (18-week-old) has both LV functional impairments, through decreased pump efficiency
(lower EF and FS), as well as changes in atrial function (lower MV A and higher E/A ratio). The
functional changes, along with increased LV mass and stroke volume, indicate the burden of the
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HFD on cardiovascular function in the obese animals. Comparisons not discussed (Table 6.1 and
Table 6.2) as well as the individual data points (Additional File 6.1) are provided.

Speckle Tracking Echocardiography and Data Discovery Pathway
Our next step was to apply the stress strain workflow to the B-Mode videos in the
parasternal short and long axes (Figure 6.2A), which included segmental strain analysis. The LV
segments are anatomically defined regions of the myocardium in both the short (Figure 6.2A) and
long (Figure 6.2B) axes. The raw data obtained from these analyses are included (Additional File
6.1). Now, with data including M-Mode, PW Doppler, and segmental strain for the baseline (6week-old) and the lean (18-week-old) and obese (18-week-old) cohorts, we applied our machine
learning pipeline (Figure 6.2C). We first examined the data for the existence of strong collinearity
within our feature sets (Supplemental Figure 6.1) and removed features with strong correlations
(>0.85) to decrease selection bias within the machine learning algorithms. Our machine learning
pipeline included a mixed supervised/unsupervised platform that allowed for discovery of unique
connections (unsupervised) and objective evaluations of the model (supervised).

Machine Learning – Obese versus Non-Obese
Our objective was to compare non-obese animals (N=72, baseline + lean groups) with
obese animals (N=24, obese group) to determine the predictive accuracy of our features for
correctly identifying each animal into its respective group. Compiling all features together from
M-Mode, PW Doppler, and strain analysis, there was a strong predictive accuracy (AUC: 0.969)
for correctly delineating between obese and non-obese animals (Figure 6.3A, line 1). We then
wanted to elucidate whether specific echocardiographic assessments (i.e. M-Mode, PW Doppler,
or strain analysis) provided additional insights. There were no differences when comparing the
compiled dataset to M-Mode (AUC: 0.969 vs. 0.968, P=0.99) (Figure 6.3A, line 2) and strain
analysis (AUC: 0.969 vs. 0.938, P=0.25), (Figure 6.3A, line 4) but a significant difference when
only PW Doppler was used (AUC: 0.969 vs. 0.746, P=0.05) (Figure 6.3A, line 3). We further
wanted to understand what features were most important in the construction of the machine
learning model.
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Using feature importance through randomForest, we show that the top two most important
features in predicting obese vs. non-obese animals were radial strain of the anterior free wall and
LV mass (Figure 6.3B). We also include the statistics for the top five most important features, as
defined by randomForest (Figure 6.3C). Of note, four of the five top features were strain-based
parameters, with only one parameter from M-Mode. Also, strain features offer a greater percent
difference between groups (radial strain of the anterior free wall, -54%, radial strain of all
segments, -45%, radial strain of the lateral wall, -64%, and radial strain rate of the anterior free
wall, -35%) compared to M-Mode (LV mass, +33%). To better understand which features were
important in the prediction of obese vs. non-obese mice, we further investigated the top five most
important features in M-Mode (Supplemental Figure 6.2A), PW Doppler (Supplemental Figure
6.3A), and strain analysis (Supplemental Figure 6.4A) individually. This also included the
traditional statistical analyses for M-Mode (Supplemental Figure 6.2B), PW Doppler
(Supplemental Figure 6.3B), and strain analysis (Supplemental Figure 6.4B). These analyses
suggest that a clear distinction is present between obese and non-obese animals when assessments
derived from M-Mode and/or strain analysis are implemented. Additionally, the anterior free wall
and lateral wall are disproportionately impacted by the obese phenotype.

Machine Learning – Post-Unpredictable Chronic Mild Stress (UCMS)
With an interest in understanding how a unique patterning may present following different
insults, we further followed these animals throughout an 8-week UCMS protocol. We assessed if,
irrespective of diet, we would be able to determine which animals received the UCMS protocol
(N=22), compared to those that did not (N=22). Again, we first examined the data for the existence
of strong collinearity within our feature sets (Supplemental Figure 6.2) and removed features
with strong correlations (>0.85) to decrease selection bias within the machine learning algorithms.
The prediction of stressed (UCMS) versus non-stressed (non-UCMS) animals was robust (AUC:
0.868) (Figure 6.4A). RandomForest was used to select the top five most important features
(Figure 6.4B) and the statistical representation of the features are also provided (Figure 6.4C). As
expected, heart rate variability (HRV) was also significantly reduced post-UCMS (-49%) (Figure
6.4D). The averages of velocity, displacement, strain, and strain rate calculated in the parasternal
short axis for the radial and circumferential dimensions (Supplemental Table 6.1) and in the long
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axis for the longitudinal and circumferential dimensions (Supplemental Table 6.2) are included,
along with all data used in the machine learning pipeline (Additional File 6.1).
Using the information gained from the post-diet and post-stress cohorts, we provide an
illustration of the myocardial regions most significantly impacted by the stressors (Figure 6.5).
We illustrate how the normal (Figure 6.5A) parasternal short and long axis segments compare to
the post-diet (Figure 6.5B) and post-stress (Figure 6.5C) groups. While the anterior free and
lateral wall are consistently altered between groups, the induction of stress (UCMS) appears to
cause a more global impact on the myocardium. Conversely, high-fat diet feeding appeared to
specifically affect the anterior free and lateral walls.
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Discussion
Recognizing the early markers of myocardial deformation is critical in alleviating the
morbidity and mortality rates associated with cardiovascular disease. In recent years, the
applications of speckle-tracking echocardiography have expanded significantly (10, 15, 19, 23).
The sensitivity and specificity associated with strain imaging plays a crucial role in its increasingly
prevalent use. Numerous studies have demonstrated the predictive value of strain
echocardiography in terms of morbidity and mortality in the context of various cardiovascular
diseases, particularly when compared to the prognostic information provided by ejection fraction
alone (13). Although the ability of speckle-tracking to identify subclinical left ventricular
dysfunction in many disease states is becoming more recognized, there is a scarcity of information
on its potential to distinguish multiple insults via regional alterations. This study highlights the
abilities of segmental stress-strain to identify specific regions of the LV that undergo wall motion
abnormalities. Further, independent of diet, segmental stress-strain acts as a sensitive diagnostic
marker for mapping additional insults, such as chronic stress (UCMS).
In 2018, 34.2 million Americans over the age of 18, were diagnosed with type 2 diabetes
mellitus (T2DM). This number continuous to grow and affect younger populations as the rate of
individuals with high-fat diet induced obesity continuously increases (1). Cardiovascular disease,
is a major cause of mortality in patients with T2DM around the world, affecting about 32% of
those individuals (8). Detection of myocardial changes prior to overt dysfunction is therefore
critical in reducing the number of cardiovascular related deaths. Notably, wall motion
abnormalities can be detected prior to complications or changes in ejection fraction as previously
demonstrated on a cohort of T2DM patients, with normal ejection fractions (6). The study revealed
that conventional parameters could not detect LV dysfunction as early as global longitudinal strain
(GLS) could, which was calculated using speckle-tracking echocardiography. Similarly, a study
on obese children and adolescents without other comorbidities revealed that, although there were
no difference between the ejection fractions of the obese and non-obese groups, GLS correlated
negatively with body mass index (BMI) (3).
Furthermore, speckle-tracking echocardiography has been utilized to look at characteristic
changes that occur in type 1 diabetes mellitus (T1DM) as compared to the changes seen in T2DM
(14). The authors demonstrated that strain and strain rate parameters are valuable in describing the
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dynamic changes in contractility, active relaxation, and LV stiffness between T1DM and T2DM
animal models. Subclinical myocardial dysfunction can also be detected by speckle-tracking
echocardiography in T1DM patients as evidenced by several previous studies (18, 20, 25). A
previous study from our laboratory, performed on a T1DM animal model, assessed speckle
tracking stress-strain, particularly using segmental analysis in both the short and long axes.
Changes in myocardial strain were detected after only 1-week post diabetic onset, while
conventional measures and diastolic dysfunction were not seen until 6 weeks post diabetic-onset.
Segmental stress-strain analyses highlighted region-specific changes, specifically in the posterior
and free wall regions throughout T1DM progression (25), while our data suggest that the anterior
free and lateral walls are most significantly impacted with diet-induced obesity.
Although there has been a recent increase in literature relating to the usefulness of speckletracking echocardiography, there is a limited number of studies that investigate region specific
changes as they correlate to specific insults. Nevertheless, a recent study that investigated the
progression of T1DM in an animal model attempted to elucidate region specific changes after
discovering decreases in both GLS and GLS rate (18). This study is of great importance as it
verified segmental changes with MALDI-Imaging mass spectrometry. However, this study does
not demonstrate how this information is applicable in a clinical setting for promoting early
detection and intervention of cardiovascular diseases. Further, traditional statistical approaches are
limited in their ability to provide information regarding generalizability and predictive accuracy.
Zhang et. al., applied machine learning to speckle-tracking echocardiography features to create a
predictive model for coronary heart disease (30). This is one example of how stress-strain imaging
can play a pivotal role in the development of early detection screening tools using artificial
intelligence approaches, which continues to hold promising future clinical applications.
Our study explores the implications of multiple insults on cardiovascular health, though
we did not follow the animals for cardiovascular outcomes (i.e. stroke, heart failure, etc.). While
we acknowledge the importance of tangible, outcome-based assessments, both the protocols
involving diet-induced obesity (validated with body weight, LV mass, and ejection fraction) and
unpredictable chronic mild stress (UCMS) (validated previously, (16, 29)) included objective
standards. Additionally, the machine learning pipeline did not identify any regions within the
parasternal long axis as significantly contributing to the differentiation of obese from non-obese
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as well as UCMS from non-UCMS mice. The parasternal long axis view of the LV is perpendicular
to the transducer, making it the best angle for reflection of the ultrasound beam (17). This suggests
that the collection of longitudinal strain data should result in less noise and signal disturbance,
further heightening our conclusions that no substantial alterations are occurring within that axis.
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Conclusion
This is the first study to present speckle-tracking echocardiography as a tool for uniquely
“fingerprinting” multiple cardiovascular insults through segmental strain analysis. These insults
included intrinsic (diet-induced obesity) and extrinsic (chronic stress) stressors to cardiovascular
function that were correctly stratified using a combination of strain-based analyses with machine
learning algorithms. The data presented highlight how clinical applications should consider
evaluating if known contributors of cardiovascular dysfunction, such as diabetes, obesity, stress,
and others, have distinctive, regional patterns that can be identified using segmental strain-based
analyses. In this way, the multifaceted contribution leading to cardiovascular disease can be better
understood, and targeted interventions applied.
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Tables
Table 6.1 – M-Mode Parameters

Parameter

Baseline a

Lean b

Obese c

Heart Rate (BPM)

475.2 ± 16.57

581.1 ± 25.83 a

474.3 ± 21.43 b

Diameter; s (mm)

1.547 ± 0.073

1.166 ± 0.103 a

1.948 ± 0.101 a,b

Diameter; d (mm)

3.079 ± 0.067

2.823 ± 0.075

3.468 ± 0.098 a,b

Volume; s (µL)

7.997 ± 0.864

3.828 ± 0.727 a

13.41 ± 1.430 a,b

Volume; d (µL)

38.71 ± 1.960

31.06 ± 2.125

51.76 ± 3.156 a,b

Stroke Volume (µL)

30.71 ± 1.240

26.72 ± 1.316

38.35 ± 1.892 a,b

Ejection Fraction (%)

81.80 ± 1.323

88.33 ± 1.667 a

76.38 ± 1.743 a,b

Fractional Shortening (%)

50.88 ± 1.510

60.11 ± 2.708 a

45.32 ± 1.770 b

Cardiac Output (mL/min)

14.00 ± 0.497

15.12 ± 0.730

17.29 ± 0.853 a

LV Mass (mg)

109.8 ± 3.198

120.5 ± 4.632

150.7 ± 5.765 a,b

LVAW; s (mm)

1.717 ± 0.031

1.938 ± 0.046 a

1.858 ± 0.044 a

LVAW; d (mm)

1.051 ± 0.025

1.213 ± 0.031 a

1.186 ± 0.048 a

LVPW; s (mm)

1.378 ± 0.409

1.635 ± 0.058 a

1.401 ± 0.051 b

LVPW; d (mm)

0.969 ± 0.037

1.112 ± 0.054

1.051 ± 0.044
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Table 6.1: M-Mode assessments for the baseline (6-week-old) (N=48), lean (18-week-old)
(N=24), and obese (18-week-old) (N=24). Outliers were removed using a ROUT test, the
D’Agostino-Pearson omnibus (K2) test was implemented to determine normal distribution, and an
ANOVA/Tukey’s post hoc test (normally distributed) or Kruskal-Wallis test/Dunn’s post hoc test
(non-normally distributed) were used to determine significance. Results were considered statically
significant if P ≤ 0.05. All data are reported as the means ± the standard error of the mean (SEM).
a

= statistically different than the baseline group, b = statistically different than the lean group, s =

systolic, d = diastolic, LV = left ventricle, AW = anterior wall, PW = posterior wall.
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Table 6.2 – Pulse Wave (PW) Doppler

Parameter

Baseline a

Lean b

Obese c

AET (ms)

41.09 ± 0.948

31.30 ± 1.559 a

39.98 ± 1.444 b

IVCT (ms)

17.10 ± 1.096

11.28 ± 0.775 a

18.19 ± 0.691 b

IVRT (ms)

19.21 ± 0.509

20.31 ± 1.194

19.09 ± 0.641

MV A (mm/s)

395.6 ± 13.48

380.9 ± 16.22

333.0 ± 11.97 a

MV Decel (mm/s2)

-26523 ± 1067

-35276 ± 2315 a

-24536 ± 1190 b

MV Decel (ms)

22.93 ± 0.747

18.53 ± 0.769 a

24.78 ± 1.220 b

MV E (mm/s)

614.9 ± 18.43

659.5 ± 27.85

606.9 ± 19.71

NFT (ms)

77.77 ± 1.767

63.22 ± 1.525 a

76.60 ± 1.813 b

LV MPI IV

0.898 ± 0.030

1.094 ± 0.090

0.965 ± 0.053

LV MPI NFT

0.908 ± 0.032

1.107 ± 0.090

0.954 ± 0.055

MV Area (mm2)

35.12 ± 1.383

41.80 ± 2.110 a

32.41 ± 1.645 b

MV E/A

1.583 ± 0.037

1.768 ± 0.078

1.869 ± 0.088 a

MV PHT (ms)

6.649 ± 0.216

5.373 ± 0.223 a

7.186 ± 0.354 b
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Table 6.2: PW Doppler assessments for the baseline (6-week-old) (N=48), lean (18-week-old)
(N=24), and obese (18-week-old) (N=24). Outliers were removed using a ROUT test, the
D’Agostino-Pearson omnibus (K2) test was implemented to determine normal distribution, and an
ANOVA/Tukey’s post hoc test (normally distributed) or Kruskal-Wallis test/Dunn’s post hoc test
(non-normally distributed) were used to determine significance. Results were considered statically
significant if P ≤ 0.05. All data are reported as the means ± the standard error of the mean (SEM).
a

= statistically different than the baseline group, b = statistically different than the lean group, LV

= left ventricle, AET = aortic ejection time, MV = mitral valve, IVCT = isovolumetric contraction
time, IVRT, isovolumetric relaxation time, Decel = deceleration, MPI = myocardial performance
index, NFT = no flow time, PHT = pressure half-time.
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Figure 6.1: Experimental paradigm and body weights. (A) High-fat diet (HFD) feeding and
stress protocol: 6-weekold, male C57BL/6J mice were randomized into lean (N=24) and obese
(N=24) groups. Mice in the obese group underwent 12 weeks of diet induced obesity (DIO), while
the lean group consumed standard chow. At 18 weeks of age, mice in the lean and obese groups
were further randomized into unpredictable chronic mild stress (UCMS) (N=22) and non-UCMS
(N=22) groups to elicit a chronically stressed phenotype over an 8-week period. Echocardiography
was performed at baseline (6 weeks, N=48), post-diet (18 weeks, N=48), and post-stress (26 weeks,
N=44) time points. (B) Body weights in grams for each cohort. All comparisons are statistically
significant except for those labeled “ns”. The D’Agostino-Pearson omnibus (K2) test was
implemented to determine normal distribution, and an ANOVA/Tukey’s post hoc test (normally
distributed) was used to determine significance. Results were considered statically significant if P
≤ 0.05. All data are reported as the means ± the standard error of the mean (SEM). Ns = not
significantly different.
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Figure 6.2:
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Figure 6.2: Segmental strain and machine learning pipeline. (A) The LV in parasternal short
axis was segmented into six regions of interest: anterior free (AF), lateral (L), posterior (P), inferior
free (IF), posterior septum (PS), and anterior septum (AS). Additionally, (B) the LV in parasternal
long axis was segmented into six regions of interest: anterior base (AB), anterior mid (AM),
anterior apex (AA), posterior apex (PA), posterior mid (PM), and posterior base (PB). (C) Data
were imported and used to create a dataset containing segmental speckle tracking stress-strain, MMode, and Pulse Wave Doppler, that were then split (75% Training/Testing and 25% Hold-out
validation sets). A mixed supervised/unsupervised machine learning model was used through the
BigML platform that provided 10-cross validation models of the Training/Testing dataset. The top
3 models for each analysis were then fused to create a more holistic model. The data were evaluated
using the AUC generated from the hold-out dataset, as an indication of the accuracy of the model
for predicting the desired outcome (HFD or UCMS).
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Figure 6.3:
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Figure 6.3: Obese versus non-obese analyses. Features derived from M-mode, Pulse Wave (PW)
Doppler, and strain analyses were used in machine learning applications for non-obese (baseline
and lean, N=72) and obese (N=24) mice. Implementation of AutoML, model optimization, and
fusion model evaluation were performed. (A) ROC curves were graphed, and AUC scores
calculated. (B) Feature importance was determined using randomForest and evaluated based on
MeanDecreaseAccuracy. (C) The top five most important features are provided with their values.
Outliers were removed using a ROUT test, the D’Agostino-Pearson omnibus (K2) test was
implemented to determine normal distribution, and a two-sided unpaired Student’s t-test (normally
distributed) or Mann Whitney test (non-normally distributed) were used to determine significance.
Results were considered statically significant if P ≤ 0.05 and indicated by “*”. All data are reported
as the means ± the standard error of the mean (SEM). Post-Diet = post high-fat diet induced
obesity.
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Figure 6.4:
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Figure 6.4:
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Figure 6.4: UCMS versus non-UCMS analyses, irrespective of diet. Features derived from
strain analyses were used in machine learning applications for non-UCMS (N=22) and UCMS
(N=22) mice at 26 weeks. Implementation of AutoML, model optimization, and fusion model
evaluation were performed. (A) The ROC curve was graphed, and AUC score calculated. (B)
Feature

importance

was

determined

using

randomForest

and

evaluated

based

on

MeanDecreaseAccuracy. (C) The top five most important features are provided with their values.
(D) Heart rate variability (HRV) is also shown for comparison. Outliers were removed using a
ROUT test, the D’Agostino-Pearson omnibus (K2) test was implemented to determine normal
distribution, and a two-sided unpaired Student’s t-test (normally distributed) or Mann Whitney test
(non-normally distributed) were used to determine significance. Results were considered statically
significant if P ≤ 0.05 and indicated by “*”. All data are reported as the means ± the standard error
of the mean (SEM).
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Figure 6.5: Overview of regional impacts of diet-induced obesity (DIO) and unpredictable
chronic mild stress (UCMS). The (A) normal, (B) post-diet, and (C) post-stress segmental strain
profiles are shown. Green indicates baseline strain function for the indicated left ventricular (LV)
region. Bright red indicates a region identified as important by one or more of the top predictive
features that is also statistically significantly different. Dark red indicates a region identified as
important by one or more of the top predictive features, but that is not statistically significantly
different. RS = radial strain, RSR = radial strain rate, CS = circumferential strain. Post-Diet = post
high-fat diet induced obesity.
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Supplemental Tables
Supplemental Table 6.1 – Short-Axis Systolic Stress-Strain

Parameter

Units

Baseline a

Lean b

Obese c

NonUCMS d

UCMS

Radial Velocity

Pk
cm/s

1.663 ±
0.067

2.200 ±
0.094 a

1.680 ±
0.060 b

2.159 ±
0.120 a,c

2.285 ±
0.110 a,c

Radial Displacement

Pk
mm

0.398 ±
0.016

0.474 ±
0.014 a

0.313 ±
0.023 a,b

0.353 ±
0.029 b

0.395 ±
0.017

Radial Strain

Pk %

20.33 ±
1.279

25.55 ±
1.039 a

11.99 ±
1.334 a,b

17.29 ±
1.875 b,c

19.30 ±
1.043 c

Radial Strain Rate

Pk 1/s

8.561 ±
0.401

12.96 ±
0.491 a

8.019 ±
0.624 b

17.25 ±
3.183 a,c

17.86 ±
3.485 a,c

Circumferential
Velocity

Pk
deg/s

324.6 ±
20.31

607.2 ±
79.89 a

292.7 ±
24.17 b

489.0 ±
38.41 a,c

600.3 ±
71.32 a,c

Circumferential
Displacement

Pk deg

3.584 ±
0.363

6.055 ±
0.635 a

2.238 ±
0.419 b

6.263 ±
0.789 a,c

5.570 ±
0.840 c

Circumferential Strain

Pk %

-22.78 ±
1.255

-23.64 ±
1.151

-16.79 ±
0.956 a,b

-20.49 ±
1.982

-22.20 ±
1.788

Circumferential Strain
Rate

Pk 1/s

-13.83 ±
1.010

-17.24 ±
1.526

-12.16 ±
1.276

-20.29 ±
1.850 a,c

-21.12 ±
1.912 a,c
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Supplemental Table 6.1: Short-axis systolic stress-strain assessments for the baseline (6-weekold) (N=48), lean (18-week-old) (N=24), obese (18-week-old) (N=24), non-UCMS (26-week-old)
(N=24), UCMS (26-week-old) (N=24). Outliers were removed using a ROUT test, the
D’Agostino-Pearson omnibus (K2) test was implemented to determine normal distribution, and an
ANOVA/Tukey’s post hoc test (normally distributed) or Kruskal-Wallis test/Dunn’s post hoc test
(non-normally distributed) were used to determine significance. Results were considered statically
significant if P ≤ 0.05. All data are reported as the means ± the standard error of the mean (SEM).
a

= statistically different than the baseline group, b = statistically different than the lean group, c =

statistically different than the obese group,

d

= statistically different than the non-UCMS group.

Pk = peak, UCMS = unpredictable chronic mild stress.
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Supplemental Table 6.2 – Long-Axis Systolic Stress-Strain

Parameter

Units

Baseline a

Lean b

Obese c

Radial Velocity

Pk
cm/s

1.348 ±
0.064

1.952 ±
0.112 a

Radial Displacement

Pk
mm

0.297 ±
0.015

Radial Strain

Pk %

Radial Strain Rate

Non-UCMS
d

UCMS

1.557 ±
0.080

1.957 ±
0.129 a

1.965 ±
0.102 a

0.354 ±
0.022

0.255 ±
0.022 b

0.296 ±
0.026

0.336 ±
0.020

13.72 ±
0.938

15.06 ±
1.454

8.300 ±
1.161 a,b

11.31 ±
1.412

13.04 ±
1.140

Pk 1/s

7.184 ±
0.409

9.932 ±
0.6481 a

7.343 ±
0.507

12.34 ±
2.513 a

18.04 ±
6.371

Longitudinal
Velocity

Pk
deg/s

0.973 ±
0.063

0.851 ±
0.064

0.975 ±
0.082

1.327 ±
0.139 a,b

1.146 ±
0.098

Longitudinal
Displacement

Pk deg

0.120 ±
0.014

0.083 ±
0.013

0.091 ±
0.011

0.119 ±
0.015

0.120 ±
0.016

Longitudinal Strain

Pk %

-9.665 ±
0.714

-9.236 ±
1.040

-8.658 ±
0.870

-7.621 ±
1.229

-8.732 ±
1.063

Longitudinal Strain
Rate

Pk 1/s

-6.602 ±
0.355

-8.329 ±
0.611

-6.934 ±
0.612

-12.74 ±
1.384 a,b,c

-10.25 ±
1.207 a
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Supplemental Table 6.2: Long-axis systolic stress-strain assessments for the baseline (6-weekold) (N=48), lean (18-week-old) (N=24), obese (18-week-old) (N=24), non-UCMS (26-week-old)
(N=24), UCMS (26-week-old) (N=24). Outliers were removed using a ROUT test, the
D’Agostino-Pearson omnibus (K2) test was implemented to determine normal distribution, and an
ANOVA/Tukey’s post hoc test (normally distributed) or Kruskal-Wallis test/Dunn’s post hoc test
(non-normally distributed) were used to determine significance. Results were considered statically
significant if P ≤ 0.05. All data are reported as the means ± the standard error of the mean (SEM).
a

= statistically different than the baseline group, b = statistically different than the lean group, c =

statistically different than the obese group, d = statistically different than the non-UCMS group.
Pk = peak, UCMS = unpredictable chronic mild stress.
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Supplemental Figure 6.1:
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Supplemental Figure 6.1: Multicollinearity – Post-Diet. Features derived from M-mode, Pulse
Wave (PW) Doppler, and strain analyses were used in machine learning applications for non-obese
(baseline and lean, N=72) and obese (N=24) mice. Multicollinearity of features was assessed using
corrplot (v.0.90) to prevent data bias. Highly correlated variables were removed to eliminate the
possibility of impacting our machine learning algorithms.
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Supplemental Figure 6.2:
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Supplemental Figure 6.2:
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Supplemental Figure 6.2: Feature Importance Post-Diet M-Mode. Features derived from Mmode for non-obese (baseline and lean, N=72) and obese (N=24) mice. (A) Feature importance
was determined using randomForest and evaluated based on MeanDecreaseAccuracy. (B) The top
five most important features are provided with their values. Outliers were removed using a ROUT
test, the D’Agostino-Pearson omnibus (K2) test was implemented to determine normal
distribution, and a two-sided unpaired Student’s t-test (normally distributed) or Mann Whitney test
(non-normally distributed) were used to determine significance. Results were considered statically
significant if P ≤ 0.05 and indicated by “*”. All data are reported as the means ± the standard error
of the mean (SEM). Post-Diet = post high-fat diet induced obesity, LV = left ventricle.
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Supplemental Figure 6.3:
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Supplemental Figure 6.3: Feature Importance Post-Diet PW Doppler. Features derived from
Pulse Wave (PW) Doppler for non-obese (baseline and lean, N=72) and obese (N=24) mice. (A)
Feature

importance

was

determined

using

randomForest

and

evaluated

based

on

MeanDecreaseAccuracy. (B) The top five most important features are provided with their values.
Outliers were removed using a ROUT test, the D’Agostino-Pearson omnibus (K2) test was
implemented to determine normal distribution, and a two-sided unpaired Student’s t-test (normally
distributed) or Mann Whitney test (non-normally distributed) were used to determine significance.
Results were considered statically significant if P ≤ 0.05 and indicated by “*”. All data are reported
as the means ± the standard error of the mean (SEM). Post-Diet = post high-fat diet induced
obesity, MV = mitral valve.
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Supplemental Figure 6.4:
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Supplemental Figure 6.4B:
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Supplemental Figure 6.4: Feature Importance Post-Diet Stress-Strain. Features derived from
stress-strain analyses for non-obese (baseline and lean, N=72) and obese (N=24) mice. (A) Feature
importance was determined using randomForest and evaluated based on MeanDecreaseAccuracy.
(B) The top five most important features are provided with their values. Outliers were removed
using a ROUT test, the D’Agostino-Pearson omnibus (K2) test was implemented to determine
normal distribution, and a two-sided unpaired Student’s t-test (normally distributed) or Mann
Whitney test (non-normally distributed) were used to determine significance. Results were
considered statically significant if P ≤ 0.05 and indicated by “*”. All data are reported as the means
± the standard error of the mean (SEM). Post-Diet = post high-fat diet induced obesity.
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Supplemental Figure 6.5:
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Supplemental Figure 6.5: Multicollinearity – Post-Stress. Features derived from stress-strain
analyses were used in machine learning applications for non-UCMS (N=22) and UCMS (N=22)
mice at 26 weeks of age. Multicollinearity of features was assessed using corrplot (v.0.90) to
prevent data bias. Highly correlated variables were removed to eliminate the possibility of
impacting our machine learning algorithms.
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Curriculum Vitae
Amina Kunovac
ak0086@mix.wvu.edu

Education
DOCTOR OF PHIOLOSOPHY | AUGUST 2021 | WEST VIRGINIA UNIVERSITY
· Applied and Molecular Pathophysiology (Division of Exercise Physiology)
· Graduate Research Assistant: GPA – 3.87
· Graduate student member of the American Heart Association
· Member of the WVU Mitochondria, Metabolism & Bioenergetics Working Group
· Member of the WVU Center of Inhalation Toxicology
· Experiential Learning (1 Credit Hour): Online Review Course in Medical Genetics and Genetic
Counseling
· Morgantown, WV
BACHELOR OF SCIENCE | MAY 2016 | UNIVERSITY OF NEW HAVEN
· B.S. Biology - Pre-Med (Magna Cum Laude)
· B.S. Forensic Science - Forensic Biology (Magna Cum Laude); Minor: Chemistry
· Member of Alpha Lambda Delta National Honor Society
· Member of Honor Society for Experiential Education
· Resident Assistant
· West Haven, CT

Manuscripts (In Preparation/Under Review)
Synergistic Transcriptomic and Mitochondrial Function Alterations after Single and Repeated Carbon
Black and Ozone Inhalation Co-exposures.
Hathaway QA*, Majumder N*, Goldsmith WT, Kunovac A, Pinti MV, Harkema JR, Castranova V, Hollander
JM, Hussain S. Submitted to Particle and Fibre Toxicology: April 14, 2021.
Primary Sequence and Secondary Structure of Nuclear-Encoded Long Non-Coding RNAs Predict Binding
to Mitochondrial PNPase.
Hathaway QA, Taylor AD, Kunovac A, Pinti MV, Newman MS, Cook CC, Winters MT, Westemeier E, Fink
GK, Durr AJ, Shepherd DL, Robart AR, Martinez I, Hollander JM. Submitted to Journal of Biological
Chemistry: April 22, 2021.
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Genome-wide expression reveals potential biomarkers in breast cancer bone metastasis.
Singh Y, Subbarao N, Jamini A, Hathaway QA, Kunovac A, Erickson B, Swarup V, and Narayan Singh H. In
preparation.
Left Ventricular Segmental Stress-Strain Identifies Unique Myocardial Deformation Patterns Following
Intrinsic and Extrinsic Stressors in Mice.
Kunovac A, Hathaway QA, Burrage EN, Coblentz T, Kelley EE, Sengupta PP, Hollander JM, Chantler PD
Manuscript Under Review at Ultrasound in Medicine and Biology (Manuscript Number UMB-D-21-00654).
Submitted September 1, 2021.

Peer-Reviewed Publications
Enhanced Antioxidant Capacity Prevents Epitranscriptomic and Cardiac Alterations in Adult Offspring
Gestationally-Exposed to ENM.
Kunovac A, Hathaway QA, Pinti MV, Durr AJ, Taylor AD, Goldsmith WT, Garner KL, Nurkiewicz TR,
Hollander JM. Nanotoxicology. 2021 May 8:1-20. doi: 10.1080/17435390.2021.1921299. Online ahead of
print. PMID: 33969789
Cardiovascular Adaptations to Particle Inhalation Exposure: Molecular Mechanisms of the Toxicology.
Kunovac A, Hathaway QA, Pinti MV, Taylor AD, Hollander JM. Am J Physiol Heart Circ Physiol. 2020 Jun
12; 1;319(2):H282-H305. doi: 10.1152/ajpheart.00026.2020. PMID: 32559138
ROS Promote Epigenetic Remodeling and Cardiac Dysfunction in Offspring Following Maternal
Engineered Nanomaterial (ENM) Exposure.
Kunovac A, Hathaway QA, Pinti MV, Goldsmith WT, Durr AJ, Fink GK, Nurkiewicz TR, Hollander JM. Part
Fibre Toxicol. 2019 Jun 18;16(1):24. doi: 10.1186/s12989-019-0310-8. PMID: 31215478
Machine Learning, Diabetes Mellitus, and Cardiovascular Risk: A Personalized Medicine Approach to
Disease Diagnosis.
Hathaway QA, Roth SM, Pinti PV, Sprando DC, Kunovac A, Durr AJ, Cook CC, Fink GK, Cheuvront TB,
Grossman JH, Aljahli GA, Taylor AD, Giromini AP, Allen JL, Hollander JM. Cardiovascular Diabetology. 2019
June 11; 18(1):78. doi: 10.1186/s12933-019-0879-0. PMID: 31185988
miRNA-378a as a key regulator of cardiovascular health following engineered nanomaterial inhalation
exposure.
Hathaway QA, Durr AJ, Shepherd DL, Pinti MV, Brandebura AN, Nichols CE, Kunovac A, Goldsmith WT,
Friend SA, Abukabda AB, Fink GK, Nurkiewicz TR, Hollander JM. Nanotoxicology. 2019 Feb 1:1-20. doi:
10.1080/17435390.2019.1570372. PMID: 30704319
Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: An Organ-Based Analysis.
Pinti MV, Fink GK, Hathaway QA, Durr AJ, Kunovac A, Hollander JM. Am J Physiol Endocrinol Metab. 2019
Feb 1;316(2):E268-E285. doi: 10.1152/ajpendo.00314.2018. Epub 2019 Jan 2. PMID: 30601700
Mitochondrial proteome disruption in the diabetic heart through targeted epigenetic regulation at the
mitochondrial heat shock protein 70 (mtHsp70) nuclear locus.
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Shepherd DL*, Hathaway QA*, Nichols CE, Durr AJ, Pinti MV, Hughes KM, Kunovac A, Stine SM, Hollander
JM. J Mol Cell Cardiol. 2018 Jun;119:104-115. doi: 10.1016/j.yjmcc.2018.04.016. Epub 2018 May 4. PMID:
29733819
*These authors contributed equally

Relevant Skills and Techniques
Four years of experience designing and executing experiments involving a wide variety of molecular
biology techniques including, but not limited to: Microbiome-sequencing analysis, RNA-seq analysis,
Statistics, Bioinformatics, Genotyping, RT-qPCR, Animal Colony Maintenance, Western Blotting, ELISAs,
Gel Electrophoresis, Mitochondrial Isolations, Mitochondrial Bioenergetic Assays, Mitochondrial
Respiration, and Clinical Specimen Handling (including right atrial appendage).
Other skills and experiences include training in the following:
· Echocardiographic analyses on fetal and adult mouse hearts
· Data Science
· Grant writing
· Manuscript writing, editing, and preparing for publication
· Coordinating and collaborating with other laboratories
· Presenting at various conferences
· Training and teaching other graduate students (laboratory techniques, writing, and how to collaborate
with other laboratories)
· Didactic Teaching

Research Presentations
Experimental Biology (EB), Virtual: 2021
Poster Presentation, abstract entitled “Identifying Unique Patterns of Myocardial Deformation through
Segmental Speckle Tracking Stress Strain Following High-Fat Diet” (April 27-30, 2021)
Cardiopulmonary Physiology (EXPH 787) – Guest Lecturer – West Virginia University, Morgantown, WV:
2020
A 1-hour lecture how to perform speckle-tracking stress strain and conventional echocardiography and in
human and mouse cohorts and the applications of each modality (September 11, 2020)
NHLBI Mitochondrial Biology Symposium, Bethesda, MD: 2019
Poster presentation, abstract entitled “Antioxidant Protection Attenuates Cardiac and Mitochondrial
Dysfunction in Offspring Following Maternal Engineered Nanomaterial Exposure” (September 27, 2019)
Experimental Biology (EB), Orlando, FL: 2019
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Poster presentation, abstract entitled “Elevated ROS and Epigenetic Remodeling Disrupt Cardiac Function
in Offspring Following Maternal Engineered Nanomaterial (ENM) Exposure” (April 9, 2019)
West Virginia University, Van Liere Research Day, Morgantown, WV: 2019
Poster presentation entitled “Maternal Engineered Nanomaterial (ENM) Exposure Augments ROS Inciting
Epigenetic Remodeling and Cardiac Dysfunction in Offspring” (March 22, 2019)
West Virginia University Center for Inhalation Toxicology (iTOX), Morgantown, WV – WINTER MEETING.
Oral Presentation talk entitled “Maternal Engineered Nanomaterial (ENM) Exposure Augments ROS and
Epigenetic Remodeling Inciting Cardiac Dysfunction in Offspring” (November 28, 2018)

Honors and Distinctions
Outstanding Doctoral Student Award – Exercise Physiology
Background: Award bestowed on individuals in the Exercise Physiology doctoral program who exhibit
exemplary performance in academic and professional standards, such as publications, GPA,
collaborations, teaching, etc.
Awarded: May 15, 2021

American Heart Association Predoctoral Fellowship
Background: Two-year predoctoral award received for project entitled “Cardiac Epitranscriptomic and
Mitochondrial Remodeling in Progeny Following Maternal Engineered Nanomaterial Exposure”.
Awarded: January 31, 2020 – December 31, 2021

Mitochondria, Metabolism & Bioenergetics Working Group Travel Award – EB 2020
Background: Award designed to monetarily support conference registration costs for mitochondrial
research. The work presented included a poster presentation entitled “Glutathione Peroxidase Influence
on Cardiac Remodeling in Progeny of Dams Exposed to Engineered Nanomaterials During Gestation”
Awarded: February 3, 2020

WVU Center for Inhalation Toxicology (iTOX) Travel Award – SOT 2020
Background: Award designed to monetarily support toxicology research. The work presented included a
poster entitled “Transient and Sustained Antioxidant Protection in Progeny Following Gestational
Engineered Nanomaterial Inhalation Exposure”.
Awarded: February 11, 2020

Peer-Reviewed Accepted Abstracts
IDENTIFYING UNIQUE PATTERNS OF MYOCARDIAL DEFORMATION THROUGH SEGMENTAL SPECKLE
TRACKING STRESS STRAIN FOLLOWING HIGH-FAT DIET
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Kunovac A, Burrage EN, Coblentz T, Kelley EE, Sengupta PP, Hollander JM, Hathaway QA, Chantler PD. –
Experimental Biology (EB), Virtual: 2021
MODELLING THE PULMONARY TRANSCRIPTOME IN A DOSE AND SUBSTRATE-DEPENDENT MANNER:
CARBON BLACK AND OZONE CO-EXPOSURE
Hathaway QA, Majumder N, Kunovac A, Xie Z, Pinti MV, Harkema JR, Nurkiewicz TR, Hollander JM, and
Hussain S. – Society of Toxicology (SOT), Virtual: 2021
GLUTATHIONE PEROXIDASE INFLUENCE ON CARDIAC REMODELING IN PROGENY OF DAMS EXPOSED TO
ENGINEERED NANOMATERIALS DURING GESTATION
Kunovac A, Hathaway QA, Taylor AD, Durr AJ, Goldsmith WT, Pinti MV, Fink GK, Nurkiewicz TR, and
Hollander JM. – Experimental Biology (EB), San Diego, CA: 2020
MICRORNA-378A LOSS ENHANCES MITOCHONDRIAL BIOENERGETICS AND LESSENS CARDIAC
CONTRACTILE DYSFUNCTION IN THE TYPE 2 DIABETIC HEART
Durr AJ, Hathaway QA, Kunovac A, Taylor AD, Pinti MV, McLaughlin SL, Shepherd DL, Singh AK, and
Hollander JM. – Experimental Biology (EB), San Diego, CA: 2020
LOSS OF FUNCTIONAL NON-CODING RNA DIVERSITY IN DIABETIC CARDIAC MITOCHONDRIA
Taylor AD, Hathaway QA, Kunovac A, Pinti MV, Cook CC, Fink GK, Durr AJ, and Hollander JM. –
Experimental Biology (EB), San Diego, CA: 2020
TRANSIENT AND SUSTAINED ANTIOXIDANT PROTECTION IN PROGENY FOLLOWING GESTATIONAL
ENGINEERED NANOMATERIAL INHALATION EXPOSURE
Kunovac A, Hathaway QA, Taylor AD, Pinti MV, Goldsmith WT, Fink GK, Durr AJ, Nurkiewicz TR, and
Hollander JM. - Society of Toxicology (SOT), Anaheim, CA: 2020
ANTIOXIDANT PROTECTION ATTENUATES CARDIAC AND MITOCHONDRIAL DYSFUNCTION IN
OFFSPRING FOLLOWING MATERIAL ENGINEERED NANOMATERIAL EXPOSURE
Kunovac A, Hathaway QA, Durr AJ, Goldsmith WT, Taylor AD, Pinti MV, Fink GK, Nurkiewicz TR, and
Hollander JM. – NHLBI Mitochondrial Biology Symposium, Bethesda, MD: 2019
APPLYING MACHINE-LEARNING TO DISEASE DIAGNOSIS THROUGH PATIENT-MATCHED OMICS
PROFILES
Hathaway QA, Roth SM, Pinti, MV, Sprando DC, Kunovac A, Durr AJ, Cook CC, Fink GK, Cheuvront TB,
Grossman JH, Aljahli GA, Taylor AD, Giromini AP, Allen JL, and Hollander JM. – NHLBI Mitochondrial Biology
Symposium, Bethesda, MD: 2019
LOSS OF MICRORNA-378A FUNCTION RESTORES MITOCHONDRIAL BIOENERGETICS IN A TYPE 2
DIABETIC MOUSE MODEL
Durr AJ, Hathaway QA, Taylor AD, Kunovac A, Pinti MV, Shepherd DL, Fink GK, and Hollander JM. – NHLBI
Mitochondrial Biology Symposium, Bethesda, MD: 2019
IMPACT OF DIABETES MELLITUS ON MITOCHONDRIAL MIRNA DIVERSITY AND RELATED CELLULAR
PATHWAYS
Taylor AD, Hathaway QA, Kunovac A, Pinti MV, Cook CC, Fink GK, Durr AJ, Shepherd DL, Robart AR, and
Hollander JM. – NHLBI Mitochondrial Biology Symposium, Bethesda, MD: 2019
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ELEVATED ROS AND EPIGENETIC REMODELING DISRUPT CARDIAC FUNCTION IN OFFSPRING
FOLLOWING MATERNAL ENGINEERED NANOMATERIAL (ENM) EXPOSURE
Kunovac A, Hathaway QA, Pinti MV, Durr AJ, Fink GK, Goldsmith WT, Nurkiewicz TR, and Hollander JM. –
Experimental Biology (EB), Orlando, FL: 2019
USING MACHINE LEARNING TO PREDICT THE DEVELOPMENT OF DIABETES AND POTENTIAL
BIOMARKERS LINKED TO CARDIAC RISK
Hathaway QA, Pinti MV, Roth SM, Sprando DC, Kunovac A, Durr AJ, Cook CC, Fink GK, Cheuvront TB,
Grossman JH, Aljahli GA, Roberts HG, Salman M, Giromini AP, and Hollander JM. – Experimental Biology
(EB), Orlando, FL: 2019
MICRORNA CHANGES IN DIABETIC CARDIAC MITOCHONDRIA: WHAT ARE THEY DOING THERE?
Pinti MV, Hathaway QA, Kunovac A, Durr AJ, Cook CC, Roberts HG, Salman M, and Hollander JM. –
Experimental Biology (EB), Orlando, FL: 2019
STRESS STRAIN SPECKLE-TACKING SEGMENTAL ANALYSIS REVEALS EARLY INDICATIONS OF DIASTOLIC
DYSFUNCTION IN A TYPE 2 MOUSE MODEL OF DIABETES MELLITUS
Durr AJ, Hathaway QA, Pinti MV, Shepherd DL, Kunovac A, and Hollander JM. – Experimental Biology (EB),
Orlando, FL: 2019
MATERNAL ENGINEERED NANOMATERIAL (ENM) EXPOSURE AUGMENTS ROS INCITING EPIGENETIC
REMODELING AND CARDIAC DYSFUNCTION IN OFFSPRING
Kunovac A, Hathaway QA, Pinti MV, Fink GK, Goldsmith WT, Durr AJ, Nurkiewicz TR, and Hollander JM. –
West Virginia University Van Liere, Morgantown, WV: 2019

Mentorship
West Virginia University | Graduate Research Assistant | January 2017 – Current
•

Summer Students
Dylan Holland (2019) – Medical school summer research rotation
o Currently: Medical student class of 2022 at West Virginia University

•

Undergraduate Students
Matt Knauff (Fall 2019 – Present) – Undergraduate part-time research
o Currently: Undergraduate student in Exercise Physiology
Garrett Fink (Spring 2018 – Present) – Undergraduate part-time research
o Currently: Undergraduate student in Exercise Physiology

•

Research Rotations
Joseph Agba (Fall 2019) – Graduate research rotations
o Currently: Undifferentiated graduate student in the Biomedical Sciences program
Andrew Giromini (Fall 2018) – Graduate research rotations
o Currently: Undifferentiated graduate student in the Biomedical Sciences program

•

Graduate Students

327

Saira Rizwan (Fall 2020-Present)-Graduate research rotations
Currently: Graduate Research Assistant for Dr. John Hollander, West Virginian University,
Department of Exercise Physiology

o

Andrew Taylor (Fall 2018-Present) – Graduate research rotations
Currently: Graduate Research Assistant for Dr. John Hollander, West Virginian University,
Department of Exercise Physiology

o

Community Outreach and Volunteer Work
Smokey Mountain Home for Children – Severiville, TN | Greene Valley Church of God | July 2018
•

7-day trip to volunteer at a home for foster children and neglected youth. Approximately 50-80
children living at the facility, with a widow’s center housing 30-40 women.

•

Work included painting, sanding, cleaning, drywall work, remodeling, moving furniture and
equipment, etc.

•

Outreach activities included talking and interacting with the youth through sports and while
working within the living quarters.
Volunteer, Yale New Haven Hospital -Children’s Surgical Unit– New Haven, CT | 2013-2015
Provided help and human connection necessary to ease the stress of the patients going through difficult
times.

Undergraduate Work Experience
Forensic Science Study Abroad Program-Chaperone - July 2016
• Assisted in coordinating a trip to Sydney, Australia and the University of Technology, Sydney-Bodies
Farm.
Resident Assistant - Office of Residential Life, University of New Haven - 2013-2016
• Develop community between 70 residents through creative programming while implementing
University policies
Resident Assistant - Forensic Science Living Learning Community-Office of Residential Life, University of
New Haven
2014-2015
• Developed community between 40 residents by creating programs involving Forensic Science topics
to introduce first-year Forensic Science students to possible career paths, while also implementing
University policies.

Undergraduate Honors and Distinctions
Inductee of the Honor Society for Experiential Education-Gold Level
April 2016
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Summer Undergraduate Research Fellow
Summer 2015
Inductee of Alpha Lambda Delta Honor Society
Spring 2013
Dean’s List, University of New Haven
2012-2016
Distinguished Scholar Award ($12,000 per academic year)
2012-2016
SAT Writing Award ($1,000 per academic year)
2012-2016

Language
Fluent
English
Written and Spoken
Bosnian
Written and Spoken
Croatian
Written and Spoken
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